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ABSTRACT 
 
In this work, hydrophilic fluorene-based derivatives that contain ethylene oxide 
substituents, have been synthesized and characterized for potential use as new fluorophores for 
bioimaging applications and for fluorescence sensing of heavy metals. Symmetrical and 
unsymmetrical fluorene derivatives based on structural types of acceptor-π-acceptor, acceptor-π-
donor, and donor-π-donor were characterized by TGA, UV-vis absorption, fluorescence 
emission, lifetime, anisotropy, and two-photon absorption (2PA) cross section. They were found 
to possess high thermal stability, high photostability, high fluorescence quantum yields, and 
generally large two-photon absorption cross sections, making them quite suitable for new probes 
in single-photon absorption and two-photon absorption fluorescence microscopy imaging. 
Novel hydrophilic fluorene derivatives were synthesized from fluorene in multiple steps 
employing the metal-catalyzed Heck coupling reaction, the Stille reaction, the Sonogashira 
reaction, the Ullmann condensation reaction, and “click” chemistry. To increase the 
hydrophilicity of the new compounds, ethylene oxide substituents were utilized for to impart 
water solubility. An alternative alkylation methodology using ethyleneoxy tosylates was 
introduced for the synthesis of ethylene oxide-containing fluorene derivatives. Several of these 
hydrophilic derivatives were incubated into various cell lines as new probes for both 
conventional and two-photon absorption fluorescence bioimaging. These compounds were 
biocompatible, exhibiting low cytotoxicity as determined by cell viability studies, and displayed 
colocalization for selected cellular organelles. 
  iv 
In addition, hydrophilic bis(1,2,3-triazolyl)fluorene derivatives were found to exhibit 
sensitive fluorescence responses in the presence of certain heavy metal, and were selective for 
sensing zinc and mercury over other a number of other metal ions relevant to living cells or other 
biological environments. The UV-vis absorption and fluorescence emission spectra of the 
complexes exhibited a blue-shifted absorption and emission for selective metal chelation upon 
binding to zinc and mercury(II) ions, resulting in an approximately two-fold enhanced 
fluorescence response. Fluorescence titration studies revealed that the complexes of 1:2 and 1:3 
ligand to metal formed with binding constant values of 108 and 1014 for zinc and mercury ions, 
respectively.  
Finally, preliminary experiments were performed to explore the possibility of employing 
select hydrophilic fluorene-based derivatives in the synthesis of hydrophilic fluorescent gold 
nanoparticles. Although results are very preliminary, the aim is to use such materials for other 
biomedical applications, such as surface enhanced scattering resonance and noninvasive 
photothermal therapy to diagnose and to treat cancers.  
Thus, this research had led to the discovery of alternative methodologies for synthesis of 
hydrophilic fluorene derivatives by alkylation with alkyl tosylates and synthesis of hydrophilic 
fluorescent molecule capped gold nanoparticles. Furthermore, several novel hydrophilic 
fluorene-based derivatives were synthesized and characterized for their linear and nonlinear 
photophysical properties, and are now available for further examination of their bioimaging and 
sensing applications. 
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CHAPTER ONE: INTRODUCTION 
 
1.1. The Goal of This Research 
 
 The ultimate goal of this research is to design, synthesis, and characterize hydrophilic 
fluorene-based derivatives as new two-photon absorbing molecules for bioimaging and 
sensing applications. From the recent literature, one can see that fluorene derivatives have 
significant potential for use as multiphoton absorbing fluorescent probes relative to other 
classes of organic molecules.1-3 Hydrophilic fluorene-based derivatives, containing 
polyethylene glycol substituents for solubility in aqueous media in the cellular environment, 
are desired for their high quantum yield, large two-photon absorption (2PA) cross sections, 
and suitability for nondestructive imaging for biological studies. On the other hand, the 
design of novel fluorene-based derivatives that sense and detect heavy metal ions like zinc4-9 
and mercury10-13 are intriguing for important biological and environmental applications. In 
addition, the design and synthesis of hydrophilic fluorene-based derivatives for complexing 
with gold nanoparticles may be of interest for several biomedical applications, including the 
diagnosis and treatment of cancerous cells,14,15 and for noninvasive photothermal therapy.16-18 
Hence, the aim of the research in this dissertation is also to explore hydrophilic fluorene-
based derivatives as new bioimaging agents in conventional confocal and two-photon 
fluorescence microscopy. 
1.2. Single-Photon Absorption and Two-Photon Absorption 
 
 In general, matter absorbs and, in some cases, emits light upon irradiation. 
Fluorescence emission occurs at a longer wavelength relative to the linear absorption 
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wavelength. Some natural minerals, such as calcite and willemite, fluorescence upon UV-vis 
light irradiation. Traces of certain transition metals contribute to this fluorescence. Since the 
16th century, this phenomenon was observed in the family Leguminosae of the tropical 
hardwood narra tree (Pterocarpus indicus), which is native to Philippine and the Mexican 
kidneywood shrub (Eysenhardtia polysastachya). Isoflavones were identified as the pigments 
responsible for a striking blue fluorescence when the wood was placed into water and 
irradiated. This fluorescent solution has been proposed for medicinal treatment for liver and 
kidney ailments.19  
Recently, a natural auto fluorescent chromophore of the Green Fluorescence Protein 
(GFP) was isolated from the Pacific Northwest jellyfish (Aequorea victoria) by Shimonura in 
1960, while the chromophore structure was elucidated in the 1980s (Fig. 1).20  
HO
N N
O
R'
R
 
Figure 1. Structure of the GFP Chromophore. 
 
In Figure 1, R and R’ are amino acid sequences (part of a large protein, typically >200 amino 
acids). The GFP chromophore emits a greenish light with a quantum yield of 0.8, and has 
gained wide spread use as a fluorescent marker for in vitro and in vivo imaging in cell 
biology. However, a synthetic GFP chromophore analog, where R and R’ were a propyl and 
methyl group, respectively, displayed a quantum yield of only 0.01, far too low for any 
practical bioimaging applications. This may be due to free rotation of the phenolic ring 
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adjacent to the C=C, quenching the fluorescence in this molecule. This highlights the 
sophistication and complexity of nature and factors contributing to fluorescence emission. 
A Jablonski electronic energy diagram (Fig. 2) illustrates fluorescence emission upon 
light irradiation.21  
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Figure 2. The Jablonski Electronic Excitation Energy Diagram. 
 
Here S0, S1, and S2 are ground state, first excited state, and second excited state, respectively; 
T1 is the first triplet state. Fluorescence results in emission of a photon upon radiative 
deactivation of the S1 to S0 state, while phosphorescence results in emission upon 
deactivation of T1 to S0. The lifetime of the excited state S1 is typically 10-7-10-10 s; 
intersystem crossing (ISC) is 10-10-10-4 s; internal conversion (IC) is 10-11-10-9 s; and the 
lifetime of the excited state T1 is 10-4-1 s. 
A simple one-photon absorption process is presented in Figure 3.  
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Figure 3. One-photon Absorption. 
 
Two-photon absorption, a process of simultaneous absorption of two photons upon 
light excitation, is depicted in Figure 4. 
 
light irradiation
hν
S0
S1
hν
 
Figure 4. Two-photon Absorption. 
 
Two-photon absorption was predicted by Goppert-Meyer22 in 1931. However, it was only 
applied for practice in the 1990s for two-photon excitation fluorescence microscopy.23-29 The 
introduction of multiphoton fluorescence excitation has shown tremendous advantage over 
one-photon fluorescence excitation in terms of three-dimensional localization in the focal 
volume of a laser beam and in greater penetration in tissues and cells, such as 1 mm for live 
imaging (Fig. 5).  
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Light Light
Confocal Microscopy 2PT Microscopy  
Figure 5. Confocal Microscopy and Two-photon Fluorescence Microscopy. 
 
Moreover, because multiphoton excitation occurs at a longer wavelength (in the visible and 
near-IR region), as the result, photodamage to the object (cell imaging) is lessened in 
comparison with one-photon excitation (i.e., excited by a shorter wavelength, typically in the 
UV region). Two-photon fluorescence excitation has been employed in the detection of 
biomolecules for enhancing sensitivity and selectivity.30,31 
1.3. Design of Multiphoton Absorbing Materials 
 
 Recently, development of new multiphoton absorbing materials with larger two-
photon cross sections has received attention for bioimaging applications32,33 and for 
photodynamic therapy.34 Some important photophysical properties for a new molecule are 
the absorption and emission range (UV-vis or near-IR), the quantum yield, the lifetime, the 
photostability (photobleaching), and the two-photon absorption (2PA) cross section. In 
general, a molecule for multiphoton absorption consists of a core chromophore (π-electron 
bridge) along with donor (electron-releasing) and/or acceptor (electron-withdrawing) groups 
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linked by a conjugated π-system. A sp-hybridized carbon conjugated π-system makes a 
molecule more rigid as the triple bond has fixed rotation.35 Design of the first type 
(symmetrical) “pull-pull” or “push-push” of molecule involves a quadrupolar construct 
containing electron donor or acceptor groups to change the molecular quadrupole moment 
based on the concept that the symmetric charge transfer of a conjugated system upon 
excitation enhances values of 2PA cross sections.36 The second type (asymmetrical) “push-
pull” molecule is dipolar or octupolar, with the concept that the charge transfer between a 
donor and an acceptor upon excitation and accounts for a larger 2PA cross section.37-39 
Recently, a computational approach based on the molecular orbital theory40,41 of the excited 
state HOMO-LUMO gap has been used to assist in the design of a new class of organic 
molecules.42-44 A high extent of π-conjugation reduced the value of the band gap, e.g., a 
small band gap (ΔEg = 1 eV) was found for polyacetylene (Table 1).45 
Table 1. The HOMO-LUMO Gap of Some Organic Molecules 
 
Compound ΔEg (eV) Color 
Naphthalene 4.8 White 
Anthracene 3.6 White 
Perylene 3.0 Yellow 
Tetracene 2.8 Orange 
Naphthacene 2.8 Orange 
Pentacene 2.2 Orange Red 
β-Carotene 1.8 Orange Red 
Polyacetylene 1.0 Red/Blue 
 
1.4. Fluorene-based Derivatives as New Fluorophores 
 
As shown in previous work, fluorene derivatives are generally known as fluorophores 
that exhibit high quantum yields, high photostability, excellent thermal stability, and large 
multiphotons absorption cross sections relative to other organic materials.46-50 Fluorene 
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derivatives can be functionalized with a variety of substituents of acceptor (A) and donor (D) 
at carbons 2 and/or 7 (X and Y), and hydrophobic or hydrophilic groups (R) at carbon 9. A 
typical A-π-D motif is shown (Fig. 6). 
 
 
 
 
Figure 6. Fluorene-based Derivatives as Fluorophores. 
 
Here X is an acceptor such as a benzothiazole, a 1,2,3-triazole, a cyano, or a nitro, while Y is 
a donor like a diphenylamino or a hydroxy moiety; and R is an alkyl or an ethylene oxide 
substituent, thereby tailoring the molecule’s solubility. 
Fluorene-based derivatives also exhibit low cytotoxicity in relative to other organic 
chromophores. However, because fluorene-based derivatives, like other hydrophobic organic 
molecules, have limited solubility in polar solvents such as methanol or aqueous media, there 
is a need for hydrophilic fluorene-based derivatives that are soluble in aqueous media, such 
as that in human body or cells, and suitable for various bioimaging applications. 
1.5. Hydrophilic versus Hydrophobic Derivatives 
 
 Since aqueous media is used for bioimaging, to increase the hydrophilicity of 
fluorene-based derivative, a polar group such as a carboxylic acid (CO2H), an alcohol or 
phenol (ROH), or a sulfonic acid (SO3H) can be utilized as a substituent. However, 
polyethylene glycol (PEG) is also known for its water soluble,51 biocompatibility52,53 low 
cellular toxicity54, and is approval by the U. S. F.D.A. for human use. PEG was employed for 
RR
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C4 C5
C6
C8C9
C10
C11 C12
C13 C7
Y (Donor)(Acceptor) X
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bioconjugation of certain liposomes to increase its circulation time.55 It is logical that 
fluorene-based derivatives should contain polyethylene glycol substituents to improve their 
water solubility for a number of biological applications. Moreover, the hydrophilicity of 
fluorene-based molecules is greatly increase by the number of ethylene oxide unit 
substituents. If the ethylene oxide unit substituents are large enough, the molecule may be 
completely soluble in water.  
1.6. The Role of Heavy Metals in Biological Studies 
 
 Heavy metal ions can disturb normal biological functions and evoke cellular stress 
responses at high levels (0.01 ppm) in the cellular environment.56,57 Among the heavy metal 
ions, zinc is the second most abundant heavy metal ion in vivo and is an essential component 
of many protein scaffolds and enzymes in cells.58,59 The human body contains approximately 
3000 zinc-proteins;60 and the zinc ion was recognized as a main mineral nutrition for cells by 
the work of Rauline on the fungus Aspergillus niger.61,62 Zinc is a major regulatory ion in a 
number of ion channels and receptors, in neural signal transmission, in metalloenzyme 
regulation, and in the metallobolism of cells, exhibiting a binding constant of 3.2 x 1013 M-1 
for zinc metallothionein (Fig. 7).63-65  
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Figure 7. The Metabolism of Zinc. 
 
Zinc also plays an important role in various biological processes, such as suppressing 
apoptosis, and in neurophysiology, such as inducing the formation and aggregation of β-
amyloid that is related to Alzheimer’s disease.66 A high concentration of Zn2+ is known to be 
a neurotoxin, and excess zinc in the brain has been implicated in neuropathology. Zinc 
release contributes to hypoglycemia-induced neuronal death.67 A zinc sensing molecule is 
quite important for biological studies and for disease diagnosis.68  
On a similar note, mercury is a nonessential heavy metal that is highly toxic to cells.69 
It is known that mercury is a severe neurotoxic, genotoxic, and immunotoxic species in 
mammals. Mercury has been found to reduce the chlorophyll content in the leaves of plants.70 
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Furthermore, mercury can induce aberrations in microtubules, ion channels, and 
mitochondria.71 Hence, methods for the sensitive and selective detection of mercury are a 
matter of great interest. 
1.7. Design of Fluorescence Sensing Molecules for Metal Ion Detection 
 
Design of a molecule for sensing of heavy metal ions, such as zinc in vivo or mercury 
in contaminated sources, involves high selectivity for zinc or mercury over other relevant 
metal ions. Since the Zn2+ ion is inert with a closed shell of 3d10 in its electronic 
configuration, fluorometric methods have been employed as a technique of choice to detect 
zinc ions for various applications.72-74 New fluorescent sensing molecules for metal ion 
detection should have high affinity, bind rapidly and reversibly, be nontoxic with high 
fluorescence quantum yield, and high photostability. To date, zinc ion sensing molecules 
employed aryl sulfonamides of 8-aminoquinoline,75 fluoresceins,76-78 porphyrin-based 
derivatives,79 and calix[4]arene.80 Calixarene, a macrocylic molecule of obligophenols linked 
by methylene bridges, was introduced recently as a sensing agent for various heavy metal 
ions.81 Current mercury sensing molecules employed include rhodamine-based,82 fluorescein-
based,83,84 a perylene derivative,85 calyx[4]arenediazacrown ether,86 and porphyrine-based 
dyes.87 Few of these were designed for two-photon excitation and many have limited 
photostability. 
In addition to zinc and mercury, cadmium and lead are contaminants that can alter the 
immune response of organisms at level of 10 ppb.88,89 Silver, which is employed in dental 
and medical materials, can induce cellular signaling at high levels.90 A calixarene-based 
molecule was also utilized to detect silver ions.91 Since multiphoton microscopy was 
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introduced and possesses a number of significant advantages over single-photon excitation, 
new metal ion sensing molecules which utilized an aza-crown ether linkage was reported that 
exhibited a large 2PA cross sections, though the synthetic complexity of this system is high 
and little is known about its photostability.92 Thus, new metal sensing 2PA fluorescent 
probes are needed. Designing of fluoroionophore is consisted a chromophore, a spacer of 
hydrocarbon, a binding group usually a nitrogen-heterocyclic or crown ether moiety (Fig. 8). 
The fluorescence can be enhanced or quenched upon binding to metal. 
SpacerChromophore Binding Group
 
Figure 8. A Conceptual Design of Chromoionophore 
1.8. Fluorene-based Derivatives for Fluorescence Sensing of Metal Ions 
 
As demonstrated in previous studies, fluorene derivatives are known for good 
photophysical properties, high luminescence quantum yields, large 2PA cross sections, and 
excellent photostability.93 Hydrophilic fluorene-based derivatives that are soluble in aqueous 
media as new fluorescent metal ion sensors for selected metal ions, such as zinc and mercury, 
are potentially quite important for biological and environmental sensing applications. This 
research detailed herein reports the investigation of three hydrophilic fluorene-based 
derivatives for highly selective sensing of significant heavy metal ions.  
1.9. Gold Nanoparticles in Biomedical Application 
 
Gold colloid and gold nanoparticles were studied extensively since the 1850s for 
 
new optical materials.94-96 Recently, gold nanoparticles are shown low toxicity materials  
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that can be used for bioimaging studies97 and for noninvasive phototherapy.98 Fluorene- 
 
based derivatives that contain gold nanoparticles can be explored for new bioimaging  
 
probes and for diagnostic of treatment of cancers. 
 
1.10. Design of Fluorescent Gold Nanoparticles as a Bioimaging Agent 
 
Cancer has been a major cause of death in the 21st century. By definition, cancer is 
the uncontrolled growth of cells with loss of differentiation which, upon metastasis, spreads 
to other tissues and organs. As a result, cancer can be life threatening to the body and must be 
treated. Cancer phototherapy and photothermal therapy use light irradiations to kill cancerous 
cells. A bioimaging agent is also used to stain or to incubate cells during the process of 
cancer treatment. The design of new molecules for diagnostic bioimaging or cancer treatment 
is intriguing for a number of biomedical applications. Figure 9 illustrates the concept for a 
fluorescent gold nanoparticle-based probe that contains a chromophore, such as a fluorene 
derivative, a spacer, such as hydrophobic hydrocarbon chain, and binding groups, like thiol 
moieties, to which gold nanoparticles can be linked.  
 
 
 
Figure 9. Design of Fluorescent Molecule Capped Gold Nanoparticles. 
 
New bioimaging materials such as hydrophilic fluorene-based capped gold 
nanoparticles may serve as new therapeutic probes, particularly since gold nanoparticles have 
been employed in photothermal therapy as a promising solution.99 Herein is reported 
preliminary experiments to design such a composite material. 
S
S AuNPsSpacer
Chromophore
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CHAPTER TWO: RESULTS AND DISCUSSION 
 
2.1. Hydrophilic Fluorene-based Derivatives for Bioimaging 
 
 The goal of this work was to synthesize a series of novel hydrophilic fluorene-based 
derivatives for bioimaging applications, and perform comprehensive molecula and 
photophysical characterization of the new compounds. The structure of symmetrical and 
unsymmetrical fluorene-based derivatives was varied by use of (a) donor and acceptor 
groups, (b) sp-hybridized carbon and sp2-hybridized carbon conjugated π-systems, and (c) 
the number of ethylene oxide units in substituents. 
2.1.1. Synthesis of Hydrophilic Fluorene-based Derivatives 
 
Fluorene-based derivatives were synthesized containing the following structural 
motifs: acceptor-π-acceptor 6a, 6b (Scheme 1), acceptor-π-donor 8a, 8b, 9a (Scheme 4), 9b-
d (Scheme 5), 8e-g (Scheme 7), 10 (Scheme 8), 8i (Scheme 9), and donor-π-donor 5e, 5f, 7g 
(Scheme 11).  
2.1.1.1. Synthesis of Acceptor-π-Acceptor Fluorene-based Derivatives 
In Scheme 1, fluorene 1 was iodinated to produce 2,7-diiodofluorene 2a in 70% yield 
using iodine (0.8 molar eq) and iodic acid in acetic acid at 70 0C. In general, the iodination of 
fluorene by iodine and iodic acid can yield 2-iodofluorene (Eq. 3) and 2,7-diiodofluorene 
(Eq. 4), depending on the molar stoichiometry ratios of fluorene, iodine, and iodic acid. In 
this reaction, iodic acid was used as an oxidant to form [I+] species100 (Eq. 1) which the 
aromatic ring (nucleophile) attacked, affording a substitution product (Eq. 2). 
Equation 1 
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                                        2I2 + HIO3 + 5H+   ↔  5[I+] + 3H2O                                         (1) 
Equation 2 
                                                  Ar-H + I+  ↔  Ar-I + H+                                                  (2) 
Equation 3 
                                   5C13H10 + 2I2 + HIO3 + 5H+  ↔  5C13H9I + 3H2O                        (3) 
Equation 4 
                             5C13H10 + 4I2 + 2HIO3 + 10H+  ↔  5C13H8I2 + 6H2O                         (4) 
The resulting product 2a was identical to literature reports upon comparison of the mp and 
the NMR spectroscopic data.101 A method for the alkylation of fluorene derivatives can 
utilize tosylates of polyethylene glycol, synthesized from commercial reagents, as a good 
leaving group (Fig. 9).102  
H -OH
H
S O
O
O
R
KOH
+H3C +
R RH R
YX X Y X Y
-TsOK  
 
Figure 10. The Mechanism of Reaction of Fluorene Derivative with Alkyl Tosylate. 
 
Compound 2a underwent alkylation with 2-(2-ethoxy ethoxy)ethyl-1-(4-
methylbenzenesulfonate) 3a and 2-(2-(2-(2-ethoxy ethoxy)ethoxy)ethoxy)methyl-1-(4-
methylbenzenesulfonate) 3b (Scheme 2) in DMSO at room temperature to obtain compounds 
4a and 4b in 55 and 40 % yield, respectively. Compounds 3a and 3b were synthesized in 95 
and 90 % yields, respectively, utilizing a nucleophilic substitution reaction of 2-(2-ethoxy 
ethoxy)ethanol and tetraethylene glycol methyl ether with 4-methylbenzenesulfonyl chloride 
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in pyridine at 5 0C for a period of 3 h. The NMR spectra of compounds 3a and 3b were 
identical to those reported in the literature.103,104 Compound 6a was synthesized in 68 % yield 
by the Sonogashira cross-coupling reaction (Appendix B1) of compound 4a with compound 
5a.105,106 The 1H NMR spectrum of compound 6a showed signals at 8, 7.8, and 7.3 δ whose 
integration represent a total of 22 aromatic protons. Compound 5a (Scheme 3) was 
synthesized from a condensation reaction of 4-iodobenzoic acid with 2-amino thiophenol to 
form the first intermediate, 2-(4-iodophenyl)benzothiazole. This was then transformed to a 
second intermediate 2-(4-(1-trimethylsilyl)ethynylphenyl)benzothiazole by the Sonogashira 
reaction with trimethylsilylacetylene in THF in 75 % yield. Finally, this was hydrolyzed in 
80 % yield with a solution of 5 % potassium hydroxide in methanol at room temperature for 
30 min. The mp of compound 5a was identical to the literature value.107 The 1H NMR 
spectrum of compound 5a showed a signal at 3.4 δ for a terminal alkyne. The 13C NMR 
spectrum of compound 6a showed signals at 90 and 92.5 ppm for sp-carbons in this 
molecule. The HRMS analysis of compounds 5a and 6a gave molecular ions at 235.0449 and 
864.3049, respectively, which were consistent with the formulas of C15H19NS and 
C55H48O4N2S2. Compound 6b was synthesized in 60 % yield via Heck coupling reaction108 
(Appendix B2) of compound 4b with 2-(4-ethenylphenyl)benzothiazole 5b, which was 
synthesized from a procedure reported in the literature.46 Signals were present in compound 
6b at 7.4, 7.8, and 8 δ which integrated for a total of 26 aromatic protons. The HRMS 
analysis of compound 6b confirmed the molecular ion at 1017.4177 for the formula 
C61H64O8N2S2.  
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Scheme 1. Synthesis of Acceptor-π-Acceptor Derivatives 6a and 6b 
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Scheme 2. Synthesis of 3a-c 
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Scheme 3. Synthesis of 5a. 
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2.1.1.2. Synthesis of Acceptor-π-Donor Fluorene-based Derivatives 
 
Scheme 4 shows the formation of 2-iodofluorene 2b, prepared in 78 % yield by 
monoiodination of fluorene using 0.4 molar eq of iodine (Eq. 3). The mp and the NMR 
spectrum of compound 2b were identical upon comparison with the values from the 
literature.109 Alkylation of compound 2b with 2-(2-ethoxy ethoxy)ethyl tosylate 3a was 
conducted to obtain 2-iodo-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 4c in 60 % yield. 
Nitration then led to 2-iodo-7-nitro-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 5c in 50 % yield. 
Heck coupling reaction of compound 5c with 5b resulted in compound 6c in 60 % yield. 6c 
was then reduced with hydrazine on 10 % Pd/C in a mixture of ethanol and THF at 70 0C to 
obtain compound 7a in 95 % yield. Alkylation of compound 7a with ethyl bromoacetate in 
DMF yielded compound 8a in 75 % yield. Finally, compound 8b was synthesized in 62 % 
yield by an Ullmann condensation reaction of 7a with iodobenzene.110 The 1H NMR 
spectrum of compound 8a showed signals at 4.21 and 1.26 δ resulting in an integration 
representing a total of 8 protons (ethoxy groups and amino methylene groups) and 6 protons 
of two ethoxy moieties in this molecule. The 13C NMR spectrum of compound 8a showed a 
signal at 170.86 ppm corresponding to ester carbons. Signals were present at 6.6, 7, 7.3, 7.5, 
and 8.0 δ which were integrated for a total of 26 aromatic protons in 8b. The HRMS of 
compounds 8a and 8b confirmed molecular ions at 821.383 and 801.3821 for the 
corresponding formulas C48H56O8N2S and C52H52O4N2S, respectively. Finally, compound 9a 
was obtained in 40 % yield by a hydrolysis reaction of compound 8a with sodium hydroxide 
in methanol at 70 0C. The MS of 9a a signal at 764 for a molecular ion of a formula of 
C44H48O8N2S. 
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Scheme 4. Synthesis of Acceptor-π-Donor Derivatives 8a, 8b, and 9a 
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 Scheme 5 illustrates that bis(1,2,3-triazolyl) fluorene derivatives 9b-d were 
synthesized from 7a and 7b by “click” chemistry, a cycloaddition reaction of an alkyne and 
an azide (Appendix B3).111-114 Click reactions are more practical and reliable for large 
thermodynamic driving forces of greater than 20 Kcal.mol-1.115-117 Compounds 7a and 7b 
underwent alkylation with propargyl bromide in DMF at 95 0C to obtain compounds 8c and 
8d, respectively. Click reactions of compounds 8c and 8d with 1-azidobutane and 1-azido-11-
undecanethiol (Scheme 5), utilizing a copper(I) catalyst, gave compounds 9b, 9c, and 9d in 
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72, 65, and 60 % yields, respectively. 1-Azidobutane was prepared by a nucleophilic 
substitution reaction of 1-bromobutane with sodium azide in DMSO at 95 0C for 24 h. The 
NMR spectrum of 1-azidobutane was identical to a literature report.118 Likewise, 1-azido-11-
undecanethiol was synthesized in 80 % overall yield from 1-bromo-11-undecanol in 3 steps 
(Scheme 6). The first step was a nucleophilic substitution reaction of 1-bromo-11-undecanol 
with sodium azide at 80 0C in acetonitrile for 20 h, yielding the first intermediate1-azido-1-
undecanol in 97% yield. This intermediate was reacted with 4-methylbenzenesulfonyl 
chloride in pyridine at 5 0C for 3 h to yield the second intermediate, 1-azido-11-undecanyl 
tosylate, in 92 % yield. Lastly, a nucleophilic substitution reaction of the tosylate with 
thiourea at 70 0C for 10 h, followed by hydrolysis with sodium hydroxide at 100 0C led to 1-
azido-11-undecanethiol. The NMR data of 1-azido-11- undecanethiol were also identical 
with values from the literature.119 
Scheme 5. Synthesis of Acceptor-π-Donor Derivatives 9b-d 
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Scheme 6. Synthesis of 1-Azido-11-Undecanethiol 
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Compounds 8e-g were synthesized in Scheme 7. First, compound 8e was prepared in 
3 steps from the Sonogashira coupling reaction of 5c with 5a at room temperature to obtain 
6e in 78 % yield, and then it was reduced by hydrazine on 10 % Pd/C to obtain 7c in 90 % 
yield. Compound 7c underwent alkylation and amine arylation with propargyl bromide and 
iodobenzene, respectively, to obtain 8e and 8f in 70 and 67 % yields, respectively. The 1H 
NMR spectrum of 8e showed signals at 6.9, 7.3, 7.9, and 8.0 δ which were integrated for a 
total of 14 aromatic protons. Signals were present at 4.13 and 2.68 δ which integrated 
corresponding to 4 aminomethylene protons and 2 alkyne protons, respectively, in 8f. In 
addition, the 13C NMR spectrum of compound 8f showed signals at 78.96 and 73.1 ppm 
which were consistent with the propargyl functionality in this molecule. The HRMS analysis 
of 8e and 8f gave molecular ions at 722.3172 and 798.03485, respectively, which consistent 
with formulas C46H46O4N2S and C52H50O4N2S, respectively. Compound 6f was synthesized 
in 60 % yield from the Stille reaction (Appendix B4) of compound 5c with (2-tri-n-
butylstannyl)benzothiazole (which was prepared according to the literature).110 Likewise, 7d 
was synthesized in 85 % yield by reduction of 6f with hydrazine on 10 % Pd/C in a mixture 
of ethanol and THF at 70 0C. Finally, compound 8g was synthesized in 60 % yield from the 
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Ullmann condensation reaction of 7d with 4-iodoanisole. The 1H NMR spectrum of 8g 
showed signals at 3.8, 6.9, 7.1, 7.4, 7.5, 7.9, and 8.1 δ that were integrated for a total of 6 
methoxy protons and 18 aromatic protons, respectively. The HRMS analysis of 8g gave a 
molecular ion at 758.3383, consistent with the formula C46H50O6N2S. 
Scheme 7. Synthesis of Acceptor-π-Donor Derivatives 8e-g 
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Fluorene-based derivative 10, with the acceptor-π-donor archetype (Scheme 8), was 
synthesized in 5 steps from 2-iodo-7-nitro-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 5c. The 
first step involved the Sonogashira reaction of 5c with trimethylsilylacetylene at room 
temperature for 12 h, resulting in 6g in 70 % yield, which was then hydrolyzed with 
potassium hydroxide to obtain 7e in 90 % yield. Click chemistry was then utilized to 
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synthesize 8h in 80 % yield from a click reaction of 7e with azidobenzene in dioxane, using 
copper(I) iodide catalyst at room temperature for 24 h. The 13C NMR spectrum of 7e showed 
a signal at 148 ppm for the presence of a carbon in the new 1,2,3-triazole moiety. 
Azidobenzene was synthesized from phenylhydrazine by utilizing a procedure reported by 
Lindsay and Allen.120 The IR spectrum of azidobenzene showed a strong absorption band at 
2125 cm-1 for an azide functionality. The NMR spectra of azidobenzene were identical upon 
comparison with the NMR data reported in the literature.121 Compound 9e was synthesized in 
90% yield via reduction of 8h with hydrazine on 10 % Pd/C at 70 0C. Finally, 10 was 
synthesized in 60 % yield by the Ullmann condensation reaction of 9e with iodobenzene in 
1,2-dichlorobenzene at 180 0C for 24 h. The 1H NMR spectrum of 10 had signals at 7.03, 
7.25, and 7.75 δ which were integrated for a total of 22 aromatic protons. The HRMS 
analysis of 10 gave a molecular ion at 708.3669, consistent with the formula C45H48N4O4. 
Scheme 8. Synthesis of Acceptor-π-Donor Derivative 10 
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Compound 8i (Scheme 9) was prepared in 4 steps from 2-iodofluorene 2b. The first 
step involved bromination of 2b with N-bromosuccinimide in propylene carbonate at 80 0C 
to obtain 2-iodo-7-bromofluorene 3d in 80 % yield. The bromoiodofluorene was alkylated 
with 3a to obtain 2-iodo-7-bromo-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 4e in 60 % yield. 
The mp and the NMR spectrum of compound 3d to literature values.122 The last steps 
involved the Sonogashira reactions of 4e consecutively with 5a and 7f, affording 8i in 31 % 
overall yield. Compound 6h was synthesized from 5a by a Sonogashira cross-coupling 
reaction selective for an iodoarene due to its higher reactivity versus bromoarene (the 
dissociation energy of C-I and C-Br bonds are 65 and 81 Kcal.mol-1 respectively).123 4-
Ethynyl-N,N-dimethylbenzenamine (7f, Scheme 10) was synthesized from an iodination 
reaction of N,N-dimethylaniline with iodine in aqueous sodium bicarbonate solution124 to 
obtain intermediate 4-iodo-N,N-dimethylbenzenamine in 70 % yield. 4-Iodo-N,N-
dimethylbenzenamine was reacted with trimethylsilylacetylene using PdCl2(PPh3) and CuI as 
catalysts125 to obtain a second intermediate, 4-(2-trimethylsilylethynyl)-N,N-
dimethylbenzenamine, in 70 % yield. Finally, the later product was hydrolyzed with a 
solution of potassium hydroxide, producing compound 7f in 80 % yield. The NMR spectra of 
7f were identical with the literature.126 The 1H NMR spectrum of 8i showed signals at 6.7, 
7.4, 7.8, and 8.1 δ which were integrated for a total of 18 aromatic protons. The 13C NMR 
spectrum of compound 8i showed signals at 92 and 88.1 ppm which were consistent with the 
presence of two sp-carbons in the new molecule. The HRMS analysis of compound 8i gave a 
molecular ion at 774.3485 for a formula of C50H50O4N2S. 
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Scheme 9. Synthesis of Acceptor-π-Donor Derivative 8i 
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Scheme 10. Synthesis of 7f 
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2.1.1.3. Synthesis of Donor-π-Donor Fluorene-based Derivatives 
Fluorene-based derivatives structural type donor-π-donor compounds 5e, 5f, and 7g 
(Scheme 11) were also synthesized. First, 5e was prepared in 72 % yield from the 
Sonogashira reaction of 4f with 4-ethynyl-N,N-dimethylbenzenamine 7f catalyzed by 
dichlorobis(triphenylphosphine)palladium(II) in THF at room temperature. The 1H NMR 
spectrum of 5e showed signals 7.4 and 6.7 δ which were integrated for a total of 14 aromatic 
protons. The 13C NMR spectrum of 5e revealed signals at 91.46, 88.08, and 51.12 ppm, 
assignable to two alkyne carbons and an amimo carbon, respectively. The HRMS analysis of 
5e gave a molecular ion at 1361.7881 for a formula of C75H112O20N2. Compound 5f was 
synthesized in 62 % yield from the Ullmann condensation of 4a with diphenylamine at 180 
0C for 24 h. The 1H NMR spectrum of 5f showed signals at 7, 7.2, and 7.5 δ which were 
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integrated for a total of 26 aromatic protons. The HRMS analysis of compound 5f gave a 
molecular ion at 732.3960, consistent with the formula C49H52O4N2. Finally, 7g was 
synthesized in 3 steps from 4a. The first step involved the Sonogashira coupling reaction of 
4a with trimethylsilylacetylene to obtain intermediate 5g in 75 % yield. Hydrolyzed of 5g 
resulted in a second intermediate 6i in 95 % yield. Lastly, a second Sonogashira reaction of 
6h with 4-iodophenol produced 7g in 58 % yield. The IR spectrum of 7g showed a broad 
absorption at 3273 cm-1 for phenolic moieties. The 1H NMR spectrum of 7g showed signals 
at 6.84 and 7.27 δ which were integrated for a total of 14 aromatic protons. The HRMS 
analysis of 7g gave a molecular ion at 630.2975 which was consistent with a formula of 
C41H42O6. Bis-phenol derivative 7g has pK1 =10.6 and pK2 =11.6, determined by a 
spectrophotometric method and calculated by the Henderson-Hasselbalch equation.127,128 This 
compound has a high quantum yield value (φFl = 0.95) for the phenolic neutral form (at pH 
<10). However, the anionic form of its phenolate anion (at pH = 11 and above) was 
nonfluorescence (φFl = 0) which can be further investigated for its fluorescent sensing of pH 
at basic media. 
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Scheme 11. Synthesis of Donor-π-Donor Derivatives 5e, 5f, and 7g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.1.4. Synthesis of Fluorescent Gold Nanoparticles 
 
 Scheme 12 shows that 11a and 11b were synthesized from reactions of 9b and 9c 
with gold nanoparticles. First, gold nanoparticles were synthesized according to the 
literature,95 then reacted with 9b and 9c to yield hybrid composites 11a and 11b, respectively. 
Scheme 12. Synthesis of Fluorescent Gold Nanoparticles 
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2.1.2. Thermogravimetric Analysis  
 
 The new hydrophilic fluorene-based derivatives generally displayed high 
thermostabilities (Figs. 11 - 24). In general, fluorene-based dervatives decomposed at 
temperatures above 300 0C with a low percentage weight loss (< 5 %). For example, 6b and 
8b (Figs. 13 and 15) exhibited a very high decomposition temperature (above 400 0C). A sp-
hybridized carbon conjugated π-system was relatively less percentage weight loss than its 
analog of a sp2-hybridized carbon conjugated π-system (Figs. 13, 15, 16). A higher number 
of ethylene oxide units in the substituents had slightly lower thermostability than is 
hydrocarbon analogs (Fig. 23). 
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Figure 11. The TGA of 5e. 
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Figure 12. The TGA of 5f. 
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Figure 13. The TGA of 6a and 6b. 
 
100 200 300 400 500 600 700
50
60
70
80
90
100
% 
We
igh
t
Temperature (C)
 Compound 7g
 
 
Figure 14. The TGA of 7g. 
100 200 300 400 500 600
0
20
40
60
80
100
% 
We
igh
t
Temperature (C)
 Compound 8f
100 200 300 400 500 600
0
20
40
60
80
100
 Compound 8b
 
Figure 15. The TGA of 8b and 8f. 
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Figure 16. The TGA of 8c and 8e. 
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Figure 17. The TGA of 8a. 
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Figure 18. The TGA of 8c and 8d. 
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Figure 19. The TGA of 8g. 
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Figure 20. The TGA of 8i. 
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Figure 21. The TGA of 9a. 
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Figure 22. The TGA of 9b. 
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Figure 23. The TGA of 9c and 9d. 
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Figure 24. The TGA of 10. 
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2.1.3. Linear Photophysical Characterization of Hydrophilic Fluorene-based Derivatives 
 
2.1.3.1. Ethylene Oxide Unit Substituents Effect on Solubility 
 In general, the hydrophilicity of new fluorene-based derivatives increases when a 
larger number of ethylene oxide units are present in the molecules. For example, by 
introduction of diethylene oxide units (n = 2) into fluorene-based derivatives make them 
soluble in polar organic solvents like ethyl acetate. However, tetraethylene oxide substituents 
(n = 4, 6b) gave good solubility only in highly polar organic solvents like THF, DMSO, and 
in alcohols. A higher degree of polyethylene oxide unit substitution (n = 10) gave water 
soluble molecules (5e and 9d). 
2.1.3.2. Photostability of Hydrophilic Fluorene-based Derivatives 
Photodecomposition analysis (ФD) of fluorene-based derivatives was determined by 
the absorption method utilizing linear (one-photon) excitation at 405 nm, and calculated 
according to the literature.129 In general, a sp-hybridized carbon conjugated π-system has 
value one order of magnitude smaller photodecomposition quantum yield (i.e., is one order of 
magnitude more photostable) in comparison to its sp2-hybridized conjugated π-system analog 
(Table 1). 
2.1.3.3. UV-vis Absorption and Fluorescence Emission of Fluorene-based Derivatives 
UV-vis absorption and fluorescence emission spectra of hydrophilic fluorene-based 
derivatives were recorded (Figs. 25 - 41). As expected, dipolar derivatives displayed a larger 
Stokes shift when the polarity of solvent increased compared to quadrupolar derivatives. A 
red shift was observed for the UV-vis absorption and fluorescence emission of hydrophilic 
fluorene-based derivatives when the conjugated π-system in the molecules increased. 
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However, a sp2-hybridized carbon conjugated π-system had a slight bathochromic shift (15-
25 nm) relative to its sp-hybridized conjugated π-system analog (Tables 2 and 3). This could 
be due to its electronic delocalization in triple bond is weaker than its analog of the double 
bond respectively. 
2.1.3.4. Quantum Yield of Hydrophilic Fluorene-based Derivatives 
The fluorescence quantum yields130 of hydrophilic fluorene-based derivatives in THF, 
toluene, and DMSO were determined and tabulated (Tables 2 and 3). The UV-vis absorption 
and fluorescence emission of compounds 6a and 6b, 8b and 8f, 8c, and 8e showed a blue-
shift both in absorption and emission for sp-hybridized carbon conjugated π-system analogs 
vs. sp2-hybridized carbon conjugated π-system analogs. 
Table 2. Linear Photophysical Characterization of Fluorene-based Derivatives in THF 
 
Solvent Tetrahydrofuran 
Compound φFl ФD.105 τ (ns) ε.10-4 λab λem ∆λ 
5e 0.75 3.6 1.27 9.8 386 460 74 
5f 0.80 1.1 1.10 5.1 376 399 23 
6a 0.95 0.35 0.71 10.3 381 405 24 
6b 0.95 2.7 0.95 14 407 449 42 
7g 0.95 1.7 0.82 10a 357 407 50 
8a 0.50 7.6 2.01 6.0 403 537 134 
8b 0.53 4.9 2.21 5.4 397 562 165 
8c 0.57 7.7 1.97 6.2 397 545 148 
8d 0.55 4.5 1.98 6.1 396 546 150 
8e 0.50 0.41 2.14 9 379 535 156 
8f 0.80 0.76 2.58 10 391 530 139 
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8g 0.85 5 3.38 4.8 409 545 136 
8i 0.30 0.24 1.32 10.5 385 539 154 
9a 0.20 32 2.06 4.7 401 589 188 
9b 0.40 2.4 2.24 5.8 409 568 159 
9c 0.43 7.3 2.29 4.8 408 570 162 
9d 0.35 3.7 2.28 4.8 409 575 166 
10 0.85 0.61 1.70 3.6 368 422 54 
a: ε = 97000 M-1.cm-1, λab =  357 nm , λem =  411 nm in acetonitrile 
 
 
Table 3. Linear Photophysical Characterizations of Fluorene-based Derivatives in Toluene 
and DMSO 
 
Solvent Toluene Dimethyl Sulfoxide 
Compound φFl ΦD.105 ε.10-4 λab λem ∆λ φFl λab λem ∆λ 
5e 0.95 3.3 8.4 381 422 41 0.89a 386 525 139 
5f 0.66 0.28 6.0 379 398 19 0.85 374 402 28 
6a 0.95 0.18 8.6 376 411 35 0.95 382 443 61 
6b 0.95 6.77 12 407 478 71 0.95 414 492 78 
7g 0.96 4.61 8.0b 357 403 46 0.92 363 419 56 
8a 0.95 23.4 5.1 403 490 87 0.55 407 631 224 
8b 0.95 8.4 5.7 393 485 92 0.68 390 621 231 
8c 0.95 22.4 5.0 396 489 93 0.25 393 623 230 
8d 0.95 32 5.2 397 491 94 0.30 395 621 226 
8e 0.95 3.3 5.8 377 459 82 0.60 385 615 230 
8f 0.95 0.12 5.5 389 463 74 0.71 389 616 227 
8g 0.95 0.90 4.0 408 491 83 0.90 409 600 191 
8i 0.95 0.76 9.9 386 459 73 0.35 389 578 189 
9a 0.95 64 3.6 388 477 89 0.30 390 555 165 
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9b 0.92 1.15 5.4 408 501 93 0.62 418 655 237 
9c 0.93 1.54 5.2 407 504 97 0.60 415 650 235 
9d 0.95 1.13 5.1 407 505 98 0.61 417 651 234 
10 0.82 0.71 3.4 371 401 30 0.30 367 439 72 
a: φ = 0.43, λab = 382 nm, λem = 516 nm in water. b: ε = 85000 M-1.cm-1, λab = 357 nm  ,λem = 423 
nm in MeOH. 
 
 
2.1.3.5. Anisotropy of Fluorene-based Derivatives 
 
 Fluorescence anisotropy analysis of hydrophilic fluorene-based derivatives aided in 
assigning various electronic transitions, e.g., corresponding to transition from the ground 
state (S0) to the first excited state (S1), and are shown in Figs. 25 - 41. The hydrophilic 
fluorene-based derivatives typically displayed values of anisotropy from 0.30 - 0.35 at 
λabmax. 
2.1.4. Nonlinear Optical Properties of Hydrophilic Fluorene-based Derivatives 
 
Two-photon absorption cross sections of hydrophilic fluorene-based derivatives with 
acceptor-π-acceptor, acceptor-π-donor, and donor-π-donor archetypes were determined, 
generally by a femtosecond two-photon upconverted fluorescence technique (Figs. 25-41). 
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Figure 25. Normalized Absorbance, Emission, Anisotropy, and 2PA of 6a in THF. 
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Figure 26. Normalized Absorbance, Emission, Anisotropy, and 2PA of 6b in THF. 
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Figure 27. Normalized Absorbance, Emission, Anisotropy, and 2PA of 5f in THF. 
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Figure 28. Normalized Absorbance, Emission, Anisotropy, and 2PA of 7g in THF. 
OO
2
2
OH
7g
HO
OO
2
2
NN
5f
  38 
 
 
 
 
 
300 400 500 600 700
0.0
0.2
0.4
0.6
0.8
1.0
No
rm
ali
ze
d A
bs
or
ba
nc
e, 
Em
iss
ion
, A
nis
otr
op
y
Wavelength (nm)
 Absorption 5e
 Emission 5e
 Anisotropy 5e
300 400 500 600 700
0
300
600
900
1200
1500
1800
 Wavelength/2 (nm)
 2P
A,
 δ 
(G
M)
 2PA 5e
   Solvent: THF
 
Figure 29. Normalized Absorbance, Emission, Anisotropy, and 2PA of 5e in THF. 
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Figure 30. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8a in Toluene. 
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Figure 31. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8b in Toluene. 
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Figure 32. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8c in Toluene. 
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Figure 33. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8e in Toluene. 
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Figure 34. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8f in Toluene. 
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Figure 35. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8g in Toluene. 
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Figure 36. Normalized Absorbance, Emission, Anisotropy, and 2PA of 8i in Toluene. 
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Figure 37. Normalized Absorbance, Emission, Anisotropy, and 2PA of 9a in THF. 
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Figure 38. Normalized Absorbance, Emission, Anisotropy, and 2PA of 9b in THF. 
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Figure 39. Normalized Absorbance, Emission, Anisotropy, and 2PA of 9c in THF. 
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Figure 40. Normalized Absorbance, Emission, Anisotropy, and 2PA of 9d in THF. 
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Figure 41. Normalized Absorbance, Emission, Anisotropy, and 2PA of 10 in THF. 
 
2.1.4.1. The Strength of Donor and Acceptor Groups 
Linear and nonlinear absorption properties of hydrophilic fluorene derivatives, 
possessing different electron donor and acceptor groups, were compared. A 1,2,3-triazole 
moiety in 10 is a weak acceptor (Fig. 41) while a hydroxy moiety is a relatively strong donor 
(Fig. 28), showing an increase in the fluorescence quantum yield. Moreover, an increase the 
strength of a donor, such as a methoxy substituent in compound 8g, contributed to the red 
shift of its UV-vis absorption and fluorescence emission spectra, and also resulted in an 
increased 2PA cross section (Fig. 35). 
2.1.4.2. Quadrupolar versus Dipolar Molecules 
Quadrupolar fluorene-based derivatives displayed a greater value of 2PA near the 
visible region (Figs. 25 and 26), however, dipolar fluorene-based derivatives exhibited a  
O
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greater 2PA at longer wavelengths in the near-IR region (Figs. 30, 35 - 40). 
2.1.4.3. Sp-hybridized Carbon Conjugated π-System vs Sp2-hybridized Carbon Conjugated  
 
π-System  
 
An extended conjugated π-system of a fluorene-based derivative exhibited red shifted 
UV-vis absorption and fluorescence emission spectra relative to shorter conjugation analogs, 
and an increase in the 2PA cross section values, e.g., 8b and 8e vs. 5f and 10 (Figs. 31 and 33 
vs. Figs. 27 and 41). For dipolar molecules, such as 8b and 8f (Figs. 31 and 34) or 8c and 8e 
(Figs. 32 and 33), there were little differences in the 2PA cross sections value of a sp2-
hybridized carbon conjugated π-system in comparison to its analogous sp-hybridized carbon 
conjugated π-system. For molecules of high symmetry, this is likely due to the fact that 2PA 
is forbidden at low energy (long wavelength) while it is allowed at higher energy. In 
addition, dipolar molecules often have low-energy charge-transfer transitions that result in 
2PA in normally two-photon forbidden (one-photon allowed) transitions. 
For quadrupolar molecules, such as 6a and 6b (Figs. 26 and 27), a higher value of the 
2PA cross section for a sp2-hybridized carbon conjugated π-system vs. its sp-hybridized 
carbon conjugated π-system analog was observed. This may be due to a large contribution of 
2PA cross sections from the charge transfer (CT) and change in the quadrupole moment that 
enhances the corresponding transition dipole moments in the excited state upon 
photoexcitation.131,132 It is likely that an alkene-π-bridge may enables a higher polarizability 
or hyperpolariability density since the double bond is longer than the triple bond (1.3 Å vs. 
1.2 Å), hence greater electronic delocolization and extent of charge transfer transition 
towards the second-order response to increase its 2PA cross sections.133,134  
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A figure of merit, FM, that accounts not only for the 2PA cross section and 
fluorescence quantum yield but, importantly, for the compound’s photostability (i.e., 
photodecomposition quantum yield) is defined in Eq. 5.  The FM values for several fluorene 
derivatives are presented in Table 4, along with values for Rhodamine B and Rhodamine 6G 
(see notes under the table). 
Equation 5 
                                                              
D
FlPA
MF Φ
=
φδ 2                                                            (5) 
Table 4. Two-photon Absorption Cross Sections and Figure of Merit of Hydrophilic 
Fluorene-based Derivatives in THF/Toluene 
 
Solvent THF Solvent Toluene 
Compound 
λex (nm) δ (GM) a,bFM.10-6 
Compound 
λex δ FM.10-6 
5e 690 1507 31.4 8a 690 357 1.5 
820 48 1 800 211 0.9 
5f 740 10 0.7 8b 690 208 2.4 
6a 690 579 157 820 75 0.8 
820 11 3 8c 690 409 1.7 
6b 690 1799 63.3 800 195 0.8 
820 94 3.3 8e 690 143 4.1 
7g 710 59 3.3 780 117 3.4 
9a 820 306 0.2 8f 700 170 130 
9b 800 342 5.7 820 255c 195 
9c 750 124 0.7 8g 690 85 8.9 
820 406 2.4 840 180 18.9 
9d 820 390 3.7 8i 690 749 93.6 
10 710 39 5.4 820 125 15.6 
a: Rhodamine B: δ2PA max = 263 GM at 700 nm; φFl = 0.40 in methanol135; ΦD (532nm) = 
8x10-7; FM = 130x106. b: Rhodamine 6G: δ 2PA max = 132 GM at 700 nm; φFl = 0.94 in 
methanol; ΦD (532 nm) = 1.3x10-6; FM = 95x106. c: δ = 260 GM by Z-scan method136 
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2.1.5. Cell Imaging with Select Hydrophilic Fluorene-based Probes 
 
Figures 42 - 45 show images of HTC 116 cells incubated with 20 μM solution of 
probes 5e, 6a, 8b, and 10 for 1 h. All images were collected at 60 x using an oil immersion 
objective with index-matching oil. Differential Interference Constrast (DIC) images were 
exposed for 400 ms; single-photon fluorescence images were exposed for 150 ms; 2-photon 
fluorescence was excited at 700 nm; and 3D images were obtained by overlaying of a series 
of X-Y plane two-photon fluorescence images. 
The images of HTC 116 cells incubated with probe 5e (Fig. 42, grids are 5 μm in the 
lower right image) showed the dye 5e entered the cells with ease as the cell exhibited good 
morphology. Indeed, cell viability experiments were conducted with high concentrations of 
the dyes (up to 50 μM), a concentration higher than that required for imaging. However, cells 
were found alive for several hours without changing their morphology.  
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Figure 42. The Images of the HTC 116 Cells Incubated Probe 5e. 
 
The images of the HTC 116 cells incubated with probe 6a (Fig. 43, grids are 5 μm in the 
lower right image) illustrate that probe 6a penetrated peripheries of the cellular membranes 
with a certain degree of localization in certain organelles. 
 
 
 
 
 
 
 
 
OO
10
10
5e
N
N
  49 
 
 
 
 
 
 
 
 
Figure 43. The Images of the HTC 116 Cells Incubated Probe 6a. 
 
The images of HTC 116 cells incubated with probe 8b (Fig. 44, grids are 5 μm in the lower 
right image) showed that probe 8b preferred peripheries of cellular membranes and exhibited 
a lesser degree of localization in certain organelles. 
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Figure 44. The Images of the HTC 116 Cells Incubated Probe 8b. 
 
The images of HTC 116 cells incubated probe 8i (Fig. 45), where the scale bars are 10 μm 
(lower left and upper right) and the grids are 5 μm (lower right), showed that dye 8i also 
penetrated into the cells with a higher degree of localization in certain organelles. 
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Figure 45. The Images of the HTC 116 Cells Incubated Probe 8i. 
 
Figure 46 showed the colocalization study of probe 5e(20 μ M) and LysoTracker Red (75  
 
nM) incubated 1h in HCT 116 towards lysosome. The single-photon images of cells exposed  
 
200 ms for 5e (left) and LysoTracker Red (middle left). The DIC image exposed 550 ms  
 
(middle right), and the overlapped images of 5e and LysoTracker Red (right). The  
 
colocalization coefficient was 0.98 and calculated by the Slide book program. 
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Figure 46. The Images of the HTC 116 Cells Incubated Probe 5e and LysoTracker Red. 
 
In general, the images of HTC 116 cells showed that hydrophilic fluorene-based derivatives 
can be employed as new fluorescent probes for single-photon and two-photon fluorescence 
excitation. The fluorescent probes dispersed well into cell membranes for a bright 
fluorescence constrast and imaging for 2PA at 700 nm and above. 
2.2. Hydrophilic Fluorene-based Derivatives for Metal Ion Sensing 
 
 Compounds 9b, 9c, and 9d were investigated for sensing of selective metal ions, since 
bis(1,2,3-triazole) moieties in these compounds may enhance metal chelation.137, 138 
2.2.1. Response towards Metals 
 
The metal ion complexes of compounds 9b-d were screened by UV-vis absorption 
and fluorescence emission spectrophotometry for selectivity sensing of metals. The 
fluorescence response factor (F/F0) was measured by comparison of the maximum integrated 
area of the corrected spectrum of the metal complex, i.e., metal and ligand, (F) with that area 
OO
10
10
5e
N
N
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of the dye, i.e., ligand, (9b-d) at initial stage (F0). The dye concentration was 4x10-6 M in 
ethanol. The relevant ions of alkali, alkaline earth, and transition metals with concentrations 
varying from 10-6 to 10-4M in ethanol (Table 5) can be divided to group A, consisting of Ba, 
Ca, Ce, Cs, Hg(I), K, La(III), Li, Mg, Mn(II), Na, and Sn(II) that showed no fluorescence 
response; group B, consisting of Al, Au, Bi(III), Cr(III), Cu(I), Cu(II), Eu(III), Fe(II), In(III), 
and Ni (Fig. 47) that displayed a slight decrease in fluorescence; group C, consisting of 
Co(III), Fe(III), Ir(III), Pd, Pt(III), Rh(III), Ru(III), and Ti(IV) that exhibited a fluorescence 
quenching response; and group D, consisting of Ag, Cd, Hg, Pb(II), and Zn where an 
enhanced fluorescence response was observed (Fig. 48).  
Table 5. Selected Metals for UV-vis and Fluorescence Sensing towards Compounds 9b-d 
 
Li 
Na Mg  Al   
K Ca  Ti V Cr Mn Fe Co Ni Cu Zn    
 Sr      Ru Rh Pd Ag Cd In Sn  
Cs Ba La   W   Ir Pt Au Hg  Pb  
              Bi 
 
Lanthanides Ce     Eu  
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Figure 47. Fluorescence Response of 9b toward Metals of Group B. 
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Figure 48. Fluorescence Response of 9b toward Metals Groups C and D. 
 
A typical quenching of the fluorescence emission spectrum of compound 9b upon addition of 
iron(III) (Fig. 49) or palladium in ethanol (Fig. 50) are shown. 
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Figure 49. Fluorescence Spectra of 9b upon Addition of Iron(III) in Ethanol. 
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Figure 50. Fluorescence Spectra of 9b upon Addition of Palladium in Ethanol. 
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The UV-vis absorption and fluorescence emission spectra of the complexes of 9b-d with zinc 
(Figs. 51 - 54), mercury(II) (Figs. 55, 56), silver (Figs. 57, 58), lead(II) (Fig. 59), and 
cadmium (Fig. 60) showed moderately enhanced fluorescence responses, and a blue-shift that 
may be due to the change of the HOMO-LUMO gap of the complex relative to the dye alone 
(Fig. 61).73 
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Figure 51. UV-vis Absorption Spectra of 9b upon Addition of Zinc in Ethanol. 
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Figure 52. Fluorescence Emission Spectra of 9b upon Addition of Zinc in Ethanol. 
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Figure 53. UV-vis Absorption Spectra of 9c upon Addition of Zinc in Ethanol. 
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Figure 54. Fluorescence Emission Spectra of 9c upon Addition of Zinc in Ethanol. 
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Figure 55. UV-vis Absorption Spectra of 9c upon Addition of Mercury in Ethanol. 
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Figure 56. Fluorescence Emission Spectra of 9c upon Addition of Mercury in Ethanol. 
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Figure 57. UV-vis Absorption Spectra of 9c upon Addition of Silver in Ethanol. 
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Figure 58. Fluorescence Emission Spectra of 9c upon Addition of Silver in Ethanol. 
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Figure 59. Fluorescence Emission Spectra of 9b upon Addition of Lead in Ethanol. 
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Figure 60. Fluorescence Emission Spectra of 9c upon Addition of Cadmium in Ethanol. 
 
 
 
 
 
 
 
 
 
 
 
Figure 61. HOMO-LUMO Diagram of the Chromophore and its Metal Complex. 
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2.2.2. Linear Photophysical Properties 
 
Linear photophysical characterizations of probes 9b-d with metals are presented in 
Table 6. 
Table 6. Linear Photophysical Characterization of 9b-d and their Metal Complexes 
 
Solvent Ethanol Tetrahydrofuran Acetonitrile 
Compound φFl λ
ab
max λ
em ∆λ λabmax λ
em ∆λ λabmax λ
em ∆λ 
9b 0.32 400 609 209 403 568 165 401 616 215 
9c 0.31 401 612 211 402 570 168 401 608 207 
9d 0.31 403 610 207 407 569 162 403 621 218 
9b+Zn 0.51 385 542 157 384 521 137 384 548 164 
9c+Zn 0.41 386 545 159 388 511 123 384 546 162 
9d+Zn 0.45 384 537 153 387 510 123 384 555 171 
9b+Hg 0.46 382 540 158 383 517 134 382 558 176 
9c+Hg 0.47 383 530 147 384 519 135 382 561 179 
9d+Hg 0.45 382 521 139 384 520 136 382 560 178 
9b+Ag 0.53 392 582 190 397 558 161 392 580 188 
9c+Ag 0.53 395 571 176 395 548 153 389 588 199 
9d+Ag 0.50 392 560 168 396 550 154 393 590 197 
 
2.2.3. Response with Solvents 
 
The UV-vis absorption and fluorescence emission of complexes of 9a-c with zinc and 
mercury were investigated in acetonitrile, ethanol, THF, and aqueous acetonitrile (Figs. 62 -
66). The UV-vis absorption and fluorescence emission spectra of the complexes of 9b-d with 
metal ions were similar in organic solvents, however, as expected, a larger Stokes shift in the 
fluorescence emission was observed when the polarity of the solvent increased.  
  61 
300 400 500 600 700 800
0.0
0.2
0.4
0.6
0.8
1.0
No
rma
lize
d A
bso
rba
nce
 an
d E
mis
sio
n
Wavelength (nm)
 9b+Hg2+ Ab
 9b+Zn2+ 
 9b+Ag+
 9b Ab
 9b+Zn2+ Em
 9b+Hg2+
 9b+Ag+
 9b Em
     Solvent: EtOH
 
Figure 62. Normalized Absorbance, Emission Spectra of 9b and Its Complexes in Ethanol. 
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Figure 63. Normalized Absorbance, Emission Spectra of 9c and Its Complexes in ACN. 
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Figure 64. Normalized Absorbance, Emission Spectra of 9d and Its Complexes in ACN. 
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Figure 65. Normalized Absorbance, Emission Spectra of 9c and Its Complexes in THF. 
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Figure 66. Normalized Absorbance, Emission Spectra of 9d and Its Complexes in THF. 
 
2.2.4. Binding Constants of Metal Complexes 
 
The binding constants of the complexation of 9b-c with metals were determined by a 
fluorescence titration method (Figs. 67 - 75). 
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Figure 67. The Linear Fit of 9b upon Addition of Zinc in Ethanol. 
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Figure 68. The Linear Fit of 9c upon Addition of Zinc in Ethanol. 
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Figure 69. The Linear Fit of 9d upon Addition of Zinc in Ethanol. 
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Figure 70. The Linear Fit of 9b upon Addition of Mercury in Ethanol. 
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Figure 71. The Linear Fit of 9c upon Addition of Mercury in Ethanol. 
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Figure 72. The Linear Fit of 9d upon Addition of Mercury in Ethanol. 
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Figure 73. The Linear Fit of 9b upon Addition of Silver in Ethanol. 
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Figure 74. The Linear Fit of 9c upon Addition of Silver in Ethanol. 
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Figure 75. The Linear Fit of 9d upon Addition of Silver in Ethanol. 
  66 
Table 7. Binding Constant Values of 9b-d with Metals in Ethanol. 
 
Compound Zn Hg Ag 
log K n log K n log K n 
9b 8.0 2 14.5 3.3 12.3 3.7 
9c 8.9 2 16.4 2.8 11 3 
9d 9 2.1 16.5 3 10.7 3.1 
 
From Table 7, the complexation of 9b-d suggested that a 2:1 metal:ligand for zinc ion and 
3:1 metal:ligand for mercury(II) and silver ions occurred. These results are consistent with 
literature reports of 2:1 metal:ligand for cobalt-quercitin,139 zinc-p-tert-butylcalix[4]arene,140 
and lithium-cryptand141 complexes. 
2.2.5. Reversibility of the Complex 
 
Complexes of 9a-c with metal ions formed rapidly (within minutes upon addition of 
metal ions), were generally stable for several hours, and were reversible, since addition of 
EDTA demonstrated that the metal can be displaced to release the uncomplexed (free) dyes 
(Eq. 6 and Figs. 76 - 78). 
Equation 6 
                                   [Dye-metal]  +  EDTA    ↔    [EDTA-metal]  +  Dye                              (6) 
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Figure 76. Fluorescence Emission of 9b/Zinc Complex toward EDTA in Ethanol. 
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Figure 77. Fluorescence Emission of 9b/Mercury Complex toward EDTA in Ethanol. 
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Figure 78. Fluorescence Emission of 9b/Silver Complex toward EDTA in Ethanol. 
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2.2.6. Two-photon Absorption Cross Sections of Metal Complexes 
 
Two-photon absorption cross sections of 9b, 9c, and their corresponding complexes 
with zinc, mercury, and silver were determined under fs excitation and shown in Figs. 70 and 
71. 2PA cross section values of the complexes decreased relative to the free dyes 9b and 9c. 
This observation may be due to a change in the transition dipole moment50 of a photoinduced 
charge transfer molecule39 (PCT) upon complexation with metal, or the presence of intra-
ligand charge-transfer (ILCT) induction from interaction of a bound cation with an electron-
donating group (such as an amino functionality) in 9b and 9c, consistent to that reported in 
the literature.142,143 These potential explanations are hypothetical and require more extensive 
work to elucidate, a subject for future investigations. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 79. 2PA Cross Sections of 9b and its Complexes in Ethanol. 
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Figure 80. 2PA Cross Sections of 9c and its Complexes in Ethanol. 
 
2.3. Hydrophilic Fluorene-based Derivatives Complexed to Gold Nanoparticles 
 
The UV-vis absorption of 11a and 11b (complexes of gold nanoparticles and 9c and 
9d, respectively) showed an absorption at 520 nm, quite typical for gold nanoparticles (Figs. 
81, 82). The fluorescence emission of nanoparticle complexes 11a and 11b also showed a 
blue shift relative to the uncomplexed dyes with 2PA cross sections of 300 GM at 820 nm. 
The Raman scattering spectra of composites 11a and 11b showed strong scattering bands as 
evidence of the surface plasmon of gold nanoparticles (Fig. 83). TEM imaging of 
nanopartcile composites 11a and 11b revealed a particle size of 15-20 nm (Figs. 84, 85). 
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Figure 81. Compound 9c and Fluorescent Gold Nanoparticle Composite 11a in THF. 
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Figure 82. Normalized Absorbance, Emission, and 2PA Cross Section of Composites 11a 
and 11b in THF. 
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Figure 83. The Raman Scattering Spectra of Composites 11a and 11b. 
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Figure 84. The TEM Image of Composite 11a. 
 
 
Figure 85. The TEM Image of Composite 11b. 
 
Two-photon cross sections of composites 11a and 11b (Figs. 86 and 87) showed a  
decrease in the 2PA cross sections for fluorescent gold nanoparticle composites in 
comparison to (uncomplexed) 9c and 9d, respectively.  
 
  72 
720 760 800 840 880 920
0
100
200
300
400
500
 9c
 11a
2P
A 
, δ
 (G
M
)
Wavelength (nm)  
 
Figure 86. 2PA Cross Sections of 9c and 11a in THF. 
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Figure 87. 2PA Cross Sections of 9d and 11b in THF. 
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CHAPTER THREE: EXPERIMENTAL 
 
3.1. Materials and General Experimental Procedures 
 
 Chemicals and solvents from commercial sources were used as received. 2-(4-
ethenylphenyl)benzothiazole 5b,46 (2-tri-n-butylstannyl)benzothiazole110 were prepared 
according to reported procedures. Metal cations (Al, Ca, Cd, Eu(III), Fe(II), Hg(II), Mg, 
Pb(II), Zn) were used as perchlorate salts, (Co(III), Cu(II), Pd, Rh(II)) were used as acetate 
salts, (Au, Ba, Cu(I), Hg(I), Ir(III-V), La(III), Li, Ni, Pt(III), Ru(III), Sn(II), Sn(IV), Ti(IV), 
V(III)) as were used as chloride salts, (Ag, Bi(III), Cr(III), In(III), Mn(II)) were used as 
nitrate salts, ceric ammonium sulfate, cesium fluoride, and rhenium iodide were used to 
prepare metal ion stock solutions. 
Caution! Safety precautions were taken when azides were synthesized since azides 
are potentially explosive. This was performed by heating at moderate temperatures and by 
working on a small scale.  
Thermal stabilities were determined using a TGA (TA Instruments Model Q5000) 
with the heating rate of 5 - 10 0C per mimute. The mp was recorded on a Mel-Temp 
apparatus. NMR spectra were recorded in deuterated chloroform or DMSO-d6 on a Mercury 
300 MHz or a Varian 500 MHz spectrometer. High resolution mass spectrometry (HRMS-
ESI) data was provided by the Mass Spectrometry Laboratory at the University of Florida. 
The silica gel for chromatography was obtained from Silicycle with particle size of 40 - 63 
μm. The pH of sample and buffer solutions144 was recorded on an Accumet Basic pH meter 
(Model AB15 Fisher Scientific). TEM imagines of samples on copper grids were recorded on 
a JEOL (Model JEM-1011) TEM. IR spectra were recorded on a Perkin-Elmer Spectrum One 
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FTIR spectrometer. UV-vis absorption spectra were obtained with a Hewlett-Packard (Model 
8453) diode-array spectrophotometer in 1.0 cm quartz cells. Fluorescence emission spectra 
were obtained with a PTI (Model MD-5020) Quantamaster fluorimeter equipped with a 75 W 
continuous Xe-arc lamp as a light source. Quantum yields and fluorescence anisotropy of the 
sample were determined according to the literature.130 The quantum yield of sample was 
mearured in triplicate by a comparison of the integrated area of the corrected emission 
spectrum of the sample with that of a known standard, such as 9,10-diphenylanthracene (φr = 
0.95 in cyclohexane) or rhodamine 6G (φr = 0.94 in methanol), and was calculated from Eq. 
7. 
Equation 7 
                                                                                                                                           (7) 
where I and Ir is the corrected integrated fluorescence intensity of the sample and the 
standard; OD and ODr is the optical density (absorbance) of the sample and the standard; and 
n and nr is the refractive index of the sample and the standard, respectively. 
Single-photon photodecomposition quantum yield (ΦD) at 405 nm was determined 
from Equation 8 according to the literature.145 
Equation 8 
                                                                                                                                           (8) 
where A(λ, 0) and A(λ, t) is the absorbance at a corresponding wavelength λ of the initial 
state (t = 0) and at time t, respectively; AAve is the average value of A(λ, 0) and A(λ, t); NA is 
the Avogadro number; ε is the molar absorption coefficiency of the sample; I is the intensity 
of the irradiation light; and ∆t is the exposure time in seconds. 
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 Fluorescence anisotropy (A) of the hydrophilic fluorene-based derivatives were 
recorded in poly THF (Mn = 250) using two polarizers for excitation and emission (Fig. 88), 
and calculated using Equation 9. 
 
 
 
 
 
 
Figure 88. A Schematic Fluorescence Anisotropy Experimental Setup. 
 
Equation 9 
                                                                                                                                           (9) 
 
where IVV is the emission intensity of vertical-vertical direction; IHV is horizon-vertical 
direction; IVH is the vertical-horizon; and IHH is the horizon-horizon direction. 
Two-photon absorption (2PA) cross sections, δ (1GM = 10-50cm4.s.photon-1.mol-1) 
were measured by a fluorescence method,146 using a Ti:sapphire, mode-locked, femtosecond 
Coherent Mira 900F laser system (Fig. 89). The pulse width of the laser was 200 fs with a 
repetition rate of 76 MHz and 700 mW of average power. The 2PE spectrum was digitally 
processed, and the average of the two-photon upconverted fluorescence emission <F> 
estimated. The numerical estimation of the 2PA cross section δ was performed by 
comparison with a known reference147 and calculated using Equation 10. 
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Figure 89. A Schematic Two-photon Absorption Experimental Setup. 
 
Equation 10 
                                                                                                                                           (10) 
where r describes the reference; <F> is the average fluorescence intensity integrated from 
two-photon upconverted fluorescence emission spectrum; n is the refractive index of the 
solvent; C is the concentration; φ is the quantum yield, and P is the incident power into the 
sample. 
3.2. UV-vis Absorption and Fluorescence Emission of Metal Complexes 
 
UV-vis absorption and fluorescence emission titrations of 9b-d upon complexing 
metal ions were performed in ethanol. A 3.0 mL dye solution was prepared and the 
corresponding metal ion stock solution was added. The resulting solution was agitated and 
spectra were recorded. Experiments were performed triplicate for a comparison of data 
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analysis. The basic equations for complexation of the ligand-metal are shown below (Eqs. 11 
- 14). 
Equation 11 
                                                                                                                                               (11) 
Equation 12 
                                                                
nMD
CK
]][[
][
=
                                                       (12) 
Equation 13 
                                                                [D]t = [D] + [C]                                                     (13) 
Equation 14 
                                                                [M]t = [M] + n[C]                                                  (14) 
where D is the dye molecule (ligand); M, metal ion; C, complex (D-M); n, molar 
stoichiometry number; K, binding constant; [D]t, total concentration of the dye molecule at 
initial state; [M]t, total concentration of the metal at initial state; [D], [M], [C], concentrations 
of the dye, metal ion, and complex, respectively. The binding constant K of the metal 
complex was determined by Equation 15 (Appendix C) with the approximation of 
concentration of free metal equal to its total concentration ([M] ≅ [M]t).148-150  
Equation 15 
                                                                                                                                               (15) 
where Fo, F, and Fm are the corrected fluorescence emission intensity of complex respectively 
at initial, t, and the final state where the complex was fully formed upon addition of metal 
ion. The binding constant K can be determined from the plot of the linear regression of 
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log[(F-F0)/(Fm-F)] against log[M] in Equation 16, derived from Equation 15, to obtain the 
intercept as log K with slope n. 
Equation 16 
                                                                                                                                               (16) 
3.3. Cell Incubation and Imaging 
 
The epithelial colorectal carcinoma cell line HCT 116, was purchased from ATCC 
(America Type Culture Collection, Manssas, VA, USA). All cells were incubated in 
Dulbecco’s modified Eagle’s Medium (DMEM, Invitrogen, Carlsbad, CA, USA), 
supplemented with 10 % fetal bovine serum (FBS, Atlanta Biologicals, Lawrenceville, GA, 
USA), 100 units/mL penicillin-streptomycin (Atlanta Biologicals, Lawrenceville, GA, USA) 
and incubated at 37 oC in a 95 % humidified atmosphere containing 5 % CO2. The HCT 116 
cells were placed onto poly-D-lysine coated glass cover slips in 24-well plates (ca. 30,000 
cells per well). The cells were grown for 36 h before being incubated with fluorescent 
probes. Stock solutions of fluorescent probes in water or DMSO were prepared as 1 mM to 2 
mM solutions, and then they were diluted to 20 µM dye solutions with the complete growth 
medium, Dulbecco’s modification of Eagle’s medium (DMEM). The dye solutions were 
freshly prepared and placed over the cells for 1 h. After incubation with a fluorescent probe, 
the cells were washed with the PBS solution (3 to 5 times) and fixed using a 3.7 % 
formaldehyde solution for 15 min at 37 oC. To each well, 0.5 mL of a solution of NaBH4 (1 
mg/mL) in the PBS solution (which was added a few drops of 6N NaOH solution) was added 
and kept for 15 min, and then replaced by an additional 0.5 mL of NaBH4. At the end of this 
period, the plates were rinsed twice with PBS solution, and then with water. Finally, the glass 
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coverslips were mounted by Prolong Gold mounting media for microscopy. Imaging by DIC 
involved 400 ms exposure, 1PA fluorescence was exposed 150 ms, and 2PA fluorescence 
excitation was performed at 700 nm. The cell titer 96 aqueous one solution reagent for HTC 
116 cells MTS viability assay was obtained from Promega. 
For fluorescence imaging, an inverted microscope/spinning disk confocal system 
(Olympus IX80 DSU) equipped with an EMCCD (Hamamatsu) was utilized, where the 
output of a filtered 100 W mercury lamp was employed as the light excitation source. A 
customized filter cube (Ex 377/50, DM 409, Em 460/50) was used. Two-photon fluorescence 
microscopy (2PFM) images were collected on a modified Olympus Fluoview FV300 
microscope system coupled to a tunable laser with exciation at or above 700 nm. A long-pass 
emission filter (cutoff 690 nm) was placed in the microscope scanhead to avoid background 
irradiance from the excitation source. Consecutive layers, separated by approximately 0.15 
µm, were recorded to create a 3D reconstruction from overlaying X-Y plane two-photon 
fluorescence images. The two-photon induced fluorescence was collected with a 60x 
microscope objective (UPLANSAPO 60x, NA= 1.35, Olympus). Single-photon images of 
probe 5e and LysoTracker Red in colocalization study used custom made filter cube (Ex 
377/50, DM 409, Em 525/40) and Texas Red filter cube (Ex 562/40, DM 593, Em 624/40).  
3.4. Preparation of 2a 
 
 Fluorene (1.70 g, 10 mmol) was weighed and dissolved in acetic acid (40 mL) at 40 
0C in a 250 mL flask. To this solution, 2.3 g of iodine (2.30 g, 9 mmol), sulfuric acid (2 mL, 
36 mmol), and a solution of iodic acid (1.30 g, 7 mmol) in water (4 mL) were added. The 
resulting solution was heated to 70 0C for 1 h. At the end of this period, the solution 
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discolored and a white precipitate formed. The resulting mixture was allowed to cool to room 
temperature, and then poured into water (200 mL). The precipitate was collected by vacuum 
filtration, washed with a solution of 2 % NaHCO3, water, and then dried under reduced 
pressure. The crude produce was recrystallized from ethyl acetate, and then dried under 
vacuo to obtain 2,7-diiodofluorene (3.0 g, 7 mmol) as a white crystal with mp of 216 - 217 
0C (70 % yield). 1H NMR (500 MHz, CDCl3, δ): 7.89 (s, Ar-H, 2H), 7.75 (m, Ar-H, 2H), 
7.52 (m, Ar-H, 2H), 3.85 (m, CH2, 2H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 144.84, 
140.39, 136.05, 134.16, 121.60, 92.47 (C-I), 39.90 (CH2). 
3.5. Preparation of 3a 
 
 To a stirring solution of 2-(2-ethoxy ethoxy)ethanol (13.50 g, 100 mmol) in dry 
pyridine (30 mL) at 5 0C in a 250 mL flask submerging in an ice-bath, 4-
methylbenzenesulfonyl chloride (19.0 g, 100 mmol) was added in small portions in 30 
minutes to maintain the temperature at 5 - 10 0C. The resulting solution was stirred at 5 0C 
for 3 h. At the end of this period, a white precipitate formed and the mixture was poured into 
a cold solution of hydrochloric acid (25 mL) in water (100 mL). The resulting solution was 
transferred into a separatory flask, and then diethyl ether (50 mL) was added. The ether phase 
was then removed. The aqueous phase was then extracted twice with portions of diethyl ether 
(100 mL). The ether phases were then combined, washed with a solution of 1 % sodium 
bicarbonate (150 mL), and then water. The ether phase was dried by anhydrous sodium 
sulfate and evaporated in vacuo to obtain compound 3a (27.0 g, 95 mmol) as a colorless 
liquid (95 % yield). 1H NMR (500 MHz, CDCl3, δ): 7.80 (d, Ar-H, 2H), 7.30 (d, Ar-H, 2H), 
4.18 (m, SO3CH2, 2H), 3.70 (m, SO3CCH2O, 2H), 3.48-3.58 (m, OCH2, 6H), 2.44 (s, PhCH3, 
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3H), 1.17 (m, CH3, 3H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 144.83, 132.90, 129.80, 
128.0, 70.80 (SO3CH2), 69.70, 69.28, 68.60, 66.61, 21.60 (Ph-CH3), 15.12 (CH3). 
3.6. Preparation of 3b 
 
 Tetraethyleneglycol methyl ether (10.5 g, 50 mmol) was utilized and methylene 
chloride employed to extract to obtain 3b (16.0 g, 48 mmol) in 96 % yield as a colorless 
liquid. 1H NMR (500 MHz, CDCl3, δ): 7.80 (d, Ar-H, 2H), 7.35 (d, Ar-H, 2H), 4.15 (m, 
SO3CH2, 2H), 3.54-3.72 (m, OCH2, 14H), 3.36 (s, OCH3, 3H), 2.45 (s, Ph-CH3, 3H). 13C 
NMR (500 MHz, CDCl3, δ (ppm)): 144.80, 132.97, 129.74, 128.00, 71.91 (SO3CH2), 70.73, 
70.67, 70.59, 70.52, 70.46, 69.25, 68.66, 59.05 (OCH3), 21.70 (Ph-CH3), 15.12 (CH3). 
3.7. Preparation of 4a 
 
2,7-Diiodofluorene (2.50 g, 6 mmol) was weighed and dissolved in dry DMSO (30 
mL) in a 100 mL flask. The solution was degassed with nitrogen for 10 minutes, and then 
potassium iodide (0.1 g, 0.6 mmol) and potassium hydroxide (1.00 g, 18 mmol) were added. 
To this solution, 2-(2-ethoxy ethoxy)ethyl tosylate 3a (5.40 g, 18 mmol) was added dropwise 
in 10 minutes. The resulting solution was stirred overnight and then it was poured into water 
(50 mL) to which methylene chloride (50 mL) was added. The organic phase was then 
removed, and the aqueous phase was extracted 3 times with methylene chloride (40 mL). The 
organic phases were combined, washed with water, dried with sodium sulfate, and then 
evaporated under reduced pressure to obtain a crude product which was further purified on a 
silica gel column using hexane and ethyl acetate (7:3) as the eluent to obtain 2,7-diiodo-9,9-
di-2-(2-ethoxy ethoxy)ethylfluorene 4a (2.0 g, 3.1 mmol) as a white solid with mp of 77 - 78 
0C (55 % yield). 1H NMR (500 MHz, CDCl3, δ): 7.78 (s, Ar-H, 2H), 7.75 (d, Ar-H, 2H), 7.22 
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(d, Ar-H, 2H), 3.40-3.45 (m, OCH2, 8H), 3.35 (m, 4H), 3.20 (m, 4H), 2.75-2.79 (m, 
CH2CH2O, 4H), 2.35-2.38 (m, CH3CH2O, 4H), 1.10-1.15 (m, CH3, 6H). 13C NMR (500 
MHz, CDCl3, δ (ppm)): 150.78, 139.12, 136.52, 132.50, 93.27 (C-I), 70.13, 69.68, 66.76, 
66.65, 51.68 (C9), 39.44 (CH2CH2O), 15.14 (CH3). HRMS calcd for C25H32O4I2, 650.3354; 
found 650.0384. 
3.8. Preparation of 4b 
 
 Compound 3b was utilized to synthesis of 2,7-diiodo-9,9-di-2-(2-(2-(2-ethoxy 
ethoxy)ethoxy)ethoxy)methylfluorene 4b as a colorless liquid (40 % yield). 1H NMR 
(500MHz, CDCl3, δ): 7.73 (s, Ar-H, 2H), 7.66-7.68 (m, Ar-H, 2H), 7.22-7.25 (m, Ar-H, 2H), 
3.52-3.61 (m, OCH2, 16H), 3.37-3.41 (m, 10H), 3.19-3.21 (m, OCH3, 4H), 2.74-2.77 (m, 
CH2CH2O, 4H), 2.32-2.34 (m, CH3CH2O, 4H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 
150.78, 139.13, 136.47, 132.42, 121.50, 93.25 (C-I), 71.91 (OCH2), 70.64, 70.53, 70.48, 
70.42, 70.36, 66.74, 59.08 (OCH3), 51.68 (C9), 39.45 (CH2CH2O). HRMS calcd for 
C31H44O8I2, 798.4938; found 798.1119. 
3.9. Preparation of 2-(4-(1-Trimethylsilyl)ethynylphenyl)benzothiazole 
 
2-(4-iodophenyl)benzothiazole was synthesized from the literature46 (mp of 154 - 155 
0C). 1H NMR (500 MHz, CDCl3, δ): 8.07-8.09 (d, Ar-H, 1H), 7.82-7.93 (m, Ar-H, 5H), 7.50-
7.53 (m, Ar-H, 1H), 7.40-7.48 (m, Ar-H, 1H). 13C-NMR (500 MHz, CDCl3, δ (ppm)): 167.53 
(C=N), 154.25 (sp2 C-N), 138.89, 135.67, 133.45, 129.31, 126.71, 125.95, 123.98, 121.95, 
120.02, 97.92 (C-I). 
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2-(4-Iodophenyl)benzothiazole (3.40 g, 10 mmol) was weighed and dissolved into a 
solution of triethylamine (60 mL) and THF (20 mL) in a 250 mL flask. The solution was 
degassed with nitrogen for 10 minutes, and then PdCl2P(Ph3)2 (0.35 g, 5 mmol), CuI (0.20 g, 
10 mmol), and trimethylsilylacetylene (1.50 g, 15 mmol) were added. The resulting solution 
was stirred overnight and then it was poured into water (100 mL) to which methylene (50 
mL) was added. The organic phase was removed. The aqueous phase was extracted 3 times 
with portions methylene chloride (150 mL), and then organic phases were combined, washed 
with water, and dried over sodium sulfate. The filtrate was evaporated under reduced 
pressure to obtain a crude product which was further purified on a silica gel column using 
hexane and ethyl acetate (8:2) as the eluent to obtain 2-(4-(2-
trimethylsilyl)ethynylphenyl)benzothiazole (2.30 g, 7.5 mmol) as a yellow solid with mp of 
61 - 630C (75 % yield). 1H NMR (500 MHz, CDCl3, δ): 7.80-7.82 (m, Ar-H, 3H), 7.65 (d, 
Ar-H,1H), 7.35-7.38 (m, Ar-H, 2H), 7.22-7.25 (m, Ar-H, 1H), 7.15-7.18 (m, Ar-H, 1H), 
0.00-0.12 (m, Si(CH3)3, 9H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 167.21 (C=N), 154.20 
(sp2-C-N), 135.20, 133.40, 132.62, 132.37, 131.79, 128.07, 127.36, 126.40, 125.50, 123.19, 
121.67, 104.44 (sp-C), 97.19 (sp-C), 0.60 (Si(CH3)3). 
3.10. Preparation of 2-(4-Ethynylphenyl)benzothiazole 5a 
 
2-(4-(1-Trimethylsilyl)ethynylphenyl)benzothiazole (1.85 g, 6 mmol) was weighed 
and dissolved in THF (25 mL) in a 100 mL flask, and then a solution of 5 % KOH in 
methanol (25 mL) was added. The resulting solution was stirred for 30 minutes at room 
temperature, and then it was poured into water (50 mL) to which methylene chloride (40 mL) 
was added. The organic phase was removed. The aqueous phase was extracted 3 times with 
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methylene chloride (50 mL). The organic phases were combined, washed with water, and 
dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a crude 
product which was further purified on a silica gel column using hexane and ethyl acetate 
(7:3) as the eluent to obtain 2-(4-ethynylphenyl)benzothiazole 5a (1.20 g, 4.8 mmol) as a 
white solid with mp of 123 - 125 0C (80 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.00-8.08 
(m, Ar-H, 3H), 7.82-7.85 (d, Ar-H,1H), 7.50-7.58 (m, Ar-H, 2H), 7.40-7.45 (m, Ar-H, 1H), 
7.25-7.29 (m, Ar-H,1H), 3.15 (s, alkyne proton, 1H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 
166.95, 154.12, 135.14, 133.73, 132.72, 127.37, 126.51, 125.48, 124.66, 123.40, 121.69, 
83.05 (sp-C), 79.54 (sp-C). HRMS calcd for C15H19NS, 235.3028; found 235.0449. 
3.11. Preparation of 6a 
 
Compound 4a (0.65 g, 1 mmol) was weighed and dissolved in THF (10 mL) and 
triethylamine (10 mL) in a 100 mL flask. The solution was degassed with nitrogen for 10 
minutes. To this solution, PdCl2P(Ph3)2 (0.10 g, 0.17 mmol), CuI (0.06 g, 0.3 mmol), 
compound 5a (0.56 g, 2.4 mmol), and a magnetic stirring bar were added. The resulting 
solution was stirred under nitrogen atmosphere for 24 h at room temperature. At the end of 
this period, it was poured into water (50 mL) to which methylene chloride (40 mL) was 
added. The organic phase was removed, and the aqueous phase was extracted 3 times with 
methylene chloride (40 mL). The organic phases were combined, washed with water, and 
dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a crude 
product which was further purified on a silica gel column using hexane and ethyl acetate 
(1:1) as the eluent to obtain 6a (0.50 g, 0.7 mmol) as a yellow solid with mp of 162 - 163 0C 
(68 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.00-8.06 (m, Ar-H, 6H), 7.81-7.86 (d, Ar-H, 
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2H), 7.55-7.67 (m, Ar-H, 9H), 7.55 (d, Ar-H, 1H), 7.45 (m, Ar-H, 2H), 7.35-7.38 (m, Ar-H, 
2H), 3.25-3.37 (m, OCH2, 8H), 3.20 (m, 4H), 2.85-2.86 (m, CH2CH2O), 4H), 2.38-2.41 (m, 
CH3CH2O, 4H), 1.07-1.09 (m, CH3,6H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 167.18 
(C=N), 154.17(sp C-N), 149.54, 140.21, 135.15, 133.17, 132.15, 131.63, 127.51, 126.60, 
126.50, 125.90, 125.70, 123.35, 122.08, 121.69, 120.11, 92.56 (sp-C), 89.82 (sp-C), 70.13, 
69.67, 66.88, 66.62, 51.42 (C9), 39.95 (CH2CH2O), 15.10 (CH3). HRMS calcd for 
C55H48O4N2S2, 865.1148; found 864.3049. 
3.12. Preparation of 6b 
 
Compound 5b was prepared from the literature.37 1H NMR (500 MHz, CDCl3, δ): 
8.07-8.09 (m, Ar-H, 3H), 7.91-7.93 (d, Ar-H, 1H), 7.51-7.55 (m, Ar-H, 3H), 7.40 (m, Ar-H, 
1H), 6.78-6.94 (m, CH=CH2, 1H), 5.87-5.90 (d, C=CH2, 1H), 5.37-5.39 (d, C=CH2, 1H). 13C 
NMR (500 MHz, CDCl3, δ): 167.69 (C=N), 154.19 (sp2 C-N), 140.15, 136.05, 135.03, 
132.89, 127.83, 127.77, 126.81, 126.38, 125.20, 123.19, 121.62, 115.67. 
Compound 4a (0.80 g, 1 mmol) was weighed and dissolved into a mixture of DMF 
(15 mL) and triethylamine (3 mL) in a 50 mL flask. A magnetic stirring bar was added and 
the solution was degassed with nitrogen for 10 minutes. To this solution, palladium acetate 
(0.08 g, 0.4 mmol), tri(o-tolyl)phosphine (0.20 g, 0.7 mmol), and compound 5b (0.57 g, 2.4 
mmol) were added. The resulting solution was then refluxed at 90 0C for 40 h. At the end of 
this period, the solution was allowed to cool to room temperature, and then it was poured into 
water (50 mL) to which methylene chloride (50 mL) was added. The organic phase was 
removed. The aqueous phase was extracted 3 times with methylene chloride (40 mL). The 
organic phases were combined, washed with water, and then dried over sodium sulfate. The 
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filtrate was removed under reduced pressure to obtain a crude product which was further 
purified on a silica gel column using ethyl acetate and THF (1:1) as the eluent to obtain 
compound 6b (0.6 g, 0.6 mmol) as a yellow-green solid with mp of 82 – 83 0C (60 % yield). 
1H NMR (500 MHz, DMSO, δ): 8.02-8.08 (dd, Ar-H, 8H), 7.90 (s, Ar-H, 2H), 7.82-7.85 (m, 
Ar-H, 6H), 7.65 (d, Ar-H, 2H), 7.45-7.57 (m, Ar-H, 8H), 3.09-3.39 (m, OCH2, 34H), 2.69-
2.72 (m, CH2CH2O, 4H). 13C NMR (500 MHz, DMSO, δ (ppm)): 167.43 (C=N), 154.12 (sp2 
C-N), 150.41, 140.80, 140.23, 136.64, 134.89, 132.07, 128.21, 128.11, 128.04, 127.95, 
127.85, 127.69, 127.50, 123.73, 123.55, 123.25, 123.11, 121.90, 121.67, 71.64, 70.16, 70.13, 
69.95, 67.85, 59.52 (OCH3), 51.26 (C9), 40.00 (CH2CH2O). HRMS calcd for C61H64O8N2S2, 
1017.3052; found 1017.4177. 
3.13. Preparation of 2b 
 
Fluorene (1.70 g, 10 mmol) was weighed and dissolved in acetic acid (20 mL) at 40 
0C in a 250 mL flask. To this solution, iodine (1.08 g, 0.4 mmol), sulfuric acid (1 mL, 1.8 
mmol), and a solution of iodic acid (0.6 g, 0.3 mmol) in water (2 mL) were added. The 
resulting solution was heated to 70 0C for 1 h. At the end of this period, the solution 
discolored and it was allowed to cool to room temperature. The solution was poured into 
water (200 mL), and the precipitate was collected by vacuum filtration. It was washed with a 
solution of 2 % NaHCO3, water, and then dried under reduced pressure. The crude produce 
was recrystallized from methanol, and then dried under vacuo to obtain compound 2b (2.3 g 
0.8 mmol) as a white solid with mp of 124 - 126 0C (78 % yield). 1H NMR (500 MHz, 
CDCl3, δ): 7.90-7.95 (s, Ar-H, 1H), 7.70-7.78 (dd, Ar-H, 2H), 7.54-7.55 (m, Ar-H, 2H),7.35-
7.40 (dd, Ar-H, 2H), 3.89 (m, CH2, 2H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 145.47, 
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142.15, 141.33, 141.11, 135.87, 134.16, 127.75, 127.65, 125.53, 121.85, 119.97, 92.21 (C-I), 
36.64 (CH2).  
3.14. Preparation of 3c 
 
Poly(ethylene glycol) methyl ether (Mn = 550, 27.50 g, 50 mmol) was utilized and 
methylene chloride and methanol (95:5) were used as the eluent to obtain compound 3c (28 
g) as a colorless liquid (yield 92 %). 1H NMR (500 MHz, CDCl3, δ): 7.78 (d, Ar-H, 2H), 7.32 
(d, Ar-H, 2H), 4.17 (m, SO3CH2, 2H), 3.55-3.67 (m, OCH2, 40H), 3.35 (s, OCH3, 3H), 2.42 
(s, Ph-CH3, 3H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 144.80, 132.91, 129.80, 127.95, 
71.90 (SO3CH2), 70.70, 70.57, 70.50, 70.47, 69.31, 69.20, 68.63, 59.04 (OCH3), 21.62 
(PhCH3). 
3.15. Preparation of 4c 
 
2-Iodofluorene 2b (1.80 g, 6 mmol) was utilized and hexane and ethyl acetate (7:3) 
was used as the eluent to obtain 2-iodo-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 4c (1.90 g, 
3.6 mmol) as a white crystal with mp of 49 - 50 0C (60 % yield). 1H NMR (500 MHz, CDCl3, 
δ): 7.78 (s, Ar-H, 1H), 7.70-7.75 (m, Ar-H, 2H), 7.22-7.25 (m, Ar-H, 2H), 7.10-7.15 (dd, Ar-
H, 2H), 3.35-3,43 (m, OCH2, 8H), 3.18-3.20 (m, OCH2, 4H), 2.75-2.78 (m, CH2CH2O, 4H), 
2.38-2.42 (m, CH3CH2O, 4H), 1.13-1.18 (m, CH3, 6H). 13C NMR (500MHz, CDCl3, δ 
(ppm)): 152.89, 150.12, 147.80, 146.0, 137.75, 137.45, 133.63, 123.66, 123.01, 120.05, 
119.01, 95.54 (C-I), 70.12, 69.59, 66.75, 66.64, 52.24 (C9), 39.19 (CH2CH2O), 15.06 (CH3). 
HRMS calcd for C25H33O4I, 524.4383; found 524.1417. 
3.16. Preparation of 4d 
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 Compound 3c was utilized, and methylene chloride and methanol (95:5) was used as 
the eluent to obtain an oily liquid 4d (40 % yield). 1H NMR(500 MHz, CDCl3, δ): 7.75 (s, 
Ar-H, 1H), 7.65-7.68 (m, Ar-H, 2H), 7.38-7.42 (m, Ar-H, 2H), 7.32-7.35 (m, Ar-H, 2H), 
3.55-3.65 (m, 50H), 3.38-3.42 (s, 6H), 2.65-2.68 (m, CH2CH2O, 4H), 2.32-2.36 (m, 
CH3CH2O, 4H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 148.33, 145.31, 137.09, 136.46, 
133.33, 129.46, 125.20, 124.48, 120.12, 118.47, 116.94, 89.62, 68.87, 68.49, 68.36, 67.66, 
67.61, 67.58, 67.53, 67.50, 63.81, 56.05 (OCH3), 48.39 (C9), 36.46 (CH2CH2O). HRMS 
calcd for C47H77O16I, 1025.0207; found 1024.9921. 
3.17. Preparation of 5c 
 
2-Iodo-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 4c (0.53 g, 1 mmol) was weighed and 
dissolved in a mixture of acetic acid (2 mL) and acetic anhydride (2 mL) in a 50 mL flask. To 
this solution, nitric acid (0.30 g, 3 mmol) was added and stirred overnight. The resulting 
solution was poured into water (50 mL), and then methylene chloride (40 mL) was added. 
The organic phase was removed, and then the aqueous phase was extracted 3 times with 
methylene chloride (40 mL). The organic phases were combined, washed with water, and 
then dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a 
crude product which was further purified on a silica gel column using hexane and ethyl 
acetate as the eluent to obtain 2-iodo-7-nitro-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 5c 
(0.30 g, 0.5 mmol) as a light yellow solid with mp of 55 - 56 0C in 50 % yield. 1HNMR (500 
MHz, CDCl3, δ): 8.15-8.17 (m, Ar-H, 2H), 7.80-7.82 (s, 1H), 7.75 -7.78 (m, Ar-H, 2H), 7.35-
7.38 (m, 1H), 3.38-3.42 (m, 4H), 3.28-3.32 (m, 4H), 3.15-3.19 (m, OCH2, 4H), 2.80-2.88 
(dd, CH2CH2O, 4H), 2.40-2,48 (dd, CH3CH2O, 4H), 1.10-1,15 (m, CH3, 6H). 13C NMR (500 
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MHz, CDCl3, δ(ppm)): 151.30, 148.32, 140.07, 139.46, 136.27, 132.45, 128.01, 127.82, 
123.52, 121.65, 119.92, 92.64 (C-I), 70.07, 69.67, 66.89, 66.60, 51.37 (C9), 39.55 
(CH2CH2O), 15.10 (CH3). HRMS calcd C25H32NIO6 for 569.4359; found 569.1268. 
3.18. Preparation of 5d 
 
 Compound 5d was obtained as a yellowish liquid (40 % yield). 1H NMR (500 MHz, 
CDCl3, δ): 8.25-8.30 (m, Ar-H, 2H), 7.75-7.82 (m, Ar-H, 3H), 7.50-7.55 (m, Ar-H, 1H), 7.50 
(m, Ar-H, 1H), 3.4--3.75 (m, 72H), 3.35-3.42 (s, 6H), 2.78-2.82 (d, CH2CH2O, 4H), 2.38-
2.42 (d, 4H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 149.85, 147.06, 144.47, 142.85, 134.74, 
134.04, 130.05, 120.78, 120.0, 117.15, 116.0, 92.51 (C-I), 74.35, 74.10, 73.84, 69.16, 68.95, 
68.75, 68.66, 68.55, 68.45, 68.33, 68.16, 67.79, 67.66, 66.41, 56.10 (OCH3), 49.22 (C9), 
36.23 (CH2CH2O). HRMS calcd for C47H76O18NI, 1070.0183; found 1070.8651. 
3.19. Preparation of 6c 
 
2-Iodo-7-nitro-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 5b (2.0 g, 3.5 mmol) was 
weighed and dissolved into 30 mL of a mixture of DMF (25 mL) and triethylamine (5 mL) in 
a 50 mL flask. The solution was degassed with nitrogen for 10 minutes, then palladium 
acetate (0.04 g, 0.17 mmol), tri(o-tolyl)phosphine (0.1 g, 0.33 mmol), and 2-(4-
ethenylphenyl)benzothiazole46 (1.0 g, 4.2 mmol) were added. The resulting solution was 
heated to 90 0C for 40 h. At the end of this period, the solution was allowed to cool to room 
temperature and then poured into water (200 mL) to which methylene chloride (50 mL) was 
added. The organic phase was removed. The aqueous phase was extracted 3 times with 
methylene chloride (40 mL). The organic phases were combined, washed with water, and 
dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a crude 
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product. It was purified on a silica gel column using hexane and ethyl acetate (3:7) as the 
eluent to obtain 2-nitro-7-styrylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 6c 
(1.40 g, 2 mmol) as a yellow solid with mp of 145 – 147 0C (60 % yield). 1H NMR (500 
MHz, CDCl3, δ): 8.12-8.15 (dd, Ar-H, 2H), 8.02-8.09 (dd, Ar-H, 3H), 7.83-7.88 (m, Ar-H, 
1H), 7.75-7.78 (dd, Ar-H, 2H), 7.65-7.70 (m, Ar-H, 3H), 7.55-7.57 (m, Ar-H, 1H), 7.48-7.52 
(m, Ar-H, 1H), 7.35-7.38 (m, Ar-H, 1H), 7.22-7.30 (m, Ar-H, 2H), 3.05-3.38 (m, OCH2, 
12H), 2.75-2.81 (dd, CH2CH2O, 4H), 2.38-2.45 (m, CH3CH2O, 4H), 1.0-1.04 (m, CH3, 6H). 
13C NMR (500 MHz, CDCl3, δ (ppm)): 167.95 (C=N), 154.22 (sp2 C-N), 151.90, 151.80, 
147.63, 146.45, 139.66, 138.34, 138.08, 135.75, 133.80, 129.89, 128.90, 128.01, 127.16, 
127.05, 126.95, 126.43, 124.85, 123.70, 123.21, 121.65, 121.55, 119.88, 118.94, 70.15, 
69.61, 66.86, 66.61, 51.95 (C9), 39.45 (CH2CH2), 15.05 (CH3). HRMS calcd for 
C40H42O6N2S, 678.8416; found 678.2827. 
3.20. Preparation of 6d 
 
 Yield 70%. 1H NMR (500 MHz, CDCl3, δ): 8.20-8.22 (dd, 2H), 8.02-8.10 (dd, 3H), 
7.85-7.90 (m, 1H), 7.70-7.75 (d, 2H), 7.62-7.68 (dd, Ar-H, 3H), 7.55-7.57 (d, Ar-H, 1H), 
7.45-7.48 (m, Ar-H, 1H), 7.30-7.35 (m, Ar-H, 1H), 7.22-7.25 (m, Ar-H, 2H), 3.40-3.62 (m, 
66H), 3.30-3.38 (m, 8H), 2.70-2.80 (d, CH2CH2O, 4H), 2.38-2.41 (m, CH3CH2O, 4H). 13C 
NMR (500 MHz, CDCl3, δ (ppm)): 167.90, 154.01, 151.7, 151.05, 147.06, 146.10, 140.00, 
138.20, 138.10, 135.02, 132.89, 130.02, 129.80, 129.50, 128.07, 127.55, 126.80, 125.99, 
125.80, 124.00, 123.80, 123.50, 123.20, 122.00, 120.00, 119.50, 119.00, 71.89, 71.00, 70.76, 
70.63, 70.52, 70.32, 70.26, 70.04, 66.80, 59.01 (OCH3), 51.89 (C9), 39.80 (CH2CH2O). 
HRMS calcd for C54H70O14N2S, 1003.212; found 1002.9711. 
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3.21. Preparation of 7a 
 
 2-Nitro-7-styrylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 6c (1.20 g, 
1.8 mmol) was weighed and dissolved in a mixture of ethanol (25 mL) and THF (25 mL) in a 
200 mL flask. The resulting solution was degassed with nitrogen for 10 minutes, and then 10 
% palladium on carbon (0.12 g) was added. The solution was heated to 60 0C under nitrogen 
atmosphere. To this resulting mixture, hydrazine hydrate (0.50 g, 10 mmol) was added 
dropwise in 10 minutes. The solution was then refluxed at 70 0C for 20 h. At the end of this 
period, the solution was allowed to cool to room temperature and then filtered using a short 
silica gel plug, and washed with THF (100 mL). The filtrate was removed under reduced 
pressure to obtain a crude product which was further purified on a silica gel column using 
ethyl acetate and THF (4:1) as the eluent to obtain 2-amino-7-styrylbenzothiazolyl-9,9-di-2-
(2-ethoxy ethoxy)ethylfluorene 7a (1.0 g, 1.6 mmol) as a yellow solid with mp of 185 – 188 
0C (90 % yield). IR (neat, cm-1): 3400, 3340, 3230 (-NH2). 1H NMR (300 MHz, CDCl3, δ): 
7.95-8.05 (m, Ar-H, 3H), 7.82-7.85 (d, Ar-H, 1H), 7.58-7.62 (d, Ar-H, 2H), 7.30-7.50 (m, 
Ar-H, 6H), 7.10-7.18 (m, Ar-H, 2H), 6.65 (s, Ar-H, 1H), 6.56-6.58 (d, Ar-H, 1H), 3.85 (s, 
NH2, 2H), 3.25-3.38 (m, OCH2, 8H), 3.15-3.18 (m, 4H), 2.62-2.78 (m, CH2CH2O, 4H), 2.21-
2.42 (m, CH3CH2O, 4H), 1.02-1.12 (m, CH3, 6H). 13C NMR (CDCl3, 300 MHz, δ (ppm)): 
167.87 (C=N), 154.15 (sp2 C-N), 151.70, 148.62, 146.76, 141.86, 140.55, 135.01, 134.65, 
132.05, 131.24, 131.04, 128.13, 127.05, 126.87, 126.61, 126.54, 126.05, 123.33, 121.82, 
121.10, 121.05, 119.10, 114.35, 110.15, 70.41, 70.00, 67.37, 66.89, 51.06 (C9), 40.40 
(CH2CH2O), 15.48 (CH3). HRMS calcd for C40H44N2O4S, 648.8586; found 648.3016. 
3.22. Preparation of 7b 
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 Yield 90 % as a light yellow liquid. IR (neat, cm-1): 3447, 3355, 3236 (-NH2), 2870, 
1602, 1468, 1354, 1293, 1248, 1101 (C-O), 1031, 958, 871, 822, 762. 1H NMR (500 MHz, 
CDCl3, δ): 8.10-8.15 (m, Ar-H, 3H), 7.90-7.93 (d, Ar-H, 1H), 7.65-7.68 (d, Ar-H, 2H), 7.40-
7.58 (m, Ar-H, 6H), 7.18-7.20 (d, Ar-H, 1H), 6.79 (s, Ar-H, 1H), 6.70 (d, Ar-H, 1H), 3.95-
4.02 (s, 2H), 3.50-3.70 (m, OCH2, 68H), 3.35-3.45 (m, OCH3,10H), 2.78-2.80 (m, 
CH2CH2O, 4H), 2.30-2,42 (d, CH3CH2O, 4H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 
167.79, 154.23, 148.48, 140.37, 135.01, 134.50, 132.27, 131.50, 131.21, 128.02, 127.84, 
126.96, 126.50, 126.20, 125.55, 123.85, 121.81, 121.50, 121.15, 121.05, 119.50, 115.48, 
114.85, 109.80, 71.92, 70.77, 70.54, 70.46, 70.30, 70.00, 67.04, 59.10 (OCH3), 50.73 (C9), 
40.05 (CH2CH2O). HRMS calcd for C58H80O14N2S, 1065.3204; found 1065.6587. 
3.23. Preparation of 8a 
 
2-Amino-7-styrylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7a (0.65 g, 
1 mmol) was weighed and dissolved into DMF (15 mL). The solution was degassed with 
nitrogen for 10 minutes, and then potassium carbonate (0.50 g, 3.6 mmol), ethyl 
bromoacetate (0.50 g, 3 mmol) were added. The resulting solution was heated under nitrogen 
atmosphere to 95 0C for 20 h. At the end of this period, the solution was allowed to cool to 
room temperature and poured into water (50 mL) to which methylene chloride (40 mL) was 
added. The organic phase was removed. The aqueous phase was extracted 3 times with 
methylene chloride (40 mL). The organic phases were combined, washed with water, and 
dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a crude 
product which was further purified on a silica gel column using hexane and ethyl acetate 
(3:7) as the eluent to obtain 0.61 g of 2-N,N-bis(2-ethylacetate)amino-9,9-di-2-(2-ethoxy 
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ethoxy)ethylfluorene 8a (0.61 g, 0.7 mmol) as a yellow solid with mp of 103 - 105 0C (75 % 
yield). 1H NMR (500 MHz, CDCl3, δ): 8.02-8.08 (m, Ar-H, 3H), 7,82-7.85 (d, Ar-H, 1H), 
7.58-7.62 (m, Ar-H, 3H), 7.40-7.58 (m, Ar-H, 3H), 7.30-7.38 (d, Ar-H, 2H), 7.25 (d, Ar-H, 
1H), 7.10-7.12 (d, Ar-H, 1H), 6.52-6.59 (m, Ar-H, 2H), 4.10-4.18 (m, CO2CH2, NCH2, 8H), 
3.30-3.38 (m, OCH2, 8H), 3.10-3.18 (m, 4H), 2.65-2.78 (m, CH2CH2O, 4H), 2.22-2.43 (m, 
CH3CH2O, 4H), 0.98-1.02 (m, CH3, 6H).13C NMR (500 MHz, CDCl3, δ (ppm)): 170.86 
(CO2C2H5), 167.98 (C=N), 154.11 (sp2 C-N), 150.55, 150.15, 148.35, 148.25, 148.08, 
140.47, 140.27, 140.13, 135.01, 134.65, 132.03, 131.25, 131.01, 127.94, 126.67, 126.35, 
126.16, 125.87, 125.32, 122.28, 122.18, 121.96, 120.75, 120.45, 118.37, 112.12, 106.42, 
70.06, 69.66, 67.05, 66.54, 61.28, 53.83 (NCH2), 50.89 (C9), 39.92 (CH2CH2O), 15.05 
(CH3), 14.27 (CH3). HRMS calcd for C48H56O8N2S, 821.039; found 820.3751. 
3.24. Preparation of 9a 
 
 Compound 8a (0.41 g, 0.5 mmol) was weighed and dissolved into a solution of  
 
30 % aqueous methanol (20 mL). To this solution, sodium hydroxide (0.12 g, 3 mmol)  
 
was added and refluxed overnight. At the end of this period, the resulting solution was  
 
allowed to cool to room temperature and then it was poured into water (30 mL) to which HCl  
 
was added to neutralize this solution. The solution was transfered into a separatory flask, and  
 
then methylene chloride (40 mL) was added. The organic phase was removed and the  
 
aqueous phase was extracted 3 times with portions of methylene chloride (100mL). The  
 
organic phases were combined, washed with water, and dried over sodium sulfate. The  
 
filtrate was removed under reduced pressure to obtain a crude product which was further  
 
purification on a silicagel column using methanol and methylene chloride (3:7) as the eluent  
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to obtain compound 9a as a light yellow solid with mp of 110 – 114 0C in 40 % yield. 1H  
 
NMR (500 MHz, CDCl3, δ): 7.98-99 (d, Ar-H, 1H), 7.8-7.9 (m, Ar-H, 2H), 7.62-7.65 (m, Ar-
H, 2H), 7.45-7.55 (m, Ar-H, 3H), 7.30-7.35 (m, Ar-H, 3H), 7.15-7.18 (d, Ar-H, 2H), 7.05-
7.08 (d, Ar-H, 1H), 6.58-6.59 (s, Ar-H, 1H), 6.50 (m, Ar-H, 1H), 4.10-4.15 (s, NCH2, 4H), 
3.10-3.43 (m, OCH2, 12H), 2.65-2.75 (d, CH2CH2O, 4H), 2.2-2.3 (m, CH3CH2, 4H), 1.26-
1.32 (m, CH3, 6H), 1.14-1.16 (m, CH3, 6H).13C NMR (500 MHz, CDCl3, δ (ppm)): 170.86 
(CO2C2H5), 167.98 (C=N), 154.11 (sp2 C-N), 150.55, 150.15, 148.35, 148.25, 148.08, 
140.47, 140.27, 140.13, 135.01, 134.65, 132.03, 131.25, 131.01, 127.94, 126.67, 126.35, 
126.16, 125.87, 125.32, 122.28, 122.18, 121.96, 120.75, 120.45, 118.37, 112.12, 106.42, 
70.06, 69.66, 67.05, 66.54, 61.28, 53.83 (NCH2), 50.89 (CH2CH2O), 39.92 (CCH2CH2O), 
15.05 (CH3), 14.27 (CH3). HRMS calcd for C44H48O8N2S, 764.8886; found 764 (traces). 
3.25. Preparation of 8b 
 
2-Amino-7-styrylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7a (0.65 g, 
1 mmol) was weighed and dissolved in 1,2-dichlorobenzene (10 mL) in a 50 mL flask. To 
this solution, potassium carbonate (0.7 g, 5 mmol), Cu powder (0.3 g, 5 mmol), 18-crown-6 
(0.10 g), and iodobenzene (0.60 g, 2.9 mmol) were added. The mixture was refluxed under 
nitrogen atmosphere at 180 0C for 24 h. At the end of this period, the solution was allowed to 
cool to room temperature. The solution was then filtered using a short silica gel plug and 
washed with ethyl acetate (100 mL). The filtrate was removed under reduced pressure to 
obtain a crude product which was purified on a silica gel column using hexane and ethyl 
acetate (3:7) as the eluent to obtain compound 8b (0.50 g, 0.6 mmol) as a yellow solid with 
mp of 44 – 45 0C (62 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.08 (d, Ar-H, 1H), 7.98 (d, 
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Ar-H, 2H), 7.92 (d, Ar-H, 1H), 7.48-7.52 (m, Ar-H, 4H), 7.41-7.45 (m, Ar-H, 4H), 7.23-7.28 
(m, Ar-H, 4H), 7.10-7.15 (m, Ar-H, 4H), 7.01-7.08 (m, Ar-H, 4H), 6.72-6.78 (d, Ar-H, 1H), 
6.63 (d, Ar-H, 1H), 3.35-3.41 (m, OCH2, 8H), 3.25-3.28 (m, 4H), 2.80-2.82 (m, CH2CH2O, 
4H), 2.16-2.19 (m, CH3CH2O, 4H), 1.12-1.15 (m, CH3, 6H). 13C NMR (500 MHz, CDCl3, δ 
(ppm)): 167.90 (C=N), 154.05 (sp2 C-N), 150.11, 147.80, 147.70, 140.14, 139.94, 135.73, 
134.53, 132.09, 129.78,129.55, 129.31, 129.21, 128.12, 127.48, 126.12, 125.75, 124.03, 
123.65, 123.48, 123.21,123.12, 122.86, 121.95, 120.56, 119.55, 119.45, 70.11, 69.72, 67.28, 
66.58, 50.96 (C9), 39.24 (CH2CH2O), 15.10 (CH3). HRMS calcd for C52H52O4N2S, 
801.0538; found 800.3742. 
3.26. Preparation of 8c 
 
 2-Amino-7-styrylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7a (0.65 g, 
1 mmol) was weighed and dissolved into DMF (15 mL). The solution was degas with 
nitrogen for 10 minutes, and then potassium carbonate (0.5 g, 3.6 mmol), sodium iodide 
(0.30 g, 2 mmol), propargyl bromide (0.36 g, 3 mmol), and a magnetic stirring bar were 
added. The resulting solution was heated to 950C for 20 h. At the end of this period, the 
solution was allowed to cool to room temperature and then poured into water (50 mL) to 
which methylene chloride (40 mL) was added. The organic phase was removed, and the 
aqueous phase was extracted 3 times with methylene chloride (40 mL). The organic phases 
were combined, washed with water, and then dried over sodium sulfate. The filtrate was 
removed under reduced pressure to obtain a crude product which was further purified on a 
silica gel column using hexane and ethyl acetate (3:7) as the eluent to obtain 2-N,N-
bispropargylamino-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 8c (0.56 g, 0.7 mmol) as a 
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yellow solid with mp of 151 – 152 0C in 70 % yield. 1H NMR (300 MHz, CDCl3, δ): 8.05-
8.10 (m, Ar-H, 3H), 7.85-7.90 (d, Ar-H, 1H), 7.75-7.82 (m, Ar-H, 2H), 7.50-7.55 (m, Ar-H, 
3H), 7.40-7.45 (m, Ar-H, 2H), 7.35-7.38 (m, Ar-H, 1H), 7.20-7.22 (d, Ar-H, 1H), 7.05-7.08 
(d, Ar-H, 1H), 6.82-6.92 (m, Ar-H, 2H), 4.05-4.10 (s, 4H), 3.32-3.38 (m, OCH2, 8H), 3.10-
3.18 (m, 4H), 2.65-2.78 (m, CH2CH2O, 4H), 2.30-2.38 (m, CH3CH2O, 4H), 1.02-1.08 (m, 
6H). 13C NMR (CDCl3, 500 MHz, δ (ppm)): 166.75, 153.22, 149.61, 147.95, 146.83, 139.83, 
139.29, 133.99, 133.86, 131.32, 131.14, 129.75, 126.92, 125.85, 125.66, 125.63, 125.32, 
124.11, 122.11, 120.59, 119.77, 119.64, 118.10, 114.13, 109.57, 77.99, 72.03, 69.06, 68.65, 
66.07, 65.56, 49.97 (C9), 39.94 (CH2CH2O), 38.59 (C-N), 14.05 (CH3). HRMS cald for 
C46H48O4N2S, 724.9562; found 724.3329. 
3.27. Preparation of 8d 
 
 Compound 7b was utilized, then methylene chloride and methanol (95:5) was used as 
the eluent to obtain compound 8d as an oily liquid (65 % yield). 1H NMR (500 MHz, CDCl3, 
δ): 8.12-8.15 (m, Ar-H, 3H), 7.92-7.95 (d, 1H), 7.65-7.72 (d, Ar-H, 2H), 7.55-7.58 (m, Ar-H, 
3H), 7.50-7.55 (m, Ar-H, 2H), 7.38-7.39 (d, Ar-H, 1H), 7.30-7.32 (d, Ar-H, 1H), 7.20-7.22 
(d, Ar-H, 1H), 6.90-6.95 (m, 2H), 4.20 (m, 4H), 3.54-3.65 (m, 70H), 3.37-3.42 (m, 12H), 
3.22 (m, 4H), 2.80 (m, CH2CH2O, 4H), 2.38-2.42 (m, CH3CH2O, 4H). 13C NMR (500 MHz, 
CDCl3, δ (ppm)): 167.77, 154.23, 150.35, 149.10, 148.00, 140.95, 140.28, 135.01, 132.33, 
132.19, 128.03, 127.84, 127.16, 126.99, 126.87, 125.95, 125.23, 123.76, 121.80, 121.35, 
119.62, 119.43, 115.78, 115.61, 110.25, 110.15, 79.50, 73.55, 71.91, 70.77, 70.65, 70.53, 
70.45, 70.41, 70.27, 69.99, 58.90 (OCH3), 50.97 (C9), 40.50 (CH2CH2O), 39.2 (C-N). HRMS 
calcd for C60H76O12N2S, 1049.3266; found 1048.7501. 
  97 
3.28. Preparation of 1-Azidobutane 
 
 1-Bromobutane (5.50 g, 40 mmol) was weighed and dissolved in DMSO (50 mL) at  
 
room temperature in a 200 mL flask to which was added sodium azide (3.90 g, 60 mmol).  
 
The solution was then heated to 95 0C under nitrogen for 24 h. At the end of this period, the  
 
solution was allowed to cool to room temperature. A white precipitate formed and the  
 
resulting mixture was poured into water (100 mL). It was transferred into a separatory flask  
 
to which diethyl ether (50 mL) was added. The organic phase was then removed. The  
 
aqueous phase was then extracted 3 times with portion of diethyl ether (100 mL). The ether  
 
phases were then combined, washed with water, dried with sodium sulfate, then evaporated  
 
under reduced pressure to yield 1-azidobutane (3.0 g, 30 mmol) in 80 % yield as a colorless  
 
liquid. IR: 2090 cm-1 (N3). 1H NMR (500MHz, CDCl3, δ): 3.18-3.21 (m, 2H), 1.49-1.55 (m,  
 
2H), 1.30-1.37 (m, 2H), 0.86-0.89 (m, 3H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 39.97 (C- 
 
N), 29.82, 18.87, 12.60 (CH3). 
 
3.29. Preparation of 1-Azido-11-Undecanol 
 
 1-Bromo-11-undecanol (5.00 g, 20 mmol) was weighed and dissolved into 
acetonitrile (125 mL) in a 500 mL flask. To this solution, sodium azide (2.00 g, 30 mmol) 
and a magnetic stirring bar were added. The resulting solution was refluxed at 80 0C under 
nitrogen for 20 h. At the end of this period, the solution was allowed to cool to room 
temperature, and then filtered and washed with acetonitrile (50 mL). The filtrate was 
evaporated under reduced pressure to obtain 1-azido-11-undecanol (4.20 g, 19 mmol) as a 
colorless liquid (97 % yield). The product was pure enough for the next reaction without 
further purification. 1H NMR (500 MHz, CDCl3, δ): 3.59-3.61 (m, 2H), 3.23-3.25 (m, 2H), 
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1.53-1.60 (m, 4H), 1.27-1.34 (m, 14H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 62.91 
(OCH2), 51.46 (C-N), 32.75, 29.54, 29.44, 29.40, 29.25, 29.12, 28.81, 26.69, 25.73. 
3.30. Preparation of 1-Azido-11-Undecanyl Tosylate 
 
 1-Azido-11-undecanol (4.00 g, 19 mmol) was weighed and dissolved into pyridine 
(10 mL) in a 100 mL flask immersed in an ice bath at 5 0C. To this solution, 4-
methylbenzenesulfonyl chloride (3.50 g, 18 mmol) was added in portions in 20 minutes. The 
resulting solution was stirred at 5 0C under nitrogen atmosphere for 3 h. At the end of this 
period, a white precipitate formed and the solution was poured into a cold solution 
hydrochloric acid (10 mL) in water (50 mL). The resulting solution was transferred into a 
separatory flask to which methylene chloride (40 mL) was added. The organic phase was 
removed, and the aqueous phase was extracted 3 times with portions of methylene chloride 
(100 mL). The organic phases were combined, washed with a solution of 1 % sodium 
bicarbonate (100 mL) and water, and then dried over sodium sulfate. The filtrate was 
removed under reduced pressure and under vacuo to obtain 1-azido-11-undecanyl tosylate 
(6.30 g, 18 mmol) as a colorless oily liquid (92 % yield). The product is pure enough for the 
next reaction without further purification. 1H NMR (500 MHz, CDCl3, δ): 7.70-7.72 (d, Ar-
H, 2H), 7.20-7.28 (d, Ar-H, 2H), 3.93-3.95 (m, 2H), 3.17-3.19 (m, 2H), 2.37-2.50 (s, 3H), 
1.44-1.57 (m, 4H), 1.15-1.36 (m, 14H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 144.65, 
133.19, 129.73, 127.91, 70.70 (SO3C), 51.46 (C-N), 29.39, 29.34, 29.10, 28.89, 28.82, 28.79, 
26.68, 25.31, 21.68. 
3.31. Preparation of 1-Azido-11-Undecanethiol 
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 1-Azido-11-undecanyl tosylate (6.00 g, 16 mmol) was weighed and dissolved into 
ethanol (40 mL) in a 250 mL flask, and a magnetic stirring bar. To this solution, thiourea 
(1.80 g, 24 mmol) was added and the solution was refluxed at 80 0C under nitrogen 
atmosphere for 10 h. At the end of this period, the solution was allowed to cool to room 
temperature, and then a solution of 10 % sodium hydroxide (60 mL) was added. The 
resulting solution was refluxed at 100 0C for 4 h. It was allowed to cool to room temperature, 
and neutralized with a solution of 10 % hydrochloric acid. The solution was transferred into a 
separatory flask to which methylene chloride (50 mL) was added. The organic phase was 
removed, and the aqueous phase was extracted 3 times with methylene chloride (40 mL). The 
organic phases were combined, washed with water, and then dried over sodium sulfate. The 
filtrate was removed under reduced pressure to obtain a crude produce as a white solid. The 
crude produce was purified on a silica gel column using hexane and methylene chloride (7:3) 
as the eluent to obtain 1-azido-11-undecanethiol (3.00 g, 13 mmol) as a colorless liquid (80 
% yield). IR (Perkin Elmer): 2098 cm-1. 1H NMR (500 MHz, CDCl3, δ): 3.15-3.20 (m, 2H), 
2.42-2.62 (m, 2H), 1.47-1.63 (m, 4H), 1.21-1.32 (m, 15H). 13C NMR (500 MHz, CDCl3, δ 
(ppm)): 51.47 (C-N3), 39.15 (C-S), 34.04, 29.45, 29.20, 29.05, 28.83, 27.72, 28.36, 26.71, 
24.66. 
3.32. Preparation of 9b 
 
 Compound 8c (0.36 g, 0.5 mmol) was weighed and dissolved into a solution of  
 
dioxane (15 mL) and triethylamine (1 mL) in a 50 mL flask at room temperature. The  
 
solution was degassed with nitrogen for 10 minutes, and then CuI (0.10 g, 0.5 mmol) and 1- 
 
azidobutane (0.20 g, 2 mmol) were added. The resulting solution was stirred under nitrogen  
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for 24 h. At the end of this period, the solution was poured into water (40 mL) to which  
 
methylene chloride (30 mL) was added. The organic phase was removed, and the aqueous  
 
phase was extracted 3 times with methylene chloride (40 mL). The organic phases were  
 
combined and then dried with sodium sulfate. The filtrate was removed under reduced  
 
pressure to obtain a crude product which was further purified on a silica gel column using  
 
ethyl acetate and THF (8:2) as the eluent to obtain compound 9b (0.33 g, 0.36 mmol) as an  
 
oily liquid in 72 % yield. 1H NMR (500 MHz, CDCl3, δ): 8.05-8.08 (m, Ar-H, 4H), 7.82-7.85  
 
(d, Ar-H, 1H), 7.62-7.65 (m, Ar-H, 2H), 7.40-7.45 (m, Ar-H, 6H), 7.30-7.35 (m, Ar-H, 1H),  
 
7.20-7.22 (m, Ar-H, 1H), 7.05-7.10 (d, Ar-H, 1H), 6.85-6.90 (m, Ar-H, 2H), 4.65-4.70 (s, N- 
 
CH2, 4H), 4.22-4.28 (d, NCCH2, 4H), 3.30-3.38 (m, OCH2, 8H), 3.10-3.18 (m, OCH2, 4H),  
 
2.75-2.78 (m, CH2CH2O, 4H), 2.22-2.30 (d, CH3CH2O, 4H), 1.82-1.89 (m, CH2, 4H), 1.26- 
 
1.35 (m, CH2, 4H), 1.09-1.13 (m, OCCH3, 6H), 0.91-0.95 (m, CH3, 6H). 13C NMR (500  
 
MHz, CDCl3, δ (ppm)): 167.80 (C=N), 154.25 (sp2 C-N), 150.98, 148.37, 145.0, 141.52,  
 
140.77, 135.87, 134.65, 134.25, 132.17, 130.84, 127.98, 126.55, 126.06, 125.78, 123.25,  
 
122.0, 121.75, 121.45, 118.85, 110.37, 108.89, 70.01, 69.81, 66.87, 66.47, 50.15 (C9),  
 
49.85(C-N), 46.0 (C-N), 39.85 (CH2CH2O), 32.12, 19.95, 14.89 (CH3), 13.67 (CH3).  
 
HRMS calcd for C54H66O4N8S, 923.2266; found 922.4922. 
 
3.33. Preparation of 9c 
 
 Compound 8a (0.36 g, 0.5 mmol) was weighed and dissolved in a solution of dioxane 
(15 mL) and triethylamine (1 mL) in a 50 mL flask at room temperature. The solution was 
degassed with nitrogen for 10 minutes, and then copper (I) iodide (0.10 g, 0.5 mmol) and 1-
azido-11-undecanethiol (0.46 g, 2 mmol) were added into the solution and heated to 70 0C 
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under nitrogen for 48 h. At the end of this period, the solution was poured into water (40 mL) 
to which methylene chloride (30 mL) was added. The organic phase was removed, and the 
aqueous phase was extracted 3 times with methylene chloride (40 mL). The organic phases 
were combined and dried over sodium sulfate. The filtrate was removed under reduced 
pressure to obtain a crude product which was further purified on a silica gel column using 
ethyl acetate and THF (8:2) as the eluent to obtain compound 9c (0.35 g, 0.25 mmol) as an 
oily liquid in 50 % yield. 1H NMR (500 MHz, CDCl3, δ): 8.10-8.15 (m, Ar-H, 4H), 7.90-7.92 
(d, Ar-H, 1H), 7.65-7.70 (d, Ar-H, 2H), 7.50-7.58 (m, Ar-H, 6H), 7.35-7.38 (m, Ar-H, 1H), 
7.30-7.34 (m, Ar-H, 1H), 7.15-7.18 (d, Ar-H, 1H), 7.05-7.10 (m, Ar-H, 2H), 4.75-4.78 (s, 
NCH2, 4H), 4.25-4.28 (m, NCCH2, 4H), 3.39-3.41 (dd, OCH2, 8H), 3.20-3.28 (m, OCH2, 
4H), 2.75-2.82 (m, CH2CH2O, 4H), 2.62-2.65 (m, 4H), 2.30-2.42 (dd, CH3CH2O, 4H), 1.82-
1.85 (m, CH2, 4H), 1.50-1.65 (m, CH2, 10H), 1.20-1.28 (m, CH2, 24H) 1.10-1.12 (m, CH3, 
6H). 13C NMR (500MHz, CDCl3, δ (ppm)): 167.85 (C=N), 154.20 (sp2 C-N), 151.05, 148.27, 
145.11, 141.54, 140.15, 135.19, 134.27, 132.18, 130.47, 127.94, 126.70, 126.22, 125.14, 
122.87, 122.15, 121.79, 121.05, 119.06, 112.58, 108.26, 70.06, 69.72, 66.83, 66.57, 51.58 
(C9), 50.39 (C-N), 46.75 (C-N), 39.13 (CH2CH2O), 30.35, 29.48, 29.42, 29.25, 29.15, 29.03, 
28.84, 28.51, 26.72, 26.53, 15.09 (CH3). HRMS calcd for C68H94O4N8S3, 1183.7218; found 
1183.6347. 
3.34. Preparation of 9d 
 
 Compound 8d (0.6 g) was utilized and 0.2 g of copper (I) complex151 was employed. 
Purification was used methylene chloride and methanol (95:5) as the eluent to obtain a 
yellow liquid (40 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.10-8.13 (m, Ar-H, 4H), 7.80-
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7.85 (d, Ar-H, 1H), 7.62-7.64 (d, Ar-H, 2H), 7.42-7.58 (m, Ar-H, 6H), 7.35-7.38 (m, Ar-H, 
1H), 7.25-7.28 (m, Ar-H, 1H), 7.18-7.20 (m, Ar-H, 1H), 6.90-6.98 (m, Ar-H, 2H), 4.70-4.75 
(s, NCH2, 4H), 4.32-4.35 (m, NCCH2, 4H), 3.42-3.62 (m, OCH2, 58H), 3.35-3.42 (m, OCH2, 
10H), 3.20-3.25 (m, OCH3, OCH2, 10H), 2.90-2.92 (m, 4H), 2.78-2.81 (m, CH2CH2O, 4H), 
2.62-2.65 (m, 4H), 2.38-2.42 (m, 4H), 1.80-1.85 (m, CH2, 4H), 1.48-1.78 (m, CH2, 10H), 
1.20-1.40 (m, CH2, CH3, 24H). 13C NMR (500MHz, CDCl3, δ (ppm)): 167.89 (C=N), 154.25 
(sp2 C-N), 151.11, 148.34, 145.01, 141.11, 140.21, 134.92, 134.62, 132.25, 130.05, 127.79, 
127.15, 125.01, 123.15, 122.27, 121.88, 121.03, 119.29, 113.59, 108.47, 72.01, 71.10, 70.92, 
70.52, 70.31, 70.11, 69.82, 66.58, 58.85 (OCH3), 50.78 (C9), 50.18 (C-N), 46.25 (C-N), 
39.53 (CH2CH2O), 30.41, 30.35, 29.56, 29.40, 29.19, 28.79, 28.56,28.21, 27.76, 27.63, 
27.41, 26.55. HRMS calcd for C74H106O8N8S3, 1331.8802; found 1332.3254. 
3.35. Preparation of 6e 
 
2-Iodo-7-nitro-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 5c (1.70 g, 3 mmol) was 
weighed and dissolved into a mixture of THF (15 mL) and triethylamine (15 mL) in a 100 
mL flask. The solution was degassed with nitrogen for 10 minutes, then PdCl2P(Ph3)2 (0.10 
g, 0.14 mmol), CuI (0.06 g, 0.32 mmol) and 2-(4-ethynylphenyl)benzothiazole 5a (0.85 g, 
3.6 mmol) were added. The resulting solution was stirred under nitrogen atmosphere for 12 
h. At the end of this period, it was poured into water (50 mL) to which methylene chloride 
(40 mL) was added. The organic phase was removed. The aqueous phase was extracted 3 
times with methylene chloride (40 mL), and then organic phases were combined, washed 
with water, and dried over sodium sulfate. The filtrate was removed under reduced pressure 
to obtain a crude product which was further purified on a silica gel column using hexane and 
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ethyl acetate (6:4) as the eluent to obtain 2-nitro-7-styrynylbenzothiazolyl-9,9-di-2-(2-ethoxy 
ethoxy)ethylfluorene 6e (1.60 g, 2.4 mmol) as a light yellow solid with mp of 126 - 127 0C 
(68 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.22-8.28 (m, Ar-H, 2H), 8.05-8.15 (m, Ar-H, 
3H), 7.88-7.90 (d, Ar-H, 1H), 7.70-7.75 (m, Ar-H, 2H), 7.62-7.68 (m, Ar-H, 3H), 7.55-7.58 
(d, Ar-H, 1H), 7.42-7.45 (m, Ar-H, 1H), 7.35-7.38 (m, Ar-H, 1H), 3.05-3.40 (t, OCH2, 12H), 
2.75-2.85 (dd, CH2CH2O, 4H), 2.38-2.45 (m, CH3CH2O, 4H), 1.05-1.08 (m, CH3, 6H). 13C 
NMR (500 MHz, CDCl3, δ (ppm)): 167.57 (C=N), 154.25 (sp2 C-N), 152.03, 149.57, 140.01, 
139.23, 135.17, 132.55, 132.13, 131.28, 130.67, 127.50, 126.79, 126.57, 126.49, 125.41, 
123.35, 121.96, 121.90, 121.69, 121.47, 119.94, 112.13, 89.79, 70.13, 69.66, 66.82, 66.62, 
51.64 (C9), 39.57 (CH2CH2O), 15.10 (CH3). HRMS calcd for C40H40O6N2S, 676.8258; found 
676.2601. 
3.36. Preparation of 7c 
 
2-Nitro-7-styrynylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 6d (1.20 g, 
1.8 mmol) was weighed and dissolved in a mixture of ethanol (25 mL) and THF (25 mL) in a 
200 mL flask at room temperature. The solution was degassed with nitrogen for 10 minutes, 
and then 10 % palladium on carbon (0.12 g) was added. The resulting solution was heated to 
60 0C under nitrogen atmosphere. To this solution, hydrazine hydrate (0.50 g, 10 mmol) was 
added dropwise in 10 minutes, and then the solution was refluxed at 70 0C for 20 h. At the 
end of this period, the solution was allowed to cool to room temperature, and then it was 
filtered using a short silica gel plug, and washed with THF. The filtrate was removed under 
reduced pressure to obtain a crude product which was further purified on a silica gel column 
using ethyl acetate and THF (4:1) as the eluent to obtain 2-amino-7-styrynylbenzothiazolyl-
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9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7c (1.10 g, 1.7 mmol) as a yellow solid with mp of 
126 – 127 0C (90 % yield). 1H NMR (300 MHz, CDCl3, δ): 8.05-8.10 (m, Ar-H, 3H), 7.85-
7.90 (d, Ar-H, 1H), 7.61-7.65 (m, Ar-H, 2H), 7.40-7.60 (m, Ar-H, 6H), 6.62-6.74 (d, Ar-H, 
2H), 3.78-3.82 (s, NH2, 2H), 3.29-3.40 (m, OCH2, 8H), 3.16-3.23 (m, 4H), 2.71-2.80 (m, 
CH2CH2O, 4H), 2.27-2.40 (m, CH3CH2O, 4H), 1.05-1.10 (m, CH3,6H). 13C NMR (CDCl3, 
500 MHz, δ (ppm)): 166.25 (C=N), 153.14 (sp2-C-N), 150.23, 147.00, 145.94, 140.64, 
134.10, 131.83, 131.01, 130.12, 129.62, 126.43, 125.43, 125.22, 125.16, 125.13, 
124.33,122.27, 120.65, 120.21, 118.43, 117.40, 113.44, 108.62, 92.15, 87.29, 69.08, 68.66, 
65.94, 65.55, 49.80 (C9), 38.87 (CH2CH2O), 14.06 (CH3). HRMS calcd for C40H42O4N2S, 
646.8428; found 646.2859. 
3.37. Preparation of 8e 
 
2-Amino-7-styrynylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7c (0.65 
g, 1 mmol) was weighed and dissolved into DMF (15 mL). The solution was degassed with 
nitrogen for 10 minutes, and then potassium carbonate (0.5 g, 3.6 mmol), sodium iodide (0.3 
g, 2 mmol), propargyl bromide (0.36 g, 3 mmol) were added. The resulting solution was then 
heated at 95 0C for 20 h under nitrogen atmosphere. At the end of this period, the solution 
was allowed to cool to room temperature and poured into water (50 mL) to which methylene 
chloride (40 mL) was added. The organic phase was removed. The aqueous phase was 
extracted 3 times with methylene chloride (40 mL), and then organic phases were combined, 
washed with water, and dried over sodium sulfate. The filtrate was removed under reduced 
pressure to obtain a crude product which was purified on a silica gel column using hexane 
and ethyl acetate (3:7) as the eluent to obtain 2-(N,N-bispropargyl)amino-7-
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styrynylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 8e (0.51 g, 0.7 mmol) as a 
yellow solid with mp of 144.5 - 145.5 0C in 70 % yield. 1H NMR (500 MHz, CDCl3, δ): 
8.01-8.10 (m, Ar-H, 3H), 7.85-7.90 (d, Ar-H, 1H),7.42-7.61 (m, Ar-H, 7H), 7.35-7.38 (m, 
Ar-H, 1H), 6.85-6.90 (m, Ar-H, 2H), 4.10-4.15 (s, NCH2, 2H), 3.31-3.38 (m, OCH2, 8H), 
3.13-3.20 (m, 4H), 2.68-2.78 (m, CH2CH2O, 4H), 2.25-2.38 (m, CH3CH2O, 4H), 1.06-1.09 
(m, CH3, 6H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 165.57 (C=N), 154.11 (sp2 C), 150.67, 
148.27, 148.11, 140.95, 135.27, 132,25, 132.06, 131.66, 131.45, 127.47, 126.47, 126.20, 
129.98, 123.32, 121.68, 121.15, 119.92,115.89, 114.75, 110.11, 93.85, 89.27, 78.96, 73.10, 
70.10, 69.69, 67.01, 66.60, 51.12 (C9), 40.92 (NCH2), 39.79 (CH2CH2O), 15.10 (CH3). 
HRMS calcd for C46H46O4N2S, 722.9404; found 722.3172. 
3.38. Preparation of 8f 
 
2-Amino-7-styrynylbenzothiazolyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7c (0.65 
g, 1 mmol) was weighed and dissolved in 1,2-dichlorobenzene (10 mL) in a 50 mL flask. To 
this solution, potassium carbonate (0.70 g, 5 mmol), Cu powder (0.3 g, 5 mmol), 18-crown-6 
(0.1 g), and iodobenzene (0.60 g, 2.9 mmol) were added. The solution was refluxed at 180 0C 
for 24 h. At the end of this period, it was allowed to cool to room temperature, and filtered 
using a short silica gel plug. The filtrate was removed under reduced pressure to obtain a 
crude product which was further purified on a silica gel column using hexane and ethyl 
acetate (3:7) as the eluent to obtain compound 8f (0.45 g, 0.6 mmol) as a yellow solid with 
mp of 145 – 146 0C in 67 % yield. 1H NMR (500 MHz, CDCl3, δ): 8.01-8.08 (m, Ar-H, 3H), 
7.82-7.88 (d, Ar-H, 1H), 7.58-7.61 (m, Ar-H, 2H), 7.42-7.55 (m, Ar-H, 3H), 7.35-7.38 (m, 
Ar-H, 1H), 7.18-7.20 (m, Ar-H, 6H), 7.02-7.08 (m, Ar-H, 5H), 6.92-6.98 (m, Ar-H, 3H), 
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3.31-3.39 (m, OCH2, 8H), 3.16-3.23 (m, 4H), 2.74-2.83 (m, CH2CH2O, 4H), 2.16-2.29 (m, 
CH3CH2O, 4H), 1.07-1.10 (m, CH3, 6H). 13C NMR (500 MHz, CDCl3, δ 
(ppm)):167.73(C=N), 154.25 (sp2-C-N), 151.52, 149.01, 148.0, 147.7, 140.15, 135.07, 
144.06, 132.61, 132.17, 132.06, 131.65, 131. 49, 128.75, 128.47, 126.73, 126.68, 126.35, 
126.27, 126.13, 125.57, 122.1, 124.21, 123.89, 123.54, 122.0, 121.80, 121.70, 120.40, 
118.65, 118.45, 118.14, 117.93, 92.27, 89.20, 70.11, 69.71, 67.16, 66.63, 51.14 (C9), 39.94 
(CH2CH2O), 15.21 (CH3). HRMS calcd for C52H50O4N2S, 799.3546; found 799.038. 
3.39. Preparation of 6f 
 
Compound 5c (0.60 g, 1 mmol) was dissolved in toluene (10 mL) in a 50 mL flask 
and the solution was degassed with nitrogen for 10 minutes. To this solution, 
tetrakis(triphenylphosphine) palladium (0.04 g) was added, and then followed by (2-tri-n-
butylstannyl)benzothiazole103 (0.70 g, 1.2 mmol). The solution was then refluxed at 110 0C 
for 12 h under nitrogen atmosphere. At the end of this period, it was allowed to cool to room 
temperature. The resulting solution was poured into water (50 mL), and then it was extracted 
by methylene chloride. The filtrate was removed under reduced pressure to obtain a crude 
produce which was further purified on a silica gel column using hexane and ethyl acetate 
(40:60) as the eluent to obtain 0.3 g of compound 5b (0.30 g, 0.52 mmol) as a yellow solid 
with mp of 64 – 65 0C (55 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.35 (s, Ar-H, 1H),8.30-
8.32 (m, Ar-H, 1H), 8.25 (s, Ar-H, 1H), 8.12-8.18 (m, Ar-H, 2H), 7.95-7.98 (d, Ar-H, 1H), 
7.85-7.92 (m, Ar-H, 2H), 7.51-7.57 (m, Ar-H, 1H), 7.22-7.25 (m, Ar-H, 1H), 3.30-3.39 (m, 
OCH2, 4H), 3.22-3.25 (m, 4H), 3.15-3.20 (m, 4H), 2.80-2.90 (m, CH2CH2O, 2H), 2.80-2.82 
(m, CH2CH2O, 2H), 2.55-2.58 (m, CH3CH2O, 4H), 1.07-1.10 (m, CH3, 6H). 13C NMR (500 
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MHz, CDCl3, δ (ppm)): 167.80 (C=N), 154.11 (sp2 C-N), 151.69, 151.50, 147.58, 145.74, 
140.81, 135.13, 134.46, 127.78, 126.25, 125.70, 125.80, 123.14, 122.53, 122.13, 121.76, 
120.20, 119.78, 119.68, 70.11, 69.56, 66.85, 66.57, 52.41 (C9), 39.28 (CH2CH2O), 15.08 
(CH3). HRMS calcd for C32H36O6N2S, 576.7062; found 576.2288. 
3.40. Preparation of 7d 
 
Compound 6f (0.58 g, 1 mmol) was dissolved in a mixture of ethanol (5 mL) and 
THF (5 mL) in a 50 mL flask. The solution was degassed with nitrogen for 10 minutes, and 
then 10 % palladium on carbon (0.06 g) was added. The solution was heated to 60 0C under 
nitrogen atmosphere. To this solution, hydrazine hydrate (0.26 g, 6 mmol) was added 
dropwise in 10 minutes, and then the resulting solution was refluxed at 70 0C for 20 h. At the 
end of this period, the solution was allowed to cool to room temperature, and then it was 
filtered using a short silica gel plug. The filtrate was removed under reduced pressure to 
obtain a crude product which was further purified on a silica gel column using hexane and 
ethyl acetate (1:4) as the eluent to obtain 2-amino-7-benzothiazolyl-9,9-di-2-(2-ethoxy 
ethoxy)ethylfluorene 7d (0.45 g, 0.8 mmol) as a yellow solid with mp of 131 - 132 0C in 85 
% yield. 1H NMR (300 MHz, CDCl3, δ): 8.01-8.04 (d, Ar-H, 2H), 7.92-7.95 (d, Ar-H, 1H), 
7.84-7.85 (d, Ar-H,1H), 7.53-7.55 (d, Ar-H,1H), 7.42-7.46 (m, Ar-H, 2H), 7.32-7.35 (m, Ar-
H, 1H), 6.75-6.78 (s, Ar-H, 1H), 6.61-6.65 (d, Ar-H, 2H), 3.25-3.36 (m, 10H), 3.11-3.18 (m, 
4H), 2.65-2.78 (m, CH2CH2O, 4H), 2.42-2.46 (m, CH3CH2O, 2H), 2.27-2.33 (m, CH3CH2, 
2H), 1.02-1.05 (m, CH3, 6H).13C NMR (500 MHz, CDCl3, δ (ppm)): 168.63 (C=N), 154.14 
(sp2 C-N), 151.75, 148.78, 146.49, 144.07, 134.89, 130.91, 130.37, 127.40, 126.25, 126.15, 
125.25, 120.76, 121.79, 121.59, 121.55, 118.48, 114.84, 110.01, 70.09, 69.66, 66.99, 66.56, 
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51.08 (C9), 39.84 (CH2CH2O), 15.13 (CH3). HRMS calcd for C32H38O4N2S, 546.7232; found 
546.2546. 
3.41. Preparation of 8g 
 
Compound 7d (0.40 g, 0.7 mmol) was weighed and dissolved in 1,2-dichlorobenzene 
(10 mL) in a 50mL flask. To this solution, potassium carbonate (0.35 g, 2.5 mmol), Cu 
powder (0.15 g, 2.5 mmol), 18-crown-6 (0.1 g), and then 4-iodoanisole (0.52 g, 2.2 mmol) 
were added and heated to 180 0C for 24 h. At the end of this period, the resulting mixture was 
allowed to cool to room temperature, and then it was filtered using a short silica gel plug. 
The filtrate was removed under reduced pressure to obtain a crude product which was further 
purified on a silica gel column using hexane and ethyl acetate (1:1) as the eluent to obtain 
compound 8g (0.33 g, 0.4 mmol) as a yellow waxy solid in 60 % yield. 1H NMR (500 MHz, 
CDCl3, δ): 8.03-8.13 (dd, Ar-H, 3H), 7.92-7.95 (d, Ar-H, 1H), 7.62-7.64 (d, Ar-H, 1H), 7.48-
7.51 (m, Ar-H, 2H), 7.36-7.39 (m, Ar-H, 2H), 7.01-7.10 (m, Ar-H, 3H), 7.0 (s, 1H), 6.85-
6.92 (m, Ar-H, 5H), 3.83 (s, OCH3, 6H), 3.36-3.43 (m, OCH2, 8H), 3.22-3.29 (m, 4H), 2.83-
2.88 (m, CH2CH2O, 4H), 2.38-2.44 (m, CH3CH2O, 2H), 2.25-2.30 (m, CH3CH2O, 2H), 1.03-
1.08 (m, CH3, 6H). 13C NMR (500 MHz, CDCl3,  δ (ppm)): 168.25 (C=N), 156.00 (sp2-C-N), 
154.10, 151.22, 149.46, 143.70, 140.83, 134.24, 131.93, 131.14, 127.38, 126.68, 126.62, 
126.52, 124.25, 122.94, 121.84, 121.63, 121.23, 120.01, 119.42, 114.78, 70.06, 69.69, 67.19, 
66.59, 55.56 (OCH3), 51.23 (C9), 39.39 (CH2CH2O), 15.10 (CH3). HRMS calcd for 
C46H50O6N2S, 758.9708; found 758.3383. 
3.42. Preparation of 6g 
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2-Iodo-7-nitro-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 5c (2.90 g, 5 mmol) was 
weighed and dissolved into a solution of triethylamine (20 mL) and THF (20 mL) in a 100 
mL flask. The solution was degassed with nitrogen for 10 minutes, and then PdCl2P(Ph3)2 
(0.18 g, 0.25 mmol) and 0.1 g of CuI (0.1 g, 0.5 mmol) were added and following up by 
trimethylsilylacetylene (0.75 g, 7.5 mmol). The resulting solution was stirred for 12 h at 
room temperature, and then it was poured into water (50 mL) to which methylene chloride 
(50 mL) was added. The organic phase was removed. The aqueous phase was extracted 3 
times with methylene chloride (40 mL), and then the organic phases were combined, washed 
with water and dried over sodium sulfate. The filtrate was removed under reduced pressure to 
obtain a crude product which was further purified on a silica gel column using hexane and 
ethyl acetate (7:3) to obtain 2-nitro-7-(1-trimethylsilyl)ethynyl-9,9-di-2-(2-ethoxy 
ethoxy)ethylfluorene 6g (2.10 g, 0.4 mmol) as a yellow oily liquid (70 % yield). 1H NMR 
(500 MHz, CDCl3, δ): 8.18-8.23 (d, Ar-H, 2H), 7.68-7.70 (d, Ar-H, 1H), 7.63-7.64 (d, Ar-H, 
1H), 7.50 (s, Ar-H, 1H), 7.44-7.46 (d, Ar-H, 1H), 3.30-3.32 (m, OCH2 4H), 3.20-3.22 (m, 
2H), 3.04-3.11 (m, 4H), 2.73-2.78 (d, CH2CH2O, 2H), 2.65-2.71 (d, CH2CH2O, 2H), 2.31-
2.43 (d, CH3CH2O, 4H), 1.05-1.18 (m, CH3, 6H), 0.20-0.32 (s, Si(CH3)3, 9H). 13C NMR (500 
MHz, CDCl3, δ (ppm)): 151.56, 151.27, 147.91, 146.59, 138.92, 132.72, 127.87, 121.91, 
121.04, 120.49, 119.74, 119.49, 105.58, 96.82, 70.99, 70.71, 67.74, 67.34, 52.65 (C9), 40.07 
(CH2CH2O), 16.06 (CH3), 0.64 (Si(CH3)3). HRMS calcd for C30H41NO6Si, 539.743; found 
539.2725. 
3.43. Preparation of 7e 
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Compound 6g (2.00 g, 3.8 mmol) was weighed and dissolved into THF (20 mL) in a 
100 mL flask. To this solution, a solution of 5 % potassium hydroxide in methanol (20 mL) 
was added and stirred for 30 minutes. At the end of this period, the resulting solution was 
poured into water (50 mL), and then methylene chloride (40 mL) was added. The organic 
phase was removed, and the aqueous phase was extracted 3 times with methylene chloride 
(40 mL). The organic phases were combined, washed with water, and then dried over sodium 
sulfate. The filtrate was removed under reduced pressure to obtain a crude product which was 
further purified on a silica gel column using hexane and ethyl acetate (7:3) as the eluent to 
obtain 2-nitro-7-ethynyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7e (1.60 g, 3.4 mmol) as a 
yellow solid with mp of 88 – 89 0C in 90 % yield. 1H NMR (500 MHz, CDCl3, δ): 8.10-8.15 
(m, Ar-H, 2H), 7.70-7.80 (m, Ar-H, 2H), 7.50-7.61 (m, Ar-H, 2H), 3.20-3.42 (t, OCH2, sp-
CH, 13H), 2.79-2.85 (m, CH2CH2O, 4H), 2.30-2.45 (m, CH3CH2O, 4H), 1.05-1.14 (m, CH3, 
6H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 150.99, 150.77, 147.40, 145.87, 138.67, 131.96, 
127.37, 123.61, 122.94, 121.16, 120.27, 119.06, 83.60, 78.81, 70.12, 69.58, 66.77, 66.60, 
52.10 (C9), 39.24 (CH2CH2O), 15.05 (CH3). HRMS calcd for C27H33O6N, 467.5698; found 
467.2302. 
3.44. Preparation of Azidobenzene 
 
Phenyl hydrazine (3.40 g, 31 mmol) was weighed in a 30 mL beaker and then was 
added into a solution of hydrochloric acid (6 mL) and water (30 mL) in a 200 mL flask at 0 - 
5 0C immersing in an ice bath. The resulting solution was stirring with a magnetic stirring bar 
and maintained at this temperature during the experimental. To this solution, diethyl ether 
(10 mL) was then added which was followed by the dropwise addition of a solution of 
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sodium nitrite (2.50 g, 36 mmol) in water (5 mL). The resulting mixture was allowed to stand 
at this temperature for an additional 15 minutes, and then diethyl ether (10 mL) was added. It 
was poured into a 100 mL separatory flask and extracted with portions of diethyl ether (45 
mL). The organic layers were combined, dried over sodium sulfate, and then evaporated 
under reduce pressure to obtain a crude product. The crude produce was purified on a silica 
gel column using hexane as eluent to obtain azidobenzene (2.2 g, 18 mmol) of a colorless 
liquid in 60 % yield. IR (neat, cm-1): 2125 (s, N3), 2094 (s, N3), 1594, 1492, 1294. 1H NMR 
(500 MHz, CDCl3, δ): 7.36-7.39 (m, Ar-H, 2H), 7.05-7.18 (m, Ar-H, 3H). 13C NMR (500 
MHz, CDCl3, δ (ppm)): 140.00, 129.78, 124.89, 119.04. 
3.45. Preparation of 8h 
 
2-Nitro-7-ethynyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 7e (1.50 g, 3 mmol) was 
weighed and dissolved in dioxane (15 mL) in a 50 mL flask. To this solution, triethylamine 
(1 mL), CuI (0.10 g, 0.5 mmol), and azidobenzene (0.50 g, 4.2 mmol) were added. The 
resulting solution was stirred under nitrogen atmosphere for 24 h. At the end of this period, 
the solution was poured into water (40 mL) to which methylene chloride (50 mL) was added. 
The aqueous phase was extracted 3 times with methylene chloride (40 mL), and then the 
organic phases were combined, washed with water, and dried over sodium sulfate. The 
filtrate was removed under reduced pressure to obtain a crude product. It was purified on a 
silica gel column using hexane and ethyl acetate (3:7) as the eluent to obtain 8h (1.30 g, 2.4 
mmol) as a light yellow solid with mp of 122 – 123 0C in 80 % yield. 1H NMR (500 MHz, 
CDCl3, δ): 8.38 (s, Ar-H, 1H), 8.30-8.38 (dd, Ar-H, 2H), 8.01-8.05 (s, Ar-H, 2H), 7.79-7.85 
(m, Ar-H, 4H), 7.51-7.61 (m, Ar-H, 2H), 7.50-7.55 (m, Ar-H, 1H), 3.34-3.39 (m, OCH2, 4H), 
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3.25-3.28 (m, 4H), 3.15-3.18 (m, 4H), 2.82-2.90 (m, CH2CH2O, 2H), 2.78-2.81 (m, 
CH2CH2O, 2H), 2.51-2.57 (m, CH3CH2O, 4H), 1.07-1.10 (m, CH3, 6H). 13C NMR (500 
MHz, CDCl3, δ (ppm)): 151.56, 150.89, 148.03 (sp2 C-N), 147.22, 146.34, 138.36, 137.22, 
131.40, 129.91, 129.90, 128.99, 125.63, 123.65, 121.88, 120.90, 120.56, 119.98, 118.99, 
118.19, 70.13, 69.59, 66.88, 66.57, 52.19 (C9), 39.39 (CH2CH2O), 15.02 (CH3). HRMS calcd 
for C33H38O6N4, 586.6864; found 586.2785. 
3.46. Preparation of 9e 
 
Compound 8h (1.00 g, 1.7 mmol) was weighed and dissolved in a mixture of ethanol 
(20 mL) and THF (20 mL) in a 100 mL flask, and then 10 % palladium on carbon (0.10 g) 
was added. The solution was degassed with nitrogen for 10 minutes, and then it was heated to 
60 0C under nitrogen atmosphere. To this solution, hydrazine monohydrate (0.50 g, 10 mmol) 
was added dropwise in 15 minutes. The resulting solution was refluxed at 70 0C under 
nitrogen atmosphere for 24 h. At the end of this period, the solution was allowed to cool to 
room temperature, and then it was filtered and washed with ethyl acetate (100 mL). The 
filtrate was removed under reduced pressure to obtain a crude product which was further 
purified on a silica gel column using ethyl acetate as the eluent to obtain 9e (0.85 g, 1.5 
mmol) as a yellow solid with mp of 156 - 157 0C in 90 % yield. 1H NMR (500MHz, CDCl3, 
δ): 8.12 (s, Ar-H, 1H), 7.82-7.86 (m, Ar-H, 4H), 7.60-7.75 (m, Ar-H, 5H), 6.45-6.50 (s, Ar-
H, 1H), 6.40-6.42 (m, Ar-H, 1H), 3.80 (s, 2H), 3.30-3.42 (m, OCH2, 8H), 3.21-3.25 (m, 4H), 
2.70-2.80 (m, CH2CH2O, 4H), 2.30-2.40 (m, CH3CH2O, 4H), 1.02-1.08 (m, CH3, 6H). 13C 
NMR (500 MHz, CDCl3, δ (ppm)): 151.04, 148.87, 148.64, 141.25, 137.14, 132.0, 129.84, 
128.75, 127.68, 125.11, 120.94, 120.92, 120.52, 120.28, 119.03, 117.43, 114.56, 110.30, 
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70.09, 69.68, 67.04, 66.56, 50.94 (C9), 39.99 (CH2CH2O), 15.08 (CH3). HRMS calcd for 
C33H40N4O4, 556.7034; found 556.3043. 
3.47. Preparation of 10 
 
Compound 9e (0.50 g, 0.9 mmol) was weighed and dissolved in 1,2-dichlorobenzene 
(10 mL) in a 50 mL flask. To this solution, potassium carbonate (0.70 g, 5 mmol), Cu powder 
(0.30 g, 5 mmol), 18-crown-6 (0.1 g), and iodobenzene (0.60 g, 2.9 mmol) were added and 
heated to reflux at 180 0C under nitrogen atmosphere for 24 h. At the end of this period, the 
solution was allowed to cool to room temperature, and then it was filtered using a short silica 
gel plug. The filtrate was removed under reduced pressure to obtain a crude product which 
was further purified on a silica gel column using hexane and ethyl acetate (2:8) as the eluent 
to obtain 10 (0.40 g, 0.56 mmol) as a yellow solid with mp of 40 – 41 0C (60 % yield). 1H 
NMR (500 MHz, CDCl3, δ): 7.62-7.64 (d, Ar-H, 1H), 7.38-7.58 (m, Ar-H, 8H), 7.42-7.45 
(m, Ar-H, 5H), 7.03-7.12 (m, aromatic, 8H), 3.38-3.45 (m, OCH2, 8H), 3.24-3.25 (m, 4H), 
2.75-2.81 (m, CH2CH2O, 4H), 2.02-2.18 (m, CH3CH2O, 4H), 1.05-1.10 (m, CH3, 6H). 13C 
NMR (500 MHz, CDCl3, δ (ppm)): 150.58, 149.25, 147.82, 147.75, 145.17, 140.01, 136.02, 
134.95, 130.17, 129.51, 129.27, 129.18, 128.98, 127.69, 126.69, 125.18, 124.18, 123.40, 
122.84, 121.78, 120.61, 119.38, 118.81, 70.05, 69.72, 67.19, 66.58, 50.98 (C9), 39.22 
(CH2CH2O), 15.13 (CH3). HRMS calcd for C45H48N4O4, 708.8989; found 708.3669.  
3.48. Preparation of 3d 
 
2-Iodofluorene (10.20 g, 35 mmols) was weighed and dissolved in propylene 
carbonate (120 mL) at 40 0C in a 250 mL flask. To this solution, N-bromosuccinimide (7.60 
g, 42 mmol) was added in portions in 15 minutes. The solution was heated to 65 0C and 
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maintained at this temperature for 4 h. At the end of this period, the resulting solution was 
then heated to 80 0C for 30 minutes and allowed to cool to room temperature. The resulting 
mixture was poured into water (200 mL) to which methylene chloride (50 mL) was added. 
The organic phase was removed. The aqueous phase was extracted 3 times with methylene 
chloride (50 mL), and then organic phases were combined, wash with water, and dried over 
sodium sulfate. The filtrate was removed under reduced pressure to obtain a crude product. It 
was recrystallyzed from ethyl acetate to obtain 2-iodo-7-bromofluorene (10.50 g, 28 mmol) 
as a white crystal with mp of 182 - 184 0C (80 % yield). 1H NMR (CDCl3, 500 MHz, δ): 7.79 
(s, Ar-H, 1H), 7.58-7.62 (m, Ar-H, 2H), 7.48-7.50 (m, Ar-H, 1H), 7.20-7.25 (m, Ar-H, 2H), 
3.75-3.77 (m, CH2, 2H). 13C NMR (CDCl3, 500 MHz, δ (ppm)): 145.02, 144.61, 140.30, 
139.76, 136.00, 134.22, 130.14, 128.25, 121.54, 121.26, 121.21, 92.30 (C-I), 36.43 (CH2). 
3.49. Preparation of 4e 
 
2-iodo-7-bromofluorene (2.30 g, 6 mmol) was utilized and hexane and ethyl acetate 
(7:3) was used as the eluent to obtain 2-iodo-7-bromo-9,9-di-2-(2-ethoxy 
ethoxy)ethylfluorene 4e (2.20 g, 3.6 mmol) as a white solid with mp of 81 - 82 0C in 60 % 
yield. 1H NMR (500 MHz, CDCl3, δ): 7.66 (s, Ar-H, 1H), 7.61 (d, Ar-H, 1H), 7.41-7.50 (dd, 
Ar-H, 3H), 7.40 (d, Ar-H, 1H), 3.38-3.40 (m, OCH2,48H), 3.28-3.30 (m, 4H), 3.15-3.18 (m, 
4H), 2.65-2.70 (m, CH2CH2O, 4H), 2.25-2.30 (m, CH3CH2O, 4H), 1.05-1.10 (m, CH3, 6H). 
13C NMR (500 MHz, CDCl3, δ (ppm)): 151.02, 150.68, 139.05, 138.50, 136.53, 132.58, 
130.64, 126.67, 121.82, 121.67, 121.25, 93.08, 70.12, 69.66, 66.77, 66.63, 51.77 (C9), 39.45 
(CH2CH2O), 15.10 (CH3). HRMS calcd for C25H32O4IBr, 603.3354; found 602.0484. 
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3.50. Preparation of 6h 
 
Compound 4e (0.60 g, 1 mmol) was weighed and dissolved in THF (10 mL) and 
triethylamine (10 mL) in a 100 mL flask. The solution was degassed with nitrogen for 10 
minutes, and then PdCl2P(Ph3)2 (0.05 g, 0.07 mmol), CuI (0.03 g, 0.16 mmol), and 
compound 5a (0.30 g, 1.2 mmol) were added. The resulting solution was stirred under 
nitrogen atmosphere for 24 h. At the end of this period, it was poured into water (50 mL) to 
which methylene chloride (40 mL) was added. The organic phase was removed. The aqueous 
phase was extracted 3 times with methylene chloride (40 mL), and then organic phases were 
combined, washed with water, and dried over sodium sulfate. The filtrate was removed under 
reduced pressure to obtain a crude product which was further purified on a silica gel column 
using hexane and ethyl acetate (1:1) as the eluent to obtain 6h (0.40 g, 0.56 mmol) as a 
yellow solid with mp of 132 – 133 0C in 60 % yield. 1H NMR (500 MHz, CDCl3, δ): 8.10-
8.15 (m, Ar-H, 3H), 7.90-7.92 (d, Ar-H, 1H), 7.65-7.70 (m, Ar-H, 3H), 7.50-7.22 (m, Ar-H, 
6H), 7.45-7.47 (m, Ar-H, 1H), 3.40-3.42 (m, OCH2, 4H), 3.35-3.38 (m, 4H), 3.18-3.21 (m, 
4H), 2.78-2.81 (m, CH2CH2O, 4H), 2.38-2.42 (m, CH3CH2O, 4H), 1.14-1.18 (m, CH3, 
6H).13C NMR (500 MHz, CDCl3, δ (ppm)): 167.62 (C=N), 154.21 (sp2-C-N), 151.98, 
148.67, 139.95, 139.23, 135.15, 133.05, 132.11, 132.00, 131.85, 131.60, 131.41, 131.21, 
127.82, 127.52, 126.54, 126.05, 125.93, 125.84, 125.37, 123.50, 122.00, 121.05, 120.01, 
92.35, 89.79. 70.02, 69.81, 67.05, 66.73,49.94 (C9), 39.87 (CH2CH2O), 15.08 (CH3). HRMS 
calcd for C40H40O4NSBr, 710.7263; found 710.1888. 
3.51. Preparation of 4-Iodo-N,N-Dimethylbenzenamine 
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N,N-dimethylbenzenamine (14.70 g, 120 mmol) was weighed and dissolved in a 
solution of sodium carbonate (15 g, 140 mmol) in water (100 mL) at 10 0C in a 250 mL flask. 
To this solution, iodine (25.40 g, 100 mmol) was added in portions in 30 minutes, and then it 
was stirred for an additional of 30 minutes. At the end of this period, the resulting solution 
was poured into water (100 mL) to which methylene chloride (50 mL) was added. The 
organic phase was removed. The aqueous phase was extracted 3 times with methylene 
chloride (50 mL), and then the organic phases were combined, washed with water (100 mL), 
and dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a 
crude product which was further purified on a silica gel column using hexane and ethyl 
acetate (7:3) as the eluent to obtain 4-iodo-N,N-dimethylbenzenamine (17 g, 69 mmol) as a  
solid with mp of 75 – 77 0C in 70 % yield. 1H NMR (500 MHz, CDCl3, δ): 7.38-7.40 (m, Ar-
H, 2H), 6.41-6.44 (m, Ar-H, 2H), 2.85-2.88 (m, NCH3, 6H). 13C NMR (500 MHz, CDCl3, δ 
(ppm)): 150.00, 137.55, 114.71, 77.44 (C-I), 40.39 (NCH3). 
3.52. Preparation of 4-(2-Trimethylsilylethynyl)-N,N-Dimethylbenzenamine 
 
4-Iodo-N,N-dimethylbenzenamine (7.24 g, 30 mmol) was weighed and dissolved into 
triethylamine (60 mL) in a 250 mL flask. The solution was degassed with nitrogen for 10 
minutes, and then PdCl2P(Ph3)2 (0.60 g, 0.85 mmol) and copper(I) iodide (0.45 g, 2.4 mmol) 
were added. To this solution, trimethylsilylacetylene (4.30 g, 44 mmol) was added and the 
solution was stirred overnight. At the end of this period, the resulting solution was poured 
into water (100 mL) to which methylene chloride (50 mL) was added. The organic phase was 
removed, and then the aqueous phase was extracted 3 times with methylene chloride (40 
mL). The organic phases were combined, washed with water, and dried over sodium sulfate. 
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The filtrate was removed under reduced pressure to obtain a crude product which was 
purified in a silica gel column using hexane and ethyl acetate (8:2) as the eluent to obtain 4-
(2-trimethylsilylethynyl)-N,N-dimethylbenzenamine (4.0 g, 19 mmol) as light yellow solid  
with mp of 88 – 89 0C in 70 % yield. 1H NMR (500 MHz, CDCl3, δ): 7.08-7.12 (m, Ar-H, 
2H), 6.35-6.37 (m, Ar-H, 2H), 2.73-2.75 (m, NCH3, 6H), 0.00-0.16 (m, Si(CH3)3, 9H). 13C 
NMR (500 MHz, CDCl3, δ (ppm)): 149.95, 132.90, 111.33, 109.61, 106.32, 90.94, 39.95 
(NCH3), 0.60 (Si(CH3)3). 
3.53. Preparation of 4-Ethynyl-N,N-Dimethylbenzenamine 7f 
 
4-(2-Trimethylsilylethynyl)-N,N-dimethylbenzenamine (2.0 g, 10 mmol) was 
weighed and dissolved in THF (10 mL) in a 100 mL flask, and then of a solution of 
potassium hydroxide (1.0 g, 18 mmol) in methanol (10 mL) was added. The resulting 
solution was stirred for 30 minutes, and then it was poured into water (50 mL) to which 
methylene chloride (50 mL) was added. The organic phase was removed. The aqueous phase 
was extracted 3 times with methylene chloride (40 mL), and then organic phases were 
combined, washed with water (50 mL), and dried over sodium sulfate. The filtrate was 
removed under reduced pressure to obtain a crude product which was further purified in a 
silica gel column using hexane and ethyl acetate (7:3) as the eluent to obtain 4-ethynyl-N,N-
dimethylbenzenamine 7f (1.10 g, 7.6 mmol) as a light yellow powder with mp of 51 - 52 0C 
in 80 % yield. 1H NMR (500 MHz, CDCl3, δ): 7.22-7.23 (m, Ar-H, 2H), 6.46-6.49 (m, Ar-H, 
2H), 2.83-2.84 (m, NCH3, sp-CH, 7H). 13C NMR (500 MHz, CDCl3, δ (ppm)):150.38, 
133.21, 111.68, 108.73, 84.87 (sp-C), 74.80 (sp-C), 40.18 (NCH3). 
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3.54. Preparation of 8i 
 
Compound 6h (0.71 g, 1 mmol) was weighed and dissolved in THF (10 mL) and 
triethylamine (10 mL) in a 100 mL flask. The solution was degassed with nitrogen for 10 
minutes, and then PdCl2P(Ph3)2 (0.05 g, 0.07 mmol), CuI (0.03 g, 0.16 mmol), and compound 
7f (0.22 g, 1.5 mmol) were added. The resulting solution was refluxed at 70 0C under 
nitrogen atmosphere for 48 h. At the end of this period, the solution was allowed to cool to 
room temperature, and poured into water (50 mL) to which methylene chloride (40 mL) was 
added. The organic phase was removed. The aqueous phase was extracted 3 times with 
methylene chloride (40 mL), and then organic phases were combined, washed with water, 
and dried over sodium sulfate. The filtrate was removed under reduced pressure to obtain a 
crude product which was purified on a silica gel column using hexane and ethyl acetate (1:1) 
as the eluent to obtain compound 8i (0.4 g, 0.5 mmol) as a yellow solid with mp of 139-140 
0C (52 % yield). 1H NMR (500 MHz, CDCl3, δ): 8.10-8.15 (m, Ar-H, 3H), 7.90-7.94 (d, Ar-
H, 1H), 7.65-7.75 (m, Ar-H, 4H), 7.50-7.58 (m Ar-H, 4H), 7.41-7.45 (m, Ar-H, 4H), 6.62-
6.65 (m, Ar-H, 2H), 3.42-3.45 (m, OCH2, 4H), 3.32-3.38 (m, 4H), 3.18-3.20 (m, 4H), 3.02 (s, 
NCH3, 6H), 2.78-2.80 (m, CH2CH2O, 4H), 2.41-2.43 (m, CH3CH2O, 4H), 1.14-1.16 (m, CH3, 
6H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 167.23 (C=N),154.15 (sp2 C-N), 150.01, 149.75, 
140.36, 138.27, 135.78, 133.09, 132.92, 132.63, 132.23, 132.13, 131.56, 127.89, 126.25, 
126.15, 126.05, 125.99, 121.88, 121.61, 120.01, 111.85, 110.01, 92.27, 92.00, 89.61, 88.05, 
70.10, 69.65, 66.87, 66.60, 51.26 (C9), 40.50 (C-N), 39.69 (CH2CH2O), 15.03 (CH3). HRMS 
calcd for C50H50O4N2S, 775.016; found 774.3485. 
3.55. Preparation of 4f 
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2,7-diiodofluorene 2a and compound 3c were utilized, and methylene chloride and 
methanol (95:5) was used as the eluent to obtain an oily liquid in 30 % yield. 1H NMR (500 
MHz, CDCl3, δ): 7.70 (s, Ar-H, 2H), 7.62-7.65 (d, Ar-H, 2H), 7.38-7.40 (d, Ar-H, 2H), 3.51-
3.65 (m, OCH2, 60H), 3.35-3.38 (s, OCH3, 6H), 3.15-3.18 (m, 4H), 2.68-2.70 (m, CH2CH2O, 
4H), 2.35-2.38 (m, 4H), 2.25-2.30 (m, CH2CH2O, 4H). 13C NMR (500 MHz, CDCl3, δ 
(ppm)): 150.76, 139.11, 136.50, 132.45, 121.60, 93.23, 71.91, 70.63, 70.59, 70.55, 70.51, 
70.40, 70.02, 69.80, 66.72, 59.05 (OCH3), 51.23 (C9), 39.43 (CH2CH2O). 
3.56. Preparation of 5e 
 
Compound 4f (0.65 g, 1 mmol) was weighed and dissolved in THF (10 mL) and of 
triethylamine (10 mL) in a 100 mL flask. The solution was degassed with nitrogen for 10 
minutes, and then 0.1 g of PdCl2P(Ph3)2 (0.1 g, 0.14 mmol), CuI (0.06 g, 0.3 mmol), and 
compound 7f (0.35 g, 2.4 mmol) were added. The resulting solution was stirred under 
nitrogen atmosphere for 24 h. At the end of this period, it was poured into water (50 mL) to 
which methylene chloride (40 mL) was added. The organic phase was removed. The aqueous 
phase was extracted 3 times with methylene chloride (40 mL), and then organic phases were 
combined, washed with water, and dried over sodium sulfate. The filtrate was removed under 
reduced pressure to obtain a crude product. It was purified on a silica gel column using 
methylene chloride and methanol (95:5) as the eluent to obtain compound 5e (0.90 g, 0.7 
mmol) as an oily liquid in 72 % yield. 1H NMR (500 MHz, CDCl3, δ): 7.60-7.62 (d, Ar-H, 
2H), 7.55-7.58 (s, Ar-H, 2H), 7.42-7.52 (m, Ar-H, 6H), 6.65-6.70 (d, Ar-H, 4H), 3.51-3.65 
(m, OCH2, 60H), 3.38-3.41 (m, OCH3, 10H), 3.19-3.21 (m, 4H), 3.01 (s, 12H), 2.75-2.85 (m, 
CH2CH2O, 4H), 2.40-2.42 (m, 4H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 150.09, 149.12, 
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139.31, 132.75, 131.23, 126.11, 123.04, 120.0, 111.84, 109.88, 91.46, 88.08, 71.91, 70.55, 
70.51, 70.49, 70.37, 70.0, 66.84, 59.06 (OCH3), 51.12 (C9), 40.24 (C-N), 39.80 (CH2CH2O). 
HRMS calcd for C75H112O20N2, 1361.7112; found 1361.7881. 
3.57. Preparation of 5f 
 
2,7-Diiodo-9,9-diethyl-2-(2-ethoxy ethoxy)fluorene 4a (0.65 g, 1 mmol) was weighed 
and dissolved in 1,2-dichlorobenzene (10 mL) in a 50 mL flask. To this solution, potassium 
carbonate (0.70 g, 5 mmol), 0.3 g of Cu powder (0.3 g, 5 mmol), 18-crown-6 (0.1 g), and 
diphenylamine (0.51 g, 3 mmol) were added and heated to reflux at 180 0C under nitrogen 
atmosphere for 24 h. At the end of this period, the resulting mixture was allowed to cool to 
room temperature, and then it was poured into a short silica gel plug and washed with ethyl 
acetate. The filtrate was removed under reduced pressure to obtain a crude product. It was 
purified on a silica gel column using hexane and ethyl acetate (8:2) as the eluent to obtain 
compound 5f (0.45 g, 0.6 mmol) in as a white powder with mp of 50 -52 0C (62 % yield). 1H 
NMR (500 MHz, CDCl3, δ): 7.45-7.48 (d, Ar-H, 3H), 7.20-7.25 (m, Ar-H, 5H), 7.00-7.17 
(m, Ar-H, 18H), 3.42-3.47 (m, OCH2, 8H), 3.25-3.28 (m, 4H), 2.85-2.92 (m, CH2CH2O, 4H), 
2.15-2.18 (m, CH3CH2O, 4H), 1.10-1.15 (m, CH3, 6H). 13C NMR (500 MHz, CDCl3, δ 
(ppm)): 150.22, 147.91, 146.80, 135.14, 129.42, 129.03, 124.18, 123.78, 123.52, 122.82, 
122.48, 120.07, 70.04, 69.75, 67.41, 66.64, 50.94 (C9), 39.09 (CH2CH2O), 15.06 (CH3) . 
HRMS calcd for C49H52O4N2, 732.9608; found 732.3960. 
3.58. Preparation of 5g 
 
Compound 4a (0.65 g, 1 mmol) was weighed and dissolved in THF (10 mL) and 
triethylamine (10 mL) in a 100 mL flask. The solution was degassed with nitrogen for 10 
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minutes, and then PdCl2P(Ph3)2 (0.1 g, 0.14 mmol), CuI (0.06 g, 0.3 mmol), and 
trimethylsilylacetylene (0.30 g, 3 mmol) were added. The resulting solution was stirred under 
nitrogen atmosphere for 24 h. At the end of this period, the solution was poured into water 
(50 mL) to which methylene chloride (40 mL) was added. The organic phase was removed. 
The aqueous phase was extracted 3 times with 40 mL of methylene chloride, and then 
organic phases were combined, washed with water, and dried over sodium sulfate. The 
filtrate was removed under reduced pressure to obtain a crude product which was purified on 
a silica gel column using hexane and ethyl acetate (8:2) as the eluent to obtain compound 5g 
(0.48 g, 0.7 mmol) as a dark yellow solid with mp of 61 -63 0C in 75 % yield. 1H NMR (500 
MHz, CDCl3, δ): 7.38-7.40 (d, Ar-H, 2H), 7.33 (s, Ar-H, 2H), 7.32-7.35 (d, Ar-H, 2H), 3.21-
3.25 (m, OCH2, 4H), 3.13-3.15 (m, 4H), 2.97-2.98 (m, 4H), 2.50-2.53 (m, CH2CH2O), 4H), 
2.18-2.21 (m, CH3CH2O, 4H), 0.95-0.97 (m, CH3, 6H), 0.10 (s, Si(CH3)3, 18H). 13C NMR 
(500 MHz, CDCl3, δ (ppm)): 149.81, 140.64, 122.82, 106.17, 95.53, 88.55 (sp-C), 86.56 (sp-
C), 70.70, 70.24, 67.39, 67.20, 51.82 (C9), 40.20 (CH2CH2O), 15.75 (CH3), 0.63 (Si(CH3)3). 
3.59. Preparation of 6i 
 
Compound 5g (0.47 g, 0.8 mmol) was weighed and dissolved in THF (10 mL) in a 
100 mL flask, and then followed by a solution of 5 % potassium hydroxide in methanol (10 
mL). The resulting solution was stirred for 30 minutes, and then it was poured into water (50 
mL) to which methylene chloride (50 mL) was added. The organic phase was removed. The 
aqueous phase was extracted 3 times with methylene chloride (40 mL), and then organic 
phases were combined, washed with water (50 mL), and dried over sodium sulfate. The 
filtrate was removed under reduced pressure to obtain a crude product which was further 
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purified on a silica gel column using hexane and ethyl acetate (7:3) as the eluent to obtain 
2,7-diethynyl-9,9-di-2-(2-ethoxy ethoxy)ethylfluorene 6i (0.34 g, 0.75 mmol) as a white solid 
with mp of 85 – 86 0C (95 % yield). 1H NMR (500 MHz, CDCl3, δ): 7.42-7.45 (d, Ar-H, 2H), 
7.35-7.39 (s, Ar-H, 2H), 7.30-7.32 (d, Ar-H, 2H), 3.41-3.43 (m, OCH2, 4H), 3.32-3.35 (m, 
4H), 3.17-3.20 (m, 4H), 2.70-2.75 (m, CH2CH2O, 4H), 2.35-2.40 (m, CH3CH2O, 4H), 1.10-
1.15 (m, CH3, 6H).  13C NMR (500 MHz, CDCl3, δ (ppm)):149.36, 140.24, 132.1, 127.0, 
121.27, 120.01, 84.21 (sp-C), 77.80 (sp-C), 70.09, 69.63, 66.79, 66.60, 51.32 (C9), 39.48 
(CH2CH2O), 15.10 (CH3). HRMS calcd for C29H34O4, 446.5852; found 446.2451. 
3.60. Preparation of 7g 
 
Compound 6i (0,36 g, 0.8 mmol) was weighed and dissolved THF (10 mL) and 
triethylamine (10 mL) in a 50 mL flask. The resulting solution was degassed with nitrogen 
for 10 minutes, and then PdCl2P(Ph3)2 (0.10 g, 0.14 mmol), CuI (0.06 g, 0.3 mmol), and 4-
iodophenol (0.55 g, 2.5 mmol) were added. The solution was stirred under nitrogen 
atmosphere for 24 h. At the end of this period, the resulting solution was poured into water 
(50 mL) to which methylene chloride (40 mL) was added. The organic phase was removed. 
The aqueous was extracted 3 times with methylene chloride (40 mL), and then organic 
phases were combined, washed with water, and dried over sodium sulfate. The filtrate was 
removed under reduced pressure to obtain a crude product which was purified on a silica gel 
column using methylene chloride and methanol (95:5) as the eluent to obtain compound 7g 
(0.30 g, 0.5 mmol) as a light yellow solid with mp of 52 – 53 0C (58 % yield). IR (neat, cm-
1): 3273 (OH), 2973, 2866, 1604, 1512, 1462, 1272, 1221, 1096, 823. 1H NMR(500 MHz, 
CDCl3, δ): 7.62-7.70 (m, Ar-H, 3H), 7.50-7.58 (m, Ar-H, 7H), 6.81-6.83 (m, Ar-H, 4H), 
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6.15-6.18 (s, OH, 2H), 3.36-3.46 (m, OCH2, 8H), 3.20-3.22 (m, 4H), 2.75-2.77 (m, 
CH2CH2O, 4H), 2.30-2.37 (m, CH3CH2O, 4H), 1.05-1.10 (m, CH3, 6H). 13C NMR (500 
MHz, CDCl3, δ (ppm)): 156.32, 149.16, 139.60, 133.31, 132.0, 131.51, 128.45, 126.10, 
122.73, 120.02, 115.70, 115.07, 90.35, 88.55, 70.08, 69.64, 66.91, 66.76, 51.14 (C9), 39.85 
(CH2CH2O), 15.01 (CH3). HRMS calcd for C41H42O6, 630.7792; found 630.2975. 
3.61. Preparation of Gold Nanoparticles 
 
Gold nanoparticles were prepared according to a procedure from the literature.93 The 
size of the gold nanoparticles was ca. 12 nm (Appendix D). 
3.62. Preparation of Nanoparticle Composite 11a 
 
  To a 150 mL solution of gold nanoparticles in a 250 mL flask, 50 mL of a solution of 
9c (2.5x10-4 M) in methylene chloride was added. The resulting solution was stirred for 1 h. 
The organic phase was separated and removed under reduced pressure to get a black waxy 
solid. It was washed with ethanol and dried in vacuo to obtain 11a. 1H NMR (500 MHz, 
CDCl3, δ): 8.00-8.02 (m, Ar-H, 4H), 7.82-7.84 (m, Ar-H, 1H), 7.56-7.58 (m, Ar-H, 2H), 
7.30-7.48 (m, Ar-H, 7H), 7.20-7.21 (m, Ar-H, 1H), 7.09-7.11 (m, Ar-H, 1H), 6.87-6.89 (m, 
Ar-H, 2H), 4.60-4.61 (s, 4H), 4.22-4.24 (m, 4H), 3.16-3.58 (m, OCH2, 12H), 2.70-2.74 (m, 
CCH2O, 4H), 2.58-2.62 (m, CH2CH2O, 4H), 2.15-2.33 (m,CH3CH2O, 4H), 1.76-1.80 (m, 
4H), 1.06-1.37 (m, CH2, CH3, 44H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 170.17 (C=N), 
154.12 (sp2 C-N), 149.10, 140.25, 134.47, 132.58, 130.79, 129.98, 127.98, 126.92, 125.86, 
125.27, 124.02, 121.95, 120.62, 118.01, 69.04 (OCH2), 68.69, 66.02, 65.56, 51.27 (C9), 
49.79 (C-N), 46.25 (C-N), 39.47 (CCH2O), 30.57, 29.31, 28.68, 28.43, 28.35, 28.18, 28.04, 
27.49, 25.47, 14.67 (CH3). 
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3.63. Preparation of Nanoparticle Composite 11b 
 
  Nanoparticle Composite 11b was prepared from 9d and gold nanoparticles to yield a 
black waxy solid. 1H NMR (500 MHz, CDCl3, δ): 8.07-8.12 (m, Ar-H, 4H), 7.92-7.96 (m, 
Ar-H, 4H), 7.67-7.68 (d, Ar-H, 1H), 7.38-7.49 (m, Ar-H, 5H), 7.24-7.26 (m, Ar-H, 2H), 
7.02-7.04 (m, Ar-H, 2H), 4.82-4.85 (s, C-N, 4H), 4.26-4.28 (m, C-N, 4H), 3.53-3.64 (m, 
OCH2, 64H), 3.30-3.37 (m, OCH3, OCH2, 8H), 3.24-3.27 (m, 8H), 2.95-2.97 (m, 4H), 2.77-
2.80 (m, CCH2O, 4H), 2.62-2.72 (m, 4H), 2.38-2.42 (m, CH2CH2O, 4H), 1.57-1.75 (m, CH2, 
14H), 1.28-1.36 (m, CH2, 24H). 13C NMR (500 MHz, CDCl3, δ (ppm)): 167.55 (C=N), 
153.80 (sp2 C-N), 148.23, 141.75, 134.10, 131.35, 127.07, 126.10, 125.52, 122.35, 120.25, 
69.85 (OCH2), 69.75, 69. 35, 69.10, 66.35, 62.01, 58.04, 50.35 (C9), 38.79 (CCH2O), 30.25, 
29.17, 28.98, 28.65, 28.47, 28.23, 28.18, 27.78, 25.89, 19.96. 
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CHAPTER FOUR: CONCLUSION 
4.1. Novel Hydrophilic Fluorene-based Derivatives for Bioimaging Applications 
 
In a summary, hydrophilic fluorene-based derivatives were synthesized and 
characterized by UV-vis absorption, fluorescence emission, anisotropy, fluorescence lifetime, 
and were found to possess high quantum yield, high photostability, and generally high 2PA 
cross sections. To increase the hydrophilicity of the new fluorene-based derivatives, ethylene 
oxide subtituents were utilized for the design of water soluble or hydrophilic probes. The sp-
hybridized carbon conjugated π-system exhibited higher photostability relative to its sp2-
hybridized carbon conjugated π-system analog, however, the λmax of its UV-vis absorption 
and fluorescence emission occurred at shorter wavelengths in comparison to the sp2-
hybridized analog. In addition, it was observed that the sp-hybridized carbon π-conjugated 
system resulted in a lower 2PA cross section in a quadrupolar molecule. Quite significantly, 
these novel hydrophilic fluorene-based derivatives were proven to be biocompatible for 
single-photon and two-photon fluorescence cellular bioimaging. In addition, the new probes 
were found to exhibit low cytotoxicity to the cells they were incubated with, and displayed 
selectivity for certain organelles upon incubation. 
4.2. Novel Hydrophilic Fluorene-based Derivatives for Selective Sensing of Metal Ions 
 
 Hydrophilic bis(1,2,3-triazolyl)fluorene-based derivatives exhibited selectivity in 
detecting zinc and mercury ions over other relevant metals, resulting in an approximately 
two-fold increase in fluorescence upon complexation. The complexes formed fast and 
reversibly with binding constants of 108 and 1014 for zinc and mercury, respectively.  The 
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derivatives that exhbited this selectivity are good candidates for further study in living cells 
and other biological enviroments. 
 Hydrophilic fluorene-based derivatives were also found to be suitable ligands for the 
preparation of fluorescent gold nanoparticles, materials that should lend themselves for future 
investigation for diagnostic (SERS) and treatment of cancer by photothermal therapy. 
4.3. Future Exploration for Novel Hydrophilic Fluorene-based Derivatives 
 
 From this study and the previous works of others,46,47,93 fluorene-based derivatives 
display a wide range of linear and nonlinear photophysical properties that are attractive for 
bioimaging applications. Further explorations are proposed in the areas listed below. 
4.3.1. Strong Donor and Acceptor Groups 
 
 Since the strength of the donor and acceptor groups, as well as the extension of the 
conjugated π-system, in fluorene-based derivatives contributed to the absorption in the UV-
vis region, to increase the absorption maximum to the near infrared region, an optimal 
window for many biological applications, a strong donor (X) such as an amino or an alkoxy 
and a strong acceptor (Y) like a cyano or a sulfonyl group can be incorporated.152-154 
4.3.2. Large Multiphoton Absorption Derivatives 
 
 Design and synthesis of new multiphoton absorbing molecules are emerging for  
nonlinear excitation fluorescence microscopy and for bioimaging applications.155-156 
Therefore, obtaining high two-photon absorptivity must be considered for the design of new 
2PA fluorescent probes. This may involve forming strong intermolecular interactions 
between donor and acceptor groups and between core π-electron systems,157,158 as well as 
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employing heteroaromatic conjugated π-systems such as thiophene or squaraine 
functionalities.159-161 
4.3.3. Fluorescence Sensing of Metal Ions In Vitro 
 
 Selected hydrophilic fluorene-based derivatives were shown to exhibit selective 
sensing of metal ions. These are promising for the detection of metal ions in vitro in living 
cells, particularly since fluorene-based derivatives generally have low toxicity to cells. To 
achieve this investigation, the first step is to incubate these hydrophilic fluorene-based 
derivatives into living cells to which various concentrations of relevant metal ions are added. 
One- or two-photon fluorescence imaging with these probes may provide a sensitive measure 
of the presence of metal ions in cellular systems. 
4.4.4. Fluorescent Gold Nanoparticles for Bioimaging 
 
 As described in previous chapters, gold nanoparticles can be explored for bioimaging, 
especially in living cells.17,18,98 It is interesting that hydrophilic fluorene-based capped gold 
nanoparticles can be detected by conventional fluorescence microscopy as well as by 
darkfield microscopy in which only scattered light from nanoparticles is detected.162 A 
cytotoxicity assay must be performed for further investigation of the fluorescent gold 
nanoparticles for bioimaging applications. 
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APPENDIX A: IR, NMR, AND HRMS SPECTRA 
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Figure 90. The 1H-NMR Spectrum of 2a 
 
 
Figure 91. The 13C-NMR Spectrum of 2a 
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Figure 92. The 1H-NMR Spectrum of 3a 
 
 
Figure 93. The 13C-NMR Spectrum of 3a 
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A 3. 3b 
 
 
 
 
 
Figure 94. The 1H-NMR Spectrum of 3b 
 
 
Figure 95. The 13C-NMR Spectrum of 3b 
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Figure 96. The 1H-NMR Spectrum of 4a 
 
 
Figure 97. The 13C-NMR Spectrum of 4a 
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Figure 98. The HRMS Spectrum of 4a 
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Figure 99. The 1H-NMR Spectrum of 4b 
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Figure 100. The 13C-NMR Spectrum of 4b 
 
 
 
Figure 101. The HRMS Spectrum of 4b 
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A 6. 2-(4-Iodophenyl)benzothiazole 
 
 
 
 
 
Figure 102. The 1H-NMR Spectrum of 2-(4-Iodophenyl)benzothiazole 
 
 
Figure 103. The 13C-NMR Spectrum of 2-(4-Iodophenyl)benzothiazole 
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A 7. 2-(4-(1-Trimethylsilyl)ethynylphenyl)benzothiazole 
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Figure 104. The 1H-NMR Spectrum of 2-(4-(1-Trimethylsilyl)ethynylphenyl)benzothiazole 
 
 
 
Figure 105. `The 13C-NMR Spectrum of 2-(4-(1-Trimethylsilyl)ethynylphenyl)benzothiazole  
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Figure 106. The 1H-NMR Spectrum of 5a 
 
Figure 107. The 13C-NMR Spectrum of 5a 
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Figure 108. The HRMS Spectrum of 5a 
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Figure 109. The 1H-NMR Spectrum of 6a 
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Figure 110. The 13C-NMR Spectrum of 6a 
 
 
 
Figure 111. The HRMS Spectrum of 6a 
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A 10. 2-(4-Ethenylphenyl)benzothiazole 
 
 
 
 
 
 
 
Figure 112. The 1H-NMR Spectrum of 2-(4-Ethenylphenyl)benzothiazole 
 
 
Figure 113. The 13C-NMR Spectrum of 2-(4-Ethenylphenyl)benzothiazole 
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Figure 114. The 1H-NMR Spectrum of 6b 
 
 
 
Figure 115. The 13C-NMR Spectrum of 6b 
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Figure 116. The HRMS Spectrum of 6b 
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Figure 117. The 1H-NMR Spectrum of 2b 
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Figure 118. The 13C-NMR Spectrum of 2b 
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Figure 119. The 1H-NMR Spectrum of 3c 
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Figure 120. The 13C-NMR Spectrum of 3c 
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Figure 121. The 1H-NMR Spectrum of 4c 
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Figure 122. The 13C-NMR Spectrum of 4c 
 
 
 
Figure 123. The HRMS Spectrum of 4c 
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Figure 124. The 1H-NMR Spectrum of 4d 
 
 
Figure 125. The 13C-NMR Spectrum of 4d 
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Figure 126. The HRMS of 4d 
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Figure 127. The 1H-NMR Spectrum of 5c 
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Figure 128. The 13C-NMR Spectrum of 5c 
 
 
Figure 129. The HRMS Spectrum of 5c 
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Figure 130. The 1H-NMR Spectrum of 5d 
 
Figure 131. The 13C-NMR Spectrum of 5d 
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Figure 132. The HRMS of 5d 
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Figure 133. The 1H-NMR Spectrum of 6c 
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Figure 134. The 13C-NMR Spectrum of 6c 
 
 
 
Figure 135. The HRMS Spectrum of 6c 
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Figure 136. The 1H-NMR Spectrum of 6d 
 
Figure 137. The 13C-NMR Spectrum of 6d 
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Figure 138. The HRMS of 6d 
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Figure 139. The IR Spectrum of 7a 
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Figure 140. The 1H-NMR Spectrum of 7a 
 
Figure 141. The 13C-NMR Spectrum of 7a 
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Figure 142. The HRMS Spectrum of 7a 
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Figure 143. The IR Spectrum of 7b 
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Figure 144. The 1H-NMR Spectrum of 7b 
 
Figure 145. The 13C-NMR Spectrum of 7b 
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Figure 146. The HRMS of 7b 
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Figure 147. The 1H-NMR Spectrum of 8a 
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Figure 148. The 13C-NMR Spectrum of 8a 
 
 
Figure 149. The HRMS Spectrum of 8a 
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Figure 150. The 1H-NMR Spectrum of 9a 
 
 
Figure 151. The 13C-NMR Spectrum of 9a 
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A 24. 8b 
 
 
 
 
 
 
 
Figure 152. The 1H-NMR Spectrum of 8b 
 
 
Figure 153. The 13C-NMR Spectrum of 8b 
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Figure 154. The HRMS Spectrum of 8b 
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Figure 155. The 1H-NMR Spectrum of 8c 
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Figure 156. The 13C-NMR Spectrum of 8c 
 
 
 
Figure 157. The HRMS Spectrum of 8c 
  163 
A 26. 8d 
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Figure 158. The 1H-NMR Spectrum of 8d 
 
 
Figure 159. The 13C-NMR Spectrum of 8d 
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Figure 160. The HRMS of 8d 
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Figure 161. The IR Spectrum of 1-Azidobutane 
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Figure 162. The 1H-NMR Spectrum of Azidobutane 
 
Figure 163. The 13C-NMR Spectrum of 1-Azidobutane 
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A 28. 1-Azido-11-Undecanol 
 
 
 
 
Figure 164. The 1H-NMR Spectrum of 1-Azido-11-Undecanol 
 
Figure 165. The 13C-NMR Spectrum of 1-Azido-11-Undecanol 
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A 29. 1-Azido-11-Undecanyl Tosylate 
 
 
 
 
 
Figure 166. The 1H-NMR Spectrum of 1-Azido-11-Undecanyl Tosylate 
 
Figure 167. The 13C-NMR Spectrum of 1-Azido-11-Undecanyl Tosylate 
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A 30. 1-Azido-11-Undecanthiol 
 
 
 
 
 
Figure 168. The IR Spectrum of 1-Azido-11-Undecanethiol 
 
  
Figure 169. The 1H-NMR Spectrum of 1-Azido-11-Undecanethiol 
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Figure 170. The 13C-NMR Spectrum of 1-Azido-11-Undecanethiol 
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Figure 171. The 1H-NMR Spectrum of 9b 
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Figure 172. The 13C-NMR Spectrum of 9b 
  
Figure 173. The HRMS Spectrum of 9b 
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Figure 174. The 1H-NMR Spectrum of 9c 
 
Figure 175. The 13C-NMR Spectrum of 9c 
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Figure 176. The HRMS Spectrum of 9c 
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Figure 177. The 1H-NMR Spectrum of 9d 
  173 
 
Figure 178. The 13C-NMR Spectrum of 9d 
 
 
 
Figure 179. The HRMS of 9d 
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Figure 180. The 1H-NMR Spectrum of 6e 
 
Figure 181. The 13C-NMR Spectrum of 6e 
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Figure 182. The HRMS Spectrum of 6e 
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Figure 183. The 1H-NMR Spectrum of 7c 
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Figure 184. The 13C-NMR Spectrum of 7c 
 
 
Figure 185. The HRMS Spectrum of 7c 
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Figure 186. The 1H-NMR Spectrum of 8e 
 
Figure 187. The 13C-NMR Spectrum of 8e 
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Figure 188. The HRMS Spectrum of 8e 
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Figure 189. The 1H-NMR Spectrum of 8f 
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Figure 190. The 13C-NMR Spectrum of 8f 
 
 
 
Figure 191. The HRMS Spectrum of 8f 
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Figure 192. The 1H-NMR Spectrum of 6f 
 
Figure 193. The 13C-NMR Spectrum of 6f 
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Figure 194. The HRMS Spectrum of 6f 
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Figure 195. The 1H-NMR Spectrum of 7d 
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Figure 196. The 13C-NMR Spectrum of Compound 7d 
 
 
 
Figure 197. The HRMS Spectrum of 7d 
  183 
A 40. 8g 
 
 
 
 
 
 
 
 
Figure 198. The 1H-NMR Spectrum of 8g 
 
Figure 199. The 13C-NMR Spectrum of 8g 
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Figure 200. The HRMS of Spectrum 8g 
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Figure 201. The 1H-NMR Spectrum of 6g 
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Figure 202. The 13C-NMR Spectrum of 6g 
 
 
 
Figure 203. The HRMS Spectrum of 6g 
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Figure 204. The 1H-NMR Spectrum of 7e 
 
Figure 205. The13C-NMR Spectrum of 7e 
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Figure 206. The HRMS Spectrum of 7e 
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Figure 207. The IR Spectrum of Azidobenzene 
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Figure 208. The 1H-NMR Spectrum of Azidobenzene 
 
 
 
Figure 209. The 13C-NMR Spectrum of Azidobenzene 
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Figure 210. The 1H-NMR Spectrum of 8h 
 
Figure 211. The 13C-NMR Spectrum of 8h 
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Figure 212. The HRMS of 8h 
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Figure 213. The 1H-NMR Spectrum of 9e 
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Figure 214. The 13C-NMR Spectrum of 9e 
 
 
Figure 215. The HRMS Spectrum of 9e 
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Figure 216. The 1H-NMR Spectrum of 10 
 
Figure 217. The 13C-NMR Spectrum of 10 
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Figure 218. The HRMS Spectrum of 10 
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Figure 219. The 1H-NMR Spectrum of 3d 
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Figure 220. The 13C-NMR Spectrum of 3d 
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Figure 221. The 1H-NMR Spectrum of 4e 
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Figure 222. The 13C-NMR Spectrum of 4e 
 
 
 
Figure 223. The HRMS Spectrum of 4e 
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Figure 224. The 1H-NMR Spectrum of 6h 
 
Figure 225. The 13C-NMR Spectrum of 6h 
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Figure 226. The HRMS Spectrum of 6h 
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Figure 227. The 1H-NMR Spectrum of 4-Iodo-N,N-Dimethylbenzeneamine 
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Figure 228. The 13C-NMR Spectrum of 4-Iodo-N,N-Dimethylbenzeneamine 
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Figure 229. The 1H-NMR Spectrum of 4-(2-Trimethylsilylethynyl)-N,N-
Dimethylbenzeneamine 
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Figure 230. The 13C-NMR Spectrum of 4-(2-Trimethylsilylethynyl)-N,N-
Dimethylbenzeneamine 
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Figure 231. The 1H-NMR Spectrum of 4-Ethynyl-N,N-Dimethylbenzeneamine 
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Figure 232. The 13C-NMR Spectrum of 4-Ethynyl-N,N-Dimethylbenzeneamine 
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Figure 233. The 1H-NMR Spectrum of 8i 
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Figure 234. The 13C-NMR Spectrum of 8i 
 
 
Figure 235. The HRMS Spectrum of 8i 
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Figure 236. The 1H-NMR Spectrum of 4f 
 
Figure 237. The 13C-NMR Spectrum of 4f 
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Figure 238. The 1H-NMR Spectrum of 5e 
 
Figure 239. The 13C-NMR Spectrum of 5e 
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Figure 240. The HRMS Spectrum of 5e 
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Figure 241. The 1H-NMR Spectrum of 5f 
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Figure 242. The 13C-NMR Spectrum of 5f 
 
 
 
Figure 243. The HRMS Spectrum of 5f 
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Figure 244. The 1H-NMR Spectrum of 5g 
 
 
Figure 245. The 13C-NMR Spectrum of 5g 
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Figure 246. The 1H-NMR Spectrum of 6i 
 
Figure 247. The 13C-NMR Spectrum of 6i 
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Figure 248. The HRMS Spectrum of 6i 
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Figure 249. The IR Spectrum of 7g 
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Figure 250. The 1H-NMR Spectrum of 7g 
 
Figure 251. The 13C-NMR Spectrum of 7g 
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Figure 252. The HRMS Spectrum of 7g 
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Figure 253. The 1H-NMR Spectrum of 11a 
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Figure 254. The 13C-NMR Spectrum of 11a 
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Figure 255. The 1H-NMR Spectrum of 11b 
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Figure 256. The 13C-NMR Spectrum of 11b 
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APPENDIX B: PROPOSED MECHANISMS OF METAL-CATALYZED 
REACTIONS 
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B1. The Sonogashira Reaction 
 
Scheme 13. Mechanism of the Sonogashira Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main steps of the Sonogashira reaction163: 
1. Oxidative addition: formation of organopalladium halides. 
2. Transmetalation: exchange ligand of organopalladium halides with organocopper 
acetylide. 
3. Reductive elimination: formation of the alkyne and regeneration of the catalyst. 
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B2. The Heck Reaction 
 
Scheme 14. Mechanism of the Heck Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main steps of the Heck reaction164: 
 
1. Oxidative addition: formation of organopalladium halides 
 
2. Insertion: addition of alkene into organopalladium complex 
 
3. Reductive elimination: formation of the alkene and regeneration of the catalyst 
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B3. The Click Reaction 
 
Scheme 15. Mechanism of the Click Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main steps of the click reaction: 
 
1. Oxidative addition: formation of organocopper acetylide. 
 
2. 1,3-Cycloaddition: addition of azide to organocopper complex. 
 
3. Redutive elimination: formation of 1,2,3-triazole and regeneration of the catalyst. 
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B4. The Stille Reaction 
 
Scheme 16. Mechanism of the Stille Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main steps of the Stille reaction165,166: 
 
1. Oxidative addition: formation of organopalladium complex. 
 
2. Transmetalation: exchange ligands between organopalladium complex and  
 
organostannane.  
 
3. Reductive elimination: formation of the alkene and regeneration of the catalyst. 
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APPENDIX C: DERIVATION OF THE EQUATION 15 
  219 
The equation (12) can be rewritten to the equation (17) as bellows. 
 
Equation 17 
                                                                          
][
][][
D
CMK n =                                               (17) 
At the initial state (t = 0), the fluorescence response is given by the equation (18) where k is 
the coefficient constant. 
Equation 18 
                                                                 F0 = kD[D]t                                                            (18) 
 
Likewise, at the interval t state, the fluorescence response is obtained from the equation (19) 
since kM = 0 for metals. 
Equation 19 
                                      F = kD[D] + kC[C] + kM[M] = kD[D] + kC[C]                                  (19) 
At the final state (t = ∞), the fluorescence response is obtained from the equation (20) as 
bellows. 
Equation 20 
                                                           Fm = kC[C]∞ = kC[D]t                                                                           (20) 
Where kD, kC, kM are the corresponding constant of dye, complex, and metal respectively; for 
metal ions, kM ≅ 0.  
Now, substitution the equation (13) into the equations (18) and (20) obtain the equations (21) 
and (22) as bellows. 
Equation 21 
  220 
                                                F0 = kD([D] + [C]) = kD[D] + kD[C]                                      (21) 
Equation 22 
                                               Fm = kC([D] + [C]) = kC[D] + kC[C]                                       (22) 
Then subtraction the equation (19) to the equation (21) obtained the equation (23). 
Equation 23 
                    F –F0 = kD[D] + kC[C] –(kD[D] + kD[C]) = kC[C] – kD[C] = (kC-kD)[C]          (23) 
Likewise, the equation (24) obtained from the equation (22) substracts the equation (19). 
Equation 24 
                    Fm-F = kC[D] + kC[C] – (kD[D] + kC[C]) = kC[D] - kD[D] = (kC-kD)[D]           (24) 
Finally, division of the equation (23) to the equation (24), and then substitution into equation 
(17) obtained the equation (15). 
                                          n
DC
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m
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Dkk
Ckk
FF
FF ][
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APPENDIX D: TEM IMAGES OF GOLD NANOPARTICLES 11a AND 11b 
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Figure 257. The TEM Image of Gold Nanoparticles 
 
 
 
Figure 258. The TEM Image of Composite11a 
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Figure 259. The TEM Image of Composite 11b 
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